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Abstract 
The analyses contained herein focus on making comparisons between model 
inferences obtained using different scales of pathogen identification, with a particular 
focus on respiratory syncytial virus (RSV).  A significant proportion of lower respiratory 
tract infections in children has been attributed to infection by RSV and as such, there 
has been global interest in understanding its transmission characteristics in order to 
plan for effective control. Mathematical models have often been used to explore 
potential mechanisms that drive the patterns observed in data collected at different 
scales. Several models have been used to explore how immunity to RSV is acquired 
and maintained, vaccination strategies and potential drivers of seasonality. However, 
most of these models do not make a distinction between the two antigenically and 
genetically distinct RSV groups (RSV A and RSV B), neither do they consider its 
ecological environment, in particular, potential interactions between RSV and other 
viral pathogens. This thesis therefore presents work done aimed at understanding the 
transmission characteristics of viral respiratory pathogens spreading in a group of 
households using a dynamic model of transmission 
 
The data analysed is cohort data collected between December 2009 and June 2010 
from 493 individual distributed across 47 households from a rural coastal community 
in Kenya. Individuals in the study had nasopharyngeal swabsamples collected twice 
weekly irrespective of symptom status. Infecting viral pathogens were identified using 
RT-PCR resulting in the identification of 4 main pathogens: RSV, human coronavirus, 
rhinovirus and adenovirus. RSV and coronavirus were further classified according to 
genetically distinct subgroups. Some of the RSV samples were sequenced to obtain 
whole genome sequences (WGS) and further classified into genetic clades/clusters.  
 
I first conducted a review of methods to identify the best way to integrate social-
temporal data and WGS genetic data into a single modelling framework for RSV. Given 
that the social-temporal data and genetic data were available at different sampling 
densities, I decided to use a model that focused on the data with the highest density. 
The results in this thesis are thus presented in three main chapters; the first focuses on 
analysing social-temporal shedding patterns of RSV identified at the group level (i.e. 
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distinguish between RSV A and RSV B); the second incorporates the available genetic 
data into the model used to analyse the social-temporal data (i.e. separating RSV-A 
into 5 clusters, and RSV-B into 7 clusters); the third is an analysis of the interaction of 
two pathogens, RSV and coronavirus, identified at two different scales.  
 
One of the main findings in this thesis is that the household setting plays an important 
role in the spread of RSV, a finding that is made clearer with added detail on pathogen 
type. In the case of the data analysed here, and the social structuring from which it 
was collected, RSV clades appeared to mimic household structure as such 
identification at this level did not drastically change the transmission characteristic 
observed with identification at the group level. However, the combination of 
epidemiological and genetic data elucidated transmission chains within the household 
enabling the identification of the sources of infant RSV infections. For this particular 
study, it was inferred that the sources of infant RSV infections were both in the same 
household as the infant and from external sources. Where infant infections occurred in 
the household, the source of infection was often a child between the ages of 2-13 
years. It was inferred that previous infection with one RSV group type reduced 
susceptibility to re-infection by heterologous group type within the same epidemic. 
Interactions were also observed between RSV and human coronavirus groups. In 
particular, previous infection with RSV B was estimated to increase susceptibility to 
corona OC43 by 81% (95% CrI: 40%, 134%). Detailed data of infection events in 
individual hosts can provide a wealth of knowledge. The inferences made from this 
study should be explored at larger spatial and temporal scales to determine the 
population level impact, and hence public-health significance, of pathogen 
interactions, whether these interactions are between strains of the same pathogen of 
between different pathogens. In planning for, and assessing the impact of, an 
intervention against a particular pathogen, investigators should not ignore the pre-
existing ecological balance and should make efforts to understand how this will be 
disrupted by an intervention against one or more pathogens.  
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1. Introduction 
1.1. RSV disease burden and epidemiology 
The continued identification of respiratory syncytial virus (RSV) as a major cause of 
acute lower respiratory infection (ALRI) is of global concern. In 2005, an estimated 33.8 
million ALRIs in children less than 5 years of age were due to RSV, resulting in 3.4 
million hospitalizations1. Ten years on, and the estimated ALRI burden due to RSV had 
not changed; 33.1 million cases were estimated to arise from an RSV infection 
resulting in 118,200 (94,600-149,400) deaths. Over 90% of the estimated RSV burden 
was carried by developing countries. 2. A recent study across sites in 7 low-income and 
low-middle-income countries looking into the aetiology of severe and very severe 
pneumonia found that RSV has the largest attributable fraction of any single pathogen, 
including bacterial pathogens3. Infants below 6 months of age experience the most 
severe disease4. Increasingly, RSV is also being identified as a disease causing pathogen 
in the elderly, with the fraction of disease due to RSV being comparable to that due to 
non-pandemic influenza5. Though studies vary in their definition of lower respiratory 
illness, this does not alter the fact that RSV has a key role to play.  
 
Individuals are repeatedly infected with RSV throughout their lives, however the risk of 
disease decreases with age, possibly the result of a combination of physiology 
(increase in airway size) and immunology (immunological maturity and past 
exposure)6,7. Immunity to RSV infection is evidently partial and transient6,8,9. Primary 
infection occurs early in life, and most children will have experienced at least one RSV 
infection by the age of two years10–13. Children are usually born with maternally 
acquired RSV specific antibodies. Though these wane quickly, high levels have been 
associated with reduced risk of severe disease in the first 3-6 months of life10,14 . 
However, the protective antibody threshold remains unclear15 and given that infection 
still occurs in the 3-6 month age group, the protective effect of maternally acquired 
antibodies is likely partial and the exact mechanisms of action are yet to be 
understood14. Age is not only a factor determining the severity of RSV-related disease, 
it has also been associated with duration of shedding (younger children have longer 
durations)16, and household/ family studies have found that for an infant, having an 
older sibling of school-going age increases the risk of infection 17–20 
 18 
 
Respiratory syncytial virus is highly transmissible, evident by its rapid spread in close 
contact settings21–23, but relative to viruses like non-pandemic influenza A, it is less 
invasive at a cellular level 24. A large proportion of RSV infections are asymptomatic25. 
Mild cases presenting with cold- like symptoms tend to resolve themselves within 2 
weeks. Severe cases that require hospitalization receive supportive therapy in the form 
of administration of supplementary oxygen, mechanical ventilation and fluid 
replacement26. Though a clear association has been observed between decreasing age 
and increased disease severity, RSV pathogenicity is likely to be multifactorial, 
involving a combination of viral and host factors that contribute to a range of infection 
presentations even within hosts of the same age27. 
 
The RSV genome is about 15000 bases long consisting of 10 genes coding for 11 
proteins. Of the three surface proteins, it is only the fusion (F) and attachment (G) 
glycoprotein that have been found to elicit protective neutralizing antibodies28. 
Respiratory syncytial virus can be categorized into two antigenically and genetically 
distinct groups, RSV A and RSV B. The two groups often co-circulate but RSV A has 
been observed to dominate a majority of outbreaks29–31. Within each group are genetic 
subgroups that are continually replaced over time29,32,33. The clustering pattern of RSV 
sequences in the long term has been found to be more temporal than geographical34–36. 
 
The spread of RSV occurs in seasonal patterns. In the temperate regions, seasonality is 
thought to be driven by low winter temperatures, in the tropics however, the drivers 
of seasonality and less well defined37–39. Given the ubiquitous nature of RSV, it is not 
uncommon to find other viral pathogens in circulation during an RSV season. 
Adenovirus and rhinovirus, which tend to be more year-round pathogens than 
seasonal, are frequently identified either to co-circulate or co-infect with RSV40–45.  
Influenza, human coronaviruses (HCoVs) and human metapneumovirus (HMPV), all of 
which have epidemic patterns of spread, have been observed to have overlapping 
epidemic timings with RSV in some settings37,41,46–50. Influenza is more frequently 
observed with RSV in temperate regions and less so in the tropics 37,43,44,51,52. There is 
evidence of interactions between RSV and other pathogens. At a cellular level, 
facilitative interactions have been demonstrated between RSV and bacterial 
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pathogens53–56 while a competitive interaction has been demonstrated between RSV 
and influenza24,57. At a host level, these interactions have sometimes been associated 
with increased disease severity or longer duration of hospital stay45,47,58–64. In a case-
control study that looked at the effect of therapeutic measures against RSV, it was 
found that there was no significant difference in the rate of occurrence of respiratory 
illness between the treatment and placebo group, however, within the placebo group, 
co-infections were more common than RSV infections65. This points to a possible 
competitive interaction between RSV and other viruses that would result in pathogen 
replacement once an RSV vaccine is in effect. How cellular and host level interaction 
then scale up to population level dynamics is understudied, a situation which could be 
remedied by the use of mathematical models informed by experimental and 
epidemiological studies66,67. Pathogen interactions, whether it is interactions between 
different strains of the same pathogen or between different pathogens, that have a 
population level impact on transmission dynamics, could also affect the effectiveness 
of vaccination strategies. The pneumococcal conjugate vaccine (PCV) has had 3 
variants so far, PCV7, PCV10, PCV13 acting against 7, 10 and 13 serotypes of the 
bacteria streptococcus pneumonia.  Though evidence of a reduction in cases of 
invasive pneumococcal disease (IPD) and pneumonia has been observed68,69, strain 
replacement which could lead to a mitigation of PCV vaccine efforts is a genuine 
concern70–72. Though active surveillance in ongoing and several theories behind 
serotype replacement are being proposed71,73, studies exploring possible multi-strain 
interactions could further elucidate the mechanism behind replacement. In contrast, 
evidence of immunomodulation following measles infection that results in a loss of 
immune memory to other infections has been used to explain the observed reduction 
in non-measles infectious disease mortality following the introduction of the measles 
mumps and rubella  (MMR) vaccine74. Consideration of only the pathogen that is the 
target of a vaccine without an understanding of its interactions with other pathogens 
could lead to an under-estimation or over-estimation of vaccine impact at the 
population level.  
1.2. Control 
As with most viral infections, there is no specific antiviral treatment for RSV infection. 
Severe cases requiring hospitalizations receive supportive therapy in the form of 
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administration of supplementary oxygen, mechanical ventilation and fluid 
replacement3,75, such facilities are often unavailable in many recourse-poor settings. 
 
Preventive therapy against severe disease in the form of a humanized monoclonal 
antibody Palivizumab is administered to high-risk infants. Despite Palivizumab being 
cost effective in preventing RSV disease in high-risk infants, such as those born 
prematurely or with congenital heart disease, in some high income countries76, at 
approximately 4458 US dollars per child for the recommended 5-month course77 it is 
not affordable for wide scale use in the general population of at-risk infants. 
Vaccination of infants <6 months of age is faced by several challenges ranging from 
interference from maternal antibodies to immunological immaturity of the recipient 
and risk of enhanced disease upon subsequent natural infection78–80. In recent years 
however, there has been increased interest in developing a vaccine with three main 
target groups in mind; infants, pregnant women and the elderly81. Infants and the 
elderly would directly benefit from the vaccination while the aim of vaccinating 
pregnant women would be to provide passive protection to the infant. There are 
currently over fifty vaccines in different stages of development with the most 
advanced being a maternal vaccine for which phase III trials were recently 
completed82–84. The trial for ResVax™, which enrolled third-trimester pregnant women 
from countries in the Northern and Southern hemisphere, failed to meet its primary 
objective of a statistically significant reduction in medically significant RSV-LRTI in the 
infants born to the vaccinated women. The results did show reasonable vaccine 
efficacy against RSV LRTI hospitalizations, but timing of the vaccine relative to 
gestational age was a key determinant of efficacy. Results of timing relative to RSV 
seasonality were not presented84. As with other vaccines in the pipeline ResVax™ was 
targeted towards the F protein as neutralizing antibodies generated against it have 
been shown to be protective against severe disease85. Of the three RSV surface 
glycoproteins, the G gene is the most variable and often used for variant typing while 
the F gene is mostly conserved86 and anti-F antibodies have been found to be cross-
reactive between RSV A and B87, meaning that a successful F-based vaccine should, in 
theory, work against RSV A and B. Whether a broad-spectrum RSV vaccine will have 
the intended effect given that interactions between RSV A and B have been shown to 
contribute to observed seasonal patterns, will be determined once any significant 
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interaction mechanisms have been considered while making projections of vaccine 
impact.  
1.3. Models for improved understanding of disease transmission  
Differences in transmission patterns and host social-demographic factors between 
locations and settings mean that a vaccine against RSV will have different efficacies 
and subsequently effectiveness. To gain a better understanding of disease 
transmission and the effect of an intervention, study investigators often use 
mathematical models88. Models represent a hypothesis of infection transmission, and 
often, they are compared to data related to the particular disease under study with an 
aim of estimating model parameters that then allow for inference on transmission 
dynamics. Some interesting insights gained from modelling include: an analysis of 
rotavirus that highlighted the role of birth rates in driving the observed seasonal 
dynamics in the United States of America89,  parameterization of a model with contact 
data revealed the importance of contact patterns in identifying at-risk groups90, and 
estimation of the basic reproductive number during an ongoing Ebola virus outbreak 
highlighted the need for increased bed capacity and case ascertainment if the 
outbreak was to be controlled91. 
 
Increasingly, combinations of data streams are being used in models of infectious 
diseases, perhaps the most popular combination is that of epidemiological and genetic 
data92–94. This combination stems from the field of phylodynamics which involves the 
incorporation of ecological and evolutionary dynamics of a pathogen, based on the 
assumption that they occur at the same timescale95. From a traditional epidemiology 
view, as opposed to molecular epidemiology, integration of genetic and 
epidemiological data has been used to infer transmission chains96–98, estimate 
reproductive numbers99–101 and other quantities of interest.  
 
A more detailed review of models in the context of RSV and phylodynamics 
approaches in provided in the next chapter. 
 
Depending on the data available and the level of detail desired in the process 
represented by the model, mathematical models can vary in complexity and by 
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association, so can the inference technique. Inference can broadly be categorized as 
either Frequentist or Bayesian. With a Frequentist approach, point estimates of 
desired parameters are obtained with confidence intervals based on an empirical 
distribution of those estimates. With Bayesian, a distribution of parameter estimates is 
obtained (the posterior) based on the data, the model and prior information. Bayesian 
inference therefore not only allows for more information on the parameter, it also 
allows for inferring latent data variables through data augmentation102,103. With 
increasing model and inference complexity comes increasing computational 
demands88 therefore a balance has to be found that suits the specific study.  
1.4. Data from the Kilifi household study cohort 
1.4.1. Description  
This PhD study was motivated in part by the availability of detailed epidemiological 
data. During a seasonal RSV outbreak beginning late 2009, members of 47 households 
in a rural location at the coast of Kenya were intensively followed up for a period 
spanning 6 months with an aim of recording the incidence of RSV and inferring who 
infects the household infant17. A household in this setting is described as composing of 
members who share a kitchen, in which case a household could be made up of 
extended family members distributed across several structures on the same 
compound. The definition of a household in this study is similar to what is used in 
national surveys in the country104. In addition to households, a homestead is defined 
as a group of individuals living in the same compound and may be composed of one or 
more households. The study was conducted in Kilifi District, an administrative district 
within the larger Kilifi county. The Kilifi Health and Demographic Surveillance System 
(KHDSS), highlighted in yellow in the map shown in Figure 1. 1, was set up within the 
District as a record of births, pregnancies, migration events and deaths. The study area 
was selected to capture the majority of patients admitted to the main referral District 
Hospital105. Matsangoni location, the household study site, as shown in Figure 1. 1, is 
at the northern tip of the KDHSS. As of 2009, Matsangoni location had a population of 
14,998 individuals distributed across 1,835 homesteads. The average number of 
individuals per homestead was 8.2106. 
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Figure 1. 1: Maps showing the household study site in geographical context as at 
September 2009.  
Left: the map of Kenya shows the position of Kilifi district. Centre: Kilifi district which is 
further divided into administrative locations. The locations within the KHDSS are 
highlighted in yellow. Right: Matsangoni location where the household study was 
carried out106. 
 
Households were recruited on the basis of having an infant born after the previous RSV 
epidemic who had at least 1 elder sibling less than 13 years old. Members of the 
household had nasopharyngeal swab (NPS) samples and clinical data collected every 3-
4 days. The samples were tested for RSV and other pathogens using an in-house real-
time multiplexed polymerase chain reaction (PCR) assay107. A sample was considered 
antigen positive if the PCR cycle threshold value was greater than 0 and less than 35. A 
Ct value of 0 is interpreted as a lack of genetic signal for the virus of interest while 
values above the threshold of 35 are interpreted as weak signals which could be due to 
environmental contamination. Near complete whole genome sequences were 
obtained for some of the RSV positive samples using the Illumina MisSeq 
platform108,109. 
 
A total of 47 households, consisting of 493 household members, were successfully 
followed up. The sizes of the household ranged from 4 to 37 members, with a median 
of 8. The largest distance between households was 6 km. Of the 493 household 
members, 272 were female and 221 were male, their age distributions are shown in 
Figure 1. 2. 
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Figure 3.7: Matsangoni map showing distribution of the recruited households (navy blue). 
Insert at top-right shows the legend and on the bottom-right is the map of the KHDSS area 
with the grey region showing Matsangoni location 
3.6 Study implementation 
3.6.1 Recruitment of field staff and training 
A careful selection and thorough training of staff was obligatory, given the intensity in 
sampling and community interactions in the study. Recruitment of the field staff was done in 
September and October 2009, about two months prior to start of the study to allow proper 
training. The underlying principle in these appointments was to build a field team with 
knowledge of the local area and who spoke and understood the local languages and would 
people. The idea of the KHDSS was conceived in 2000 to
create a longitudinal community-based study linked, at
inception, to hospital morbidity surveillance by inte-
grating the existing clinical and field-based research
infrastructure.
The rationale for the project was (i) to define the in-
cidence and prevalence of significant local diseases of
childhood; (ii) to evaluate the impact of new commu-
nity-based interventions against infectious diseases;
and (iii) to provide an epidemiological sampling frame
for cross-sectional surveys and case–control studies at
the research programme. Although it was established as
a framework for epidemiological studies, it also func-
tions as a demographic surveillance system and was
affiliated to The INDEPTH network (http://www
.indepth-network.org/) in August 2005.
What does it cover now?
At the outset, the project aimed to define rates of
mortality, migration and fertility in a setting that
lacked formal vital registration systems; to estimate
the incidence of major infectious diseases (invasive
bacterial infections and malaria) in children; to test
the association between genetic risk factors (espe-
cially haemoglobinopathies) and infectious diseases
in childhood; to calculate the operational effectiveness
of a new conjugate vaccine against invasive H. influ-
enzae type b disease; and to define the prevalence and
incidence of epilepsy in the community.
Additional objectives studied subsequently include:
defining vaccine coverage for routine childhood
immunizations and estimating the impact of access
to hospital care and vaccines on morbidity and mor-
tality; calculating the excess mortality among children
discharged from hospital; defining the incidence
of potentially vaccine-preventable viral infections
of childhood including rotavirus and respiratory syn-
cytial virus and estimating the direct and indirect ef-
fects of routine immunization with pneumococcal
conjugate vaccine.
Where is the HDSS area?
As the underlying rationale for the study was to
create a community-based surveillance system linked
to hospital-based disease surveillance, we set the geo-
graphical boundaries of the KHDSS with reference to
the area served by KDH. An area of 891 km2 was
selected (Figure 1) as the smallest number of admin-
istrative sublocations that collectively included
the stated sublocation of residence of at least 80%
of paediatric inpatients in the preceding 3 years
(1998–2000). KDH is located in Kilifi town, 38 south
of the equator and KHDSS extends up and down the
coastal strip for 35 km from Kilifi. KDH is the only
inpatient facility offering paediatric services in the
KHDSS area. The local economy is based on subsist-
ence farming of maize, cassava, cashew nuts and
coconuts as well as goats and dairy cows. Two large
agricultural estates, two research institutes and sev-
eral tourist hotels contribute to local employment.
In 2001, the area was mapped using ArcGIS Desktop
software (ESRI, Redlands, CA) by surveyors using
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methods since 2007 (Berkley et al. 2010; Hammitt et al. 2012). Data from this inpatient study 
was used in identifying the start and end of RSV season as described later.  
KDH is the main inpatient referral facility in the district but there were 23 public health 
centres and dispensaries offering outpatient services within the District in 2009 (Figure 3.2). 
The dispensaries provide primary health care; and are staffed by nurses, clinicians, and a 
public health officer, all with a diploma level training. 
 
Figure 3.2: Map of the Kilifi District showing administrative locations in KHDSS (light 
yellow areas) and health facilities (circles filled in red) in the district as at September 2009 
Location
Study site
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Figure 1. 2: Histograms showing the age distribution of the household members.  
 
A total of 16928 samples were collected from 483 household members. The mean 
sampling interval was 3.7 days (SD=2.3). The median number of samples collected per 
participant was 41, the range of samples collected was between 1 and 48. Figure 1. 3 
shows the distribution of the number of sampled collected per individual for all the 
participants, and for the different participant age groups. Of the 16928 samples, 1780 
were positive for rhinovirus, 1274 for human coronavirus, 1232 for adenovirus and 537 
for RSV41,110. 
 
 
Figure 1. 3: Histograms showing the distribution of the total number of samples 
collected from the study participants. 
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1.4.1. Past work 
Given that the data has been available for almost a decade, a substantial amount of 
work has already come out of it revealing several factors about RSV transmission. 
School-going children were linked to initiating household outbreaks leading to infant 
infection17. Bigger household size and infection with RSV group B, higher age, shorter 
duration of infection, lower peak viral load, absence of concurrent RSV infections 
within the household, and no prior human rhinovirus infections were found to be 
independently associated with increased risk of asymptomatic infection25. Shedding 
durations were found to be longer than previously established, 11.2 days on average 
relative to a previous range of 3.9-7.4 days. The length of shedding durations was 
associated with age and severity of disease and reveal potential interactions with 
other respiratory viruses16. Individuals experiencing their first infection in an RSV 
season were found to shed more virus relative to secondary infections; <1 year old, 
symptomatic shedders and RSV A and B co-infected individuals were identified as most 
likely to transmit due to their relatively higher viral loads110. In this particular study 
setting respiratory virus infections and associated illness, are ubiquitous in households. 
The most frequently detected virus was rhinovirus (10.5% of samples), followed by 
human coronaviruses (HCoV) (7.5%), adenovirus (7.3%) and RSV (3.2%)107. Relative to 
changes observed prior to an upper respiratory tract infection (URTI), the increase in 
the concentration of Streptococcus pneumonia with RSV or rhinovirus infection was 
modest. This potentially pointed to the link between viral URTIs and pneumococcal 
disease not being as straightforward as previously thought111.  
  
In 2016 the first rhinovirus genomes from Kenya were generated from samples 
collected by the household study112. A joint epidemiological and phylogenetic analysis 
of rhinovirus sequences of the VP4/VP2 gene junction from 5 of the 47 households 
identified 3 species and 26 known subspecies/types in circulation. Repeat infections 
were common, with up to 8 at an individual level and 13 at a household level in a span 
of 6 months. Temporal clustering of types was observed within households. Almost all 
of the reinfections were with heterologous types, indicative of acquisition of immunity 
against homologous re-infections. Increasing age was associated with decreased 
infection rate, decreased re-infection rates, decreased duration of shedding and 
decreased proportion of symptomatic cases. Asymptomatic individuals were not 
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associated with decreased infectivity and there was evidence of competition between 
the species113. A recent phylogenetic analysis of human coronavirus (HCoV) sequences 
from cases in the household study and cases in an inpatient surveillance study found 
evidence that changes to the HCoV-NL63 genome are not immune driven114. A 
phylogenetic analysis of RSV A whole genome sequences from 13 households aimed at 
inferring transmission chains showed that cases arise more from within household 
spread rather than multiple introductions109. A subsequent analysis of RSV A and RSV B 
whole genome sequences from 20 households found that where transmission pairs 
could be resolved, the source of infant infection was most likely either a toddler or a 
school-aged child. However, the conclusion of this study was that there was 
insufficient diversity in the genomic data for the sequence data alone to be able to 
fully resolve transmission chains hence they recommended an integrated data analysis 
combining the genetic data with epidemiological data108. To somewhat concur with 
this, an analysis of shared minor variants derived from deep sequencing of some of the 
RSV samples failed to provide further resolution in the transmission chain beyond that 
derived from consensus whole genome sequences115. 
1.5. Motivation for the PhD 
At conceptualization, the aim of this PhD project was to gain a better understanding of 
RSV transmission dynamics by appropriately analysing a combination of 
epidemiological and genetic data from a longitudinal household study. The results of 
this work were intended to inform control strategies and future study designs. The 
specific objectives were: 
 
• To review current literature in data integration methods and decide on a 
technique best suited for the data available and analytical objectives. 
• To use all available genetic and epidemiological data (including social 
relationships) to gain a better understanding of the transmission dynamics of 
RSV in terms of (realized and potential) transmission chains and the factors 
affecting RSV viral diversity. This will be done in three parts: first using only 
epidemiological data to infer parameters, second using only epidemiological 
data to infer transmission chains and finally using epidemiological and genetic 
data to infer transmission chains.  
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• To identify the added benefit of viral genetic sequence data in understanding 
transmission of RSV; and use the methodology to inform on how to efficiently 
collect data for such analyses and obtain feedback on where we can continue 
to collect data for further inference. 
• To use the integrated data framework developed to explore intervention 
strategies such as vaccination in terms of the target populations, timings and 
frequency. 
 
That said, the data available still drove the direction of the analysis which was flexible 
enough to go in new directions without deviating too far from the initial purpose.  
1.6. Computation  
Most of the analysis in this thesis was carried out on the R platform116. R is a freely 
available software with a large community of users and contributors and therefore 
broad applicability, including analysis of genetic data. All the models used in the 
analyses presented in this thesis were formulated to suite the household data. Given 
that the data represented a densely sampled small subset of a community, the models 
are not overly complicated and it was therefore not necessary to apply complex 
inference techniques, the use of Metropolis-Hasting MCMC (MH-MCMC) was 
sufficient117. MH-MCMCM was implemented successfully in R, in some instances using 
pre-existing packages and other times having to write my own functions. However, 
with the inclusion of sequence data, the model became more complicated including 
several iterative steps in calculating the likelihood function. In addition, given that 
sequence data was not available for all the cases I had to extend the MCMC algorithm 
to include data augmentation. Increased complexity in the model and inference 
technique meant the analysis was significantly slower to execute and would have 
taken weeks to run in R. As such, I moved to using the julia platform118. For simplicity I 
prepared the data in R, saved it at CSV files that were then used in julia. The julia 
results were then exported as CSV files into R as it has better developed graphics. Even 
in julia, the analysis still took several days to run, as such I outsourced the computing 
to a cluster computer based at the KEMRI-Wellcome Trust Research Programme in 
Kilifi, Kenya. Further details of the methods are provided in subsequent chapters. All 
the R and julia code used to generate the main analysis is freely available under the 
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GNU Lesser General Public License v3.0 and can be found at 
https://github.com/Ikadzo/HH_Transmission_Model. 
1.7. Structure of the thesis 
Though the PhD is by thesis, not by publication, the main results in this thesis are 
written in research paper format as some of them have already been published and 
the rest are intended for publication. Following this introductory chapter are five more 
chapters: 
Review of models of RSV transmission dynamics and methods for including genetic 
information: This chapter is a review of models that have been used on RSV and 
approaches in phylodynamics.  
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Paper 1: Model based estimates of transmission of respiratory syncytial virus within 
households. Given the choice of approach arrived at after a review of the methods, 
this chapter is the first stand-alone analysis of the epidemiological data. It is written in 
paper format and has an abstract, introduction, methods, results, discussion and 
references section. This analysis has already been published119. 
 
Paper 2: Integrating epidemiological and genetic data with different sampling densities 
into a dynamic model of RSV transmission. This chapter in an extension of the model 
presented in the previous chapter with modifications made to allow the use of genetic 
information. The analysis is presented in paper format; however, this work is yet to be 
submitted for publication. 
 
Paper 3: A multi-pathogen model of infection investigating potential interactions 
between respiratory syncytial virus and coronavirus. This chapter is an extension of the 
model in Paper 1 modified to allow the use of data from multiple pathogens. The 
analysis is presented in paper format; however, this work is yet to be submitted for 
publication. 
 
Discussion. Unlike the discussion subsections in the previous three chapters, this is an 
overall discussion tying together all the conclusions and implications for future work.  
 
Appendices. This section contains supplementary information referenced in different 
sections of the thesis. 
 
Prior to each chapter written for publication is a copy of a ‘research paper cover sheet’ 
signed by one of my supervisors and myself. This is a requirement for this thesis 
format. Given that the main results have been presented in paper format that are 
meant to be independently readable, there is some repetition in the content of each 
paper, particularly the introduction.  The references are at the end of each chapter as 
opposed to being at the end of the thesis, even for the chapters that are not written in 
paper format. 
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1.8. Additional information  
1.8.1. Ethics statement 
For the data collection, informed written consent was obtained from all the study 
participants or their parents/guardian. The KEMRI-Scientific and Ethical Review 
Committee in Kenya provided ethical approval. The analysis presented here falls under 
the expected results from the original data collection study, however, additional 
ethical approval was obtained from the Observational / Interventions Research Ethics 
Committee at the London School of Hygiene and Tropical Medicine. The ethical 
approval letters can be found in appendix section A1: Ethical approval. 
1.8.2. Training 
To be able to meet the objectives of this PhD I attended several trainings and 
workshops in order to develop the required skills. I attended a 4-day course from 14-
17 June 2016 at the London School of Hygiene and Tropical Medicine on model fitting 
and inference for infectious disease dynamics ran by Dr Sebastian Funk. The training 
used the R platform. I attended a 3-month distance-learning course on bioinformatics 
hosted at KEMRI-Wellcome Trust in Kilifi, Kenya. The course was run and sponsored by 
the Pan African Bioinformatics Network for H3Africa (H3ABioNet) and it ran from 6th 
July to 9th October 2016. I attended a one-day phylodynamics workshop on the 15th of 
February 2018 given by Professor Simon Frost of the Alan Turing Institute in the UK. I 
was part of a team of three facilitators of a Bayesian statistics workshop from 4-6 June 
2018 on the Stan platform ran by Dr Michael Betancourt https://betanalpha.github.io/. 
I attended a 5-day interactive bioinformatics workshop from 20-26 September 2018 
sponsored and ran by The Global Initiative for Neuropsychiatric Genetics Education in 
Research (GINGER). The most recent and final bit of my training was on coding on the 
julia platform, which I picked up while attending the 3-day Epirecipes workshop from 
1-3 October 2018 at the Alan Turing institute organized by Professor Simon Frost.  
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2. Review of models of RSV transmission dynamics and 
methods for including genetic information  
In this chapter I present my review of the methods in two parts: first a review of some 
of the models that have been used in the context of RSV, second, I review models used 
in phylodynamics analysis. In the final section I present the logic in deciding which 
methods to apply to the data available. 
2.1. Models of respiratory syncytial virus 
Mathematical models of infectious disease transmission (from here on referred to 
simply as models), as mentioned in the previous chapter, are often used to improve 
understanding on infection and/or disease dynamics, following from which the same 
tools can be used to make projections for the future with or without an intervention. 
Models allow one to represent their assumptions of the natural history of a disease in 
a manipulatable system of equations, a fundamental element of which is the feedback 
process between the number of infectious hosts and the risk of infection to the 
susceptible population. Models at the population level are often compartmental, 
meaning individuals are grouped into compartments representing their state relative 
to the infection under study. The most basic is the deterministic, ordinary differential 
equation (ODE), SIR model. In this model individuals are assumed to be susceptible (S), 
they get infected at a rate λ and move to the infected (I) class and after a duration of 
infection ./ they recover into the R class where they have lifelong immunity.  The 
process of transition from one compartment to the next is represented by a system of 
ODE’s. Figure 1. 4 shows a flow chart for the SIR model, the accompany equations and 
sample model projections.  
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Figure 1. 4: A flow chart for the SIR model, the model equations and sample 
deterministic model projections.  
Panel A): The main disease states in the SIR model are represented by the blue boxes, 
the transitions are shown by the blue arrow and the rates of transitions between 
compartments and shown by symbols on top of the blue arrows. The dashed yellow 
arrow shows the feedback process between the size of the infected compartment and 
the rate of exposure λ. Panel B): the set of ODE’s for the SIR model showing the rates 
of change in each compartment (dS, dI ,dR) per change in time (dt). Panel C): Sample 
model projections for the SIR model, the values of the parameters used were 
c=10/person/day, q= 0.05 and  0 = 0.2/person/day.  
 
Given a population of size N, the rate of exposure λ is determined by an individual’s 
contact rate (c), the probability that a contact is with an infectious person (I/N) and 
the probability of transmission given an infectious contact (q). Contact rates can be 
density dependent (increase with increase in population density) or frequency 
dependent (do not change with population density). A deterministic model does not 
allow for stochasticity when making predictions, as such given the same value for the 
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model parameters, the deterministic SIR model will project the same time series of 
cases an example of which is shown in Figure 1. 4. 
 
If the disease of interest has a latency period, where an individual is infected but not 
yet infectious, then an exposed compartment E is introduced into the SIR structure 
resulting in an SEIR model. If immunity to infection is not lifelong and individuals can 
become susceptible again after some time, then a transition is introduced out of the R 
compartment back to the S compartment, giving the SIRS model. If the infection does 
not confer any immunity and individuals are susceptible again as soon as they stop 
shedding, then the R compartment is dropped from the model and from I, individuals 
go back into the S compartment, giving the SIS model. If the infection confers partial 
immunity, i.e. previously infected individuals are less susceptible to future infections, 
then the R compartment is replaced by an S2 compartment of reduced susceptibility. 
These extensions of the SIR are depicted in Figure 1. 5. 
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Figure 1. 5: Possible extensions of the basic SIR model representing different 
assumptions about the natural history of an infection.  
Panel I): The SEIR model which assumes a period of latency prior to onset of 
infectiousness. Panel II): The SIRS model that assumes immunity to infection is 
transient and is lost after a period = 1 23 . Panel III): The SIS model that assumes no 
immunity following infection. Panel IV): The SIS2 model that assumes individuals 
develop partial lifelong immunity following infection. 
 
Numerous other variations of this simple model are possible and have been made to 
explore a broad range of assumptions1,2. The host population can also be modelled 
using network models or individual based models, depending on what dynamics are of 
interest and the nature of the population of interest2. 
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Though epidemiological studies investigating factors associated with RSV transmission 
have provided some useful insights, it is though mathematical models that the 
interaction of such factors can be explored, and the overall resultant dynamics 
analysed. In this section, some of the models that have been used in the context of 
RSV are reviewed, highlighting the main assumptions that went into them and the 
main inferences that were drawn. The first set of models to be discussed are those 
that take an international view of RSV by analysing data from multiple countries. The 
advantage of such analysis is that they could potentially pick up on the broader RSV 
specific characteristics and identify differences between countries that could be 
important for how interventions are planned. RSV occurs in seasonal patterns, but the 
exact drivers of seasonality are not well defined. It is common practice for 
mathematical models to use trigonometric functions to force oscillations in model 
projections (seasonal forcing applied to the rate of exposure, λ), nonetheless, even in 
doing so a comparative analysis of the forcing functions for different locations can give 
some insight. One of the earlier studies was conducted by Weber et al. using data from 
the Gambia, USA, Finland and Singapore3. The study explored structural uncertainty by 
fitting two different compartmental ODE models with seasonal forcing. Their results 
highlighted the sensitivity of the inferred transmissibility of RSV to the model 
structure, the model assuming transient full immunity and lifelong partial immunity 
following primary infection gave higher values of the basic reproductive number 
compared to the SIRS model of transient full immunity. They also found evidence that 
different locations have different factors driving seasonality. An attempt to use rainfall 
and temperature data to explain seasonality in the tropical countries, was 
unsuccessful, leading the authors to conclude the perhaps it is a combination of 
meteorological and social factors driving the seasonal patterns. In 2005 White et al. 
analysed data from the UK and Finland using a deterministic compartmental model 
that distinguished between RSV A and RSV B4. They found that in addition to seasonal 
forcing, the interactions between RSV groups were required to produce the observed 
seasonal patterns. The group interactions were homogenous across locations, but the 
seasonality parameters were not. In addition, they found that the data supported the 
existence of transient partial immunity following infection more so for homologous 
group reinfection than heterologous.  They also estimated that RSV A was about 8% 
more transmissible than RSV B, perhaps providing an explanation for A being the 
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dominant group in most epidemics. This study brings out the importance of 
distinguishing between the RSV groups when investigating transmission determinants, 
the concluding remarks advocated for longitudinal cohort data in order to obtain a 
biologically realistic multigroup model for RSV. 
 
Both the Weber and White models were unable to determine the role of young 
children in RSV epidemiology and they highlighted this as an open question. In a 
second multi-country analysis using data from 9 locations distributed over 7 country 
locations White et al. used nested deterministic compartmental models to gain a 
better understanding of RSV natural history. The study found that the data supported 
the existence of lifelong partial immunity however waning immunity also provided 
visually good fits to the data.  They used a seasonal forcing function, but based on the 
estimates of the peak timing, they found no indication that temperature had a role to 
play therefore there was no clear indication of what could be driving the observed 
differences in seasonality among the countries in the data5.  The amplitude parameter 
in the seasonal forcing function not only varied by location but also by model 
structure. Whereas most of the locations seem to agree on the order of best fitting 
models, Finland, which has biennial rather than annual epidemic cycles had a different 
order. It would appear that if the driving forces of seasonality cannot be accounted for, 
different locations could end up supporting different model structures and hence 
natural histories in particular, the duration of immunity. The authors hypothesize that 
there might be similar seasonality drivers across different pathogens e.g. RSV and 
measles, but the variation in timing could be due to differences in immune 
mechanisms between the pathogens. Unfortunately, more models looking at 
multicounty data were not found in the literature, there were however statistical 
analyses that have found some associations between RSV and meteorological factors. 
Bloom-Feshbach et al. conducted a time series analysis of clinical, geographical and 
socio-economic data from over 50 countries and compared the variation between RSV 
and influenza epidemiology6 . The study found that RSV cases peaked in the winter 
months in temperate countries but the pattern driving peak incidence in the tropics 
was less apparent. In another time series analysis of data from two locations in the 
Philippines and one in Japan, the study concluded that seasonality had more to do 
with the amplitude and variation in climatic factors than with actual absolute values7. 
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At a narrower geographical scale, several other studies have attempted to understand 
seasonality drivers and immune mechanisms. In the USA Pitzer et al, combined a 
statistical and dynamic age-structured compartmental model with seasonal forcing 
and lifelong partial immunity to analyse data from different states. They found that the 
strongest link to seasonal variation in RSV was potential evapotranspiration, which is a 
measure of the demand for water from the atmosphere8. There was an indication from 
one of the states that birth rates could also be driving transmission, but this, along 
with being able to tease apart climatic effects from social patterns, required further 
studies. Interestingly a regression analysis on data spanning 16 years from a single 
state in the US found that early epidemic timing was significantly associated with 
higher population density9. Models of RSV transmission fitted to data from Spain have 
found that most cases occurred in the winter months10,11 and through a combination 
of climatic and clinical data established an association between mean temperature and 
atmospheric pressure, and RSV activity12. Studies from Scotland trying to understand 
drivers of RSV transmission found that RSV transmission was favourable when daily 
ranges in humidity were narrow13. Paynter et al fit a compartmental model to data 
from the Philippines spanning 5 years14. They found that the peak in the 
transmissibility parameter in the model preceded the peak in cases and, intriguingly, 
seasonal malnutrition and rainfall could be driving transmission. 
 
Using an age-structured compartmental model with seasonal forcing and complete but 
waning immunity calibrated to clinical data from Western Australia spanning a 6-year 
period, Moore et al were able to reproduce the observed biennial seasonal patterns 
with estimated infectious period ranging from 8-11 days and the duration of immunity 
being 160 days15. Given the longer duration of time in-between epidemics, it is 
perhaps intuitively understandable that a model in such a setting would support the 
idea of waning complete immunity, however, it is interesting that when White5 fit a 
nested model to Finland’s biennial data, an assumption of partial lifelong immunity 
gave the best fit. This further strengthens the idea that unless seasonality drivers at a 
given local area are well understood, contrasting natural histories of RSV could be 
inferred.  
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If the natural history of RSV inferred from models can be so variable, what impact is 
this likely to have on vaccination programs?  Pan-Ngum et al showed that despite 
structural uncertainty in models, reflecting uncertainty in immunity development and 
loss following natural infection, vaccines that act to reduce the duration of infection 
and infectivity are predicted to have the largest impact on cases16. Surprisingly, 
maternal vaccination was predicted to have only moderate effects. This is not the only 
modelling study to suggest that a maternal vaccination might not be the most optimal 
strategy. A deterministic compartmental model by Kinyanjui et al sought to establish 
the optimal age to vaccinate against RSV, with a particular focus on the inherent 
mixing assumptions17. Results using a contact matrix derived from contact diaries were 
compared to results obtained using a synthetic contact matrix. Though both structures 
support the vaccination of older infants 5-10 months old, which would result in 
significant herd immunity, the two different contact matrices predict different 
mechanisms of vaccine action; the synthetic matrix is such that contacts patterns are 
dominated by children and so the vaccine works through preventing children from 
transmitting to the very young, as such it works by reducing secondary infections 
rather than primary. With the diary-based matrix the force of infection by age shows 
that primary cases drive transmission as such the vaccination strategy works by 
impacting primary cases. This work highlights the importance of mixing assumptions 
and social structure as additional factors that affect model predictions. To further 
explore the effect of social structure, Poletti et al. simulated RSV infection on a 
synthetic population grouped according to households and schools18. Given estimated 
transmission chains, this study found that household transmission was responsible for 
about 38.3% (35.4,40.9) of infant infection and that school-age children played a key 
role introducing infection to the household. The impact of vaccination was dependent 
on the duration of immunity but in general, second to infant vaccination at 3 months 
of age, annual vaccination of all primary school students (aged 7 to 15 years on 
average) would result in preventing a significant proportion of infant and community 
infection. Vaccinating pregnant mothers to protect the infant was effective if it 
provided an additional 4 months of maternally acquired immunity, beyond the 4 
months assumed to occur naturally (i.e. a total of 8 months). Despite infant vaccination 
being optimal in this study, the risk of maternal antibody interference means 3 months 
might be too early to vaccinate, in fact Nyiro et al. used a catalytic compartmental 
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model to analyse the seroprevalence profile of children aged between 0 and 145 
months and found that targeting vaccination at infants 5 months and older would 
archive the highest rate of seroconversion19. Yamin et al. used contact data, 
information on viral load during the course of an infection and data on behaviour 
change due to RSV symptoms, to parameterize the force of infection in an age 
structured compartmental model with seasonal forcing, waning immunity and altered 
infectiousness and disease severity following primary infection20. They calibrated the 
model to RSV incidence in 5 states in the US and found that vaccinating children <5 
years old was the most effective strategy, owing to the fact that they were more 
infectious (higher viral load and longer durations of infections) and had more frequent 
contacts. There was, however, geographical variability in predicted vaccine 
effectiveness across states part of which was attributed to differences in seasonal 
patterns and population demography. In work that looked at 11 RSV seasons in the 
USA, Goldstein et al. found that children aged between 3 and 6 years old played an 
important role in propagating the RSV epidemics21. These studies suggest that even in 
the face of uncertainty in how immunity to RSV is built up, a vaccine targeted at the 
group most likely to infect others would have the biggest impact on overall 
transmission. It is therefore crucial to establish generalizable transmission chains in a 
given setting. Several epidemiological studies have found an association between 
having an older sibling and an increased risk of infant infection, though no direct 
infection link between the older siblings and the infant was confirmed22–24. These 
results answer questions raised over 10 years ago by Weber3 and White4 on the role of 
children in RSV epidemiology. 
 
There have also been modelling studies predicting the benefits of a maternal 
vaccination. Hogan et al calibrated an age-structure compartmental model to data 
from an electronic birth cohort followed up during the period from 1996 to 201225. In 
this study they found that a maternal vaccination would lead to a 6-37% reduction in 
hospitalization in the <3-month-old age group and 30-46% reduction in the 3-5-month-
old age group. An analysis by Scheltema et al. modelled antibody kinetics starting from 
trans-placental transfer to waning post-delivery using parameters derived from 
literature26. They then looked at RSV cases from hospital admission in the UK and the 
Netherlands and reported deaths in the literature from 20 countries. Based on the age 
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of the infant at the time of the RSV related outcome (hospitalization or death), and the 
inferred antibody dynamics from their model, they estimated how many cases would 
have been averted had a vaccine been administered to the mothers in the third 
trimester of pregnancy.  They found that at least 62% of admissions would have been 
prevented in the UK and 76% in the Netherlands, while globally, at least 29% of the 
reported deaths would have been avoided. Similar to the strategy applied to pertussis, 
Brand et al. explored the benefits of a two-vaccine strategy aimed at pregnant women 
and their household cohabitants. Calibrated to data from a low-income country, the 
study found that a 50% reduction in RSV hospitalizations is possible if the maternal 
vaccine effectiveness can achieve 75 days of additional protection for new-borns 
combined with a 75% coverage of their birth household co-inhabitants (∼7.5% 
population coverage)27. 
 
Other than the study by White et al.28, few others have explored interactions between 
RSV groups. Through estimating group specific reproductive numbers, Otomaru et al 
did find that the range for RSV A was 0.92-1.33 and that for RSV B was 1.04 -1.76, 
variation being due to epidemic under study and the location. Where time and 
location results were comparable, RSV A had a slightly higher reproductive number 
than RSV B, consistent with findings from the White et al. study. These estimates were 
much lower than expected however, the method used to derive them did not include 
any assumptions of immunity, which from the previous studies, were noted to 
influence model inference. Going a level beyond looking at RSV group dynamics, Chan 
et al. were interested in understanding drivers of viral diversity and used a 
compartmental model to establish that viral populations in large cities with dense host 
populations are more likely to generate new variants29. Comparing RSV to other 
pathogens Gonzales et al. built models looking at RSV at the molecular level and 
compared in vitro30 and in vivo31 infections of RSV and influenza. The first study found 
that as a result of RSV having a slower rate of spread from cell to cell, RSV titres 
increased at a slower rate and reached peak value much later than influenza. The 
second study found that the infectious cell lifespan was shorter for RSV than influenza. 
These interactions could shape population level dynamics. 
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Going beyond using models to infer transmission dynamics and predict vaccine impact, 
tools for forecasting and tracking ongoing infection trends have been developed in the 
USA. Using data from 10 RSV seasons, Reis and Shaman built a forecasting tool with 
70% accuracy at predicting the peak of an outbreak 4 weeks in advance32. In another 
first, Oren et al. attempted to track the trends in RSV cases using internet search data 
and found that the regression based method worked fairly well33. 
 
Taken together, it is clear that RSV has different seasonal transmission dynamics in 
different climate zones, different countries and even within a country, local areas can 
have different patterns of transmission.  Questions still exist on the exact drivers of 
transmission, more so from tropical low-income countries from which there is a 
paucity of data. In the temperate regions, the role of lower temperatures especially in 
winter months seems to be quite clear. However, climatic factors alone are not enough 
to explain variations in seasonal patterns and other demographic factors such as birth 
rates have also been proposed.  In a theoretical modelling study, Hogan et al. built a 
model that was able to replicate 4 distinct seasonal patterns that have been observed 
in real data and identified birth rates as having a key role in shaping some of these 
patterns34. However even while accounting for difference in birth rates, a seasonal 
forcing function was still necessary implying that other factors are still influencing 
seasonality and called for further investigations into the effect of social and climatic 
factors.  
 
To be able to disentangle and quantify the effect of different factors such as natural 
history (interactions between the groups and duration of group specific immunity), 
climatic variables, birth rates, social factors such as crowding behaviours and the role 
of immunity in driving seasonality, a lot of data is needed. To start with, future work 
could fit dynamic models to the data from Pacheco et al.35 that give a global overview 
of RSV seasonality. Additional data on the country-level birth rates and average 
descriptions of climate would also be needed. Quantifying the effect of social factors 
would be harder to do at a global scale, but it might be possible within country say by 
grouping locations into rural or urban.  
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Despite marked difference in seasonality across locations, the benefits of vaccination 
programs targeting pregnant women, infants or young children have been identified.  
However, further investigations into the transmission dynamics of RSV in tropical low-
income counties are warranted. Countries with functional and consolidated national 
healthcare registries such as the USA, Australia and Scotland can use electronic records 
to map transmission, which makes access to data easier. The WHO has recently 
embarked on a strategy for global RSV surveillance based on the global influenza 
surveillance and response system, which is promising36. In addition to looking at 
disease-related factors that influence vaccine effectiveness, studies should also look 
into how a vaccination program might be impacted by population social-demographic 
factors.  
2.2. Approaches in phylodynamics 
Phylodynamics as a field was first formally defined by Grenfell as the unification of 
immunodynamics, epidemiology and evolutionary biology, processes that potentially 
simultaneously influence pathogen diversity, in understanding the drivers of observed 
pathogen phylogenies at different scales 37. The main underlying assumption is that 
the three processes occur at the same timescale. By definition, phylodynamics first 
came into existence with the aim of understanding observed patterns of genetic 
sequences data, hence naturally, methods were biased towards detailed models of 
pathogen evolution and simple birth-death models were used to represent hypotheses 
of the epidemiological processes38. Increasing complexity in the epidemiological 
models within a phylodynamics framework made it difficult to infer the 
epidemiological parameter solely based on observed phylogenies, the use of other 
complementary data then became useful in distinguishing between competing 
phylodynamics hypotheses39. From a traditional epidemiology perspective, most of the 
applications of phylodynamics have been aimed at determining the transmission 
characteristics such as the reproductive number40–42 or transmission chains43–45 during 
an outbreak, more so for viral outbreaks.  
 
This review of methods will focus on phylodynamics approaches that were aimed at 
inferring epidemiological dynamics from sequence data. The first broad 
characterization of the methods I will make is grouping them either as methods that 
 53 
simultaneously infer epidemiological and evolutionary dynamics, or those that apply a 
two-step inference process beginning with the evolutionary dynamics. Methods such 
as42,46–50 that break the inference process into two parts start by fitting a model of 
evolution to the sequence data available, resulting in a phylogenetic tree showing 
relatedness of the sequences based on the inferred model parameters. Following from 
this, transmission trees46 or other epidemiological characteristics of interest such as 
the basic reproductive number47 or hazard ratios42 are inferred. Such methods have 
the advantage of being less computationally intensive than their simultaneous 
inference counterparts, however, they could potentially result in inconsistencies 
between the inferred evolutionary and epidemiological dynamics. Methods of 
simultaneous inference therefore tend to be preferred, in which case the parameters 
of a model of evolution and that of an epidemiological model of transmission are 
inferred instantaneously and are therefore allowed to interact40,43–45,50–53. Depending 
on the complexity of the models of evolution and epidemiology and the mechanism of 
interaction e.g. through a joint likelihood function, one might then be required to use a 
sophisticated inference technique such as the methods developed by Lau et al. 53 and  
Li et al. 40.   
 
Phylodynamics methods can also be distinguished by the kind of data used. The basic 
requirement is that for every case under study, at least one genetic sequence and the 
sampling times are available. The inclusion of other data describing the infection 
episode and/or the demographics of the host have led to a broad spectrum of 
methods. To take into account the importance of within host pathogen evolution, 
methods have been developed that can accommodate more than one sequence per 
infected host53–55. Though most of these methods assume that if a host has multiple 
sequences they are from the same infection episode, a few do allow multiply infected 
hosts55. In addition to sequence sampling times, data giving information on possible 
exposure times has also been used, particularly for nosocomial infections56. Host 
demographic information such as location 44,45,52,57 and recent contacts43 has also been 
used to enrich analyses, with contact information proving highly valuable in clarifying 
likely infection sources. The use of other data to complement the sequence data has 
the added advantage of allowing more complex epidemiological models to be used.  
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Most methods initially assume that every case has a genetic sequence attached to it, 
however in reality this is seldom the case. Either not all cases have been observed and 
therefore not all cases have a sequence available for analysis, or some cases have been 
observed but for one reason or the other, do not have a genetic sequence. Several 
approaches have been used to tackle the issue of an incomplete observation of the 
cases in a particular temporal window and geographical region (often considered an 
outbreak), the most popular of which is to estimate the proportion of the outbreak 
that is unobserved43,51,55. The method by Didelot et al. accounts for missing sequences 
by allowing additional branches on the transmission tree to be introduced46, while the 
more complicated approach by Lau et al. tries to infer the missing sequences in an 
outbreak53. The first approach is simpler conceptually and computationally. The Lau 
method requires the use of a sophisticated model of evolution that tries to infer how a 
genetic sequence might have evolved in a period of time given an initial guess of an 
introductory sequence, also known as a master sequence. Accounting for unobserved 
cases can be crucial to an analysis depending on the timeframe under consideration 
and the pathogen under study. Despite the range of ways to account for missing cases, 
if a significant fraction of the outbreak is missing data, then no amount of 
computational suaveness can make up for poor data, as a recent study comparing 
different methods found58.  
 
A transmission bottleneck refers to the limitation of the amount of viral diversity that 
is passed on from the infecting host to the infected one. A complete bottleneck 
therefore refers to the situation where only a single strain is passed on. Transmission 
bottlenecks can also influence the observed phylogeny at a population level, as such, 
additional assumptions regarding the size of the bottleneck have to be made when 
analysing population level phylogenies.  Most methods assume a complete 
transmission bottleneck, in that only one lineage is passed on at the time of a 
transmission event46,50,54.  For acute infections, relaxing this assumption may not have 
a significant impact on inferred dynamics, however, for chronic infections such as HIV 
where there is a significant amount of within host diversity, one might need to 
consider an incomplete transmission bottleneck in order to make accurate inference. 
Volz et al. developed a method that looks at both the population and within-host 
pathogen diversity and allows for an incomplete transmission bottleneck. This method, 
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surprisingly, does not require infected hosts to have multiple sequences available for 
analysis59.  
 
Several phylodynamics analyses have been conducted for RSV. Tan et al analysed 33 
RSV A genomes from the Netherlands, Belgium and the USA spanning a period from 
2001 to 201160. In their analysis, they found implications that nonselective 
epidemiological processes, rather than immune pressure, likely play a bigger role in 
shaping viral diversity observed from the phylogeny. A study carried out using RSV A 
and RSV B genes of the F protein using samples from Northern Taiwan found that the 
rate of evolution was dynamic over time, with an increase observed between 2005 and 
2010. They did not find evidence of positive selection61. A positive selection analysis 
carried out by Do et al. using whole genomes for RSV A and RSV B collected over 2 
consecutive epidemics found some evidence of positive selection on the G gene both 
at the population and within host level62. In an analysis of 26 sequences obtained over 
78 days from chronically infected immune-compromised child, Grad et al found some 
evidence of an adaptive immune response, however further studies are warranted to 
validate this finding which could be a result of the unique host factors63. As noted by 
Tan et al.60 , the results of a positive selection analysis could be influenced by the study 
design, of note is the difference in temporal and geographical scale between the 
studies that find evidence of positive selection and those that do not. It would appear 
that in the short term over a local scale (i.e. within a country or an individual), the RSV 
genome is likely to show evidence of positive selection whereas in the long term, it is 
not. Analysis of sequences collected at a large geographical scale, whether in the short 
or long term, could benefit from the inclusion of additional data on the outbreak to aid 
in distinguishing between competing hypotheses.  
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3. Paper 1: Model based estimates of transmission of 
respiratory syncytial virus within households. 
 
3.1. Overview 
This chapter was written in fulfilment of the first part of the second objective. It 
presents a primary analysis of the social-temporal data from the household cohort 
study described in Chapter 1. The work in this chapter was published as Kombe, I. K., 
Munywoki, P. K., Baguelin, M., Nokes, D. J. & Medley, G. F. Model-based estimates of 
transmission of respiratory syncytial virus within households. Epidemics 1–11 (2018).  
 
3.2. Role of candidate 
I formulated the equations and conducted the numerical analysis and wrote the first 
draft of the paper. Revisions were made with feedback, input, and guidance from my 
supervisors Graham F. Medley and D. James Nokes, and advisor Marc Baguelin. Patrick 
K. Munywoki (PKM) was responsible for the original study design and data collection 
that led to the data used in my analysis, information he provided on the data helped to 
identify its limitations. Charles Agoti, George Githinji and Sam Brand provided 
comments on the analysis.  
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3.3. Abstract 
Introduction 
Respiratory syncytial virus (RSV) causes a significant respiratory disease burden in the 
under 5 population. The transmission pathway to young children is not fully quantified 
in low-income settings, and this information is required to design interventions.  
Methods  
We used an individual level transmission model to infer transmission parameters using 
data collected from 493 individuals distributed across 47 households over a period of 6 
months spanning the 2009/2010 RSV season. A total of 208 episodes of RSV were 
observed from 179 individuals. We model competing transmission risk from within 
household exposure and community exposure while making a distinction between RSV 
groups A and B.  
Results 
We find that 32-53% of all RSV transmissions are between members of the same 
household; the rate of pair-wise transmission is 58% (95% CrI: 30-74%) lower in larger 
households (≥8 occupants) than smaller households; symptomatic individuals are 2-7 
times more infectious than asymptomatic individuals i.e. 2.48 (95% CrI: 1.22-5.57) 
among symptomatic individuals with low viral load and 6.7(95% CrI: 2.56-16) among 
symptomatic individuals with high viral load; previous infection reduces susceptibility 
to re-infection within the same epidemic by 47% (95% CrI: 17%-68%) for homologous 
RSV group and 39% (95%CrI: -8%-69%) for heterologous group; RSV B is more 
frequently introduced into the household, and RSV A is more rapidly transmitted once 
in the household.  
Discussion 
Our analysis presents the first transmission modelling of cohort data for RSV and we 
find that it is important to consider the household social structuring and household 
size when modelling transmission. The increased infectiousness of symptomatic 
individuals implies that a vaccine against RSV related disease would also have an 
impact on infection transmission. Together, the weak cross immunity between RSV 
groups and the possibility of different transmission niches could form part of the 
explanation for the group co-existence.  
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3.4. Introduction 
Respiratory syncytial virus (RSV) is an ubiquitous RNA virus infection that is a major 
cause of lower respiratory tract disease in children under 5 years of age worldwide 1,2.  
The estimated global burden of RSV associated acute lower respiratory tract infection 
(ALRI) in 2015 in under 5 year olds is 33.0 million (21.6-50.3), most of which occurs in 
developing countries (30.5 million) 3. Of the 3.2 (2.7 -3.8) million hospital admissions 
associated with RSV in the under 5s, 1.4 (1.2-1.7) million occurred in the 0-5 months 
age group, and 1.2 (1.0-1.5) million occurred in developing countries.  
 
Despite 50 years of vaccine research none is yet licensed for the prevention of RSV 
infection or disease.  There are currently over fifty vaccines in different stages of 
development: many with the aim of prevention of early infant RSV disease.  While the 
most advanced (in phase III trials) is a maternal vaccine to boost transplacental 
antibody transfer 4,5,  a variety of product types and range of strategies for protecting 
young children are under investigation including indirect protection  by targeting older 
infants, elder siblings and family cocooning 6–8.   
 
Prior to vaccine introduction, drivers of transmission need to be well understood in 
order to predict the potential public health impact of implementation. Investigating 
outbreaks within the household setting could help to further characterize RSV 
transmission. The household is an important unit of study for diseases that are 
transmitted through close contact. The quantitative analysis of household outbreaks 
has been conducted for influenza 9–15. This has led to quantification of transmissibility 
within the household, improved understanding of the factors that determine level of 
transmission such as household size and effectiveness of different household level 
interventions 16. To date studies of RSV transmission within households or families 
have been largely observational. One of the earliest is a household cohort study in the 
USA in which 36 families were followed up for 2 months during the 1974/1975 RSV 
season 17. This study found that RSV attack rates in households were high, more so in 
infants. Older siblings to infants were found to be the most likely index cases in 
household outbreaks, and illness was found to have an age-related severity. Several 
other studies over the years across different settings have highlighted the importance 
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of older children in household outbreaks18–20 which could have implications for control 
strategies 21.  
 
In Kenya, a household cohort study conducted in a rural coastal community during the 
2009/2010 RSV epidemic has revealed several patterns. In addition to the importance 
of older children20, bigger household size and infection with RSV group B, among other 
factors, were found to be independently associated with increased risk of 
asymptomatic infection 22; shedding duration estimates (using molecular diagnostics) 
were 11.2 days on average, and longer than  the previous range reported of 3.9-7.4 
days 23; individuals experiencing the first infection of an RSV season were found to 
shed more virus relative to secondary infections; children under 1 year old, 
symptomatic shedders and RSV A and B co-infected individuals were identified as the 
most likely to transmit due to their relatively higher viral loads 24. 
 
RSV can be categorized into two antigenically and genetically distinct groups, RSV A 
and RSV B 25. These groups, thought to have diverged about 350 years ago 26, have 
been observed to co-exist geographically and temporally with most outbreaks being 
dominated by RSV A and, in some locations, clear patterns of alternating dominance 27. 
Within the RSV groups are subgroups or genotypes whose frequency changes from 
season to season, with some genotypes undergoing complete replacement over time 
28–33. This pattern of group and genotype replacement is thought to be due to a herd 
immunity effect 25,27,34,35. A phylogenetic analysis of RSV A sequences from the Kenyan 
household study showed that most infections arise from a single variant introduction 
followed by accumulation of household specific variation, i.e. cases arise more from 
within household spread rather than multiple introductions 36. 
 
However, there is yet to be a mechanistic analysis of RSV household outbreak data 
that consolidates information on the characteristics of infection episodes and 
characteristics of the host population into a single dynamic framework.  Inference 
could then be drawn on the competing risks of within household exposure and 
community (external to household) exposure, in order to quantify the importance of 
households in RSV transmission. We proposed to use an individual-based approach 
within a Bayesian framework to analyse the household cohort data from Kenya to 
 69 
further understand transmission dynamics. We also explore the differences and 
interactions between RSV groups. 
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3.5. Methods 
Data 
The data to be used were collected from a household cohort study conducted in rural 
coastal Kenya within the Kilifi Health and Demographic Surveillance System (KHDSS) 
during the 2009/2010 RSV epidemic. Details of the study have been published 
elsewhere 20,22,23,37. In brief, the infant-centric study recruited household members 
using the criteria that the infant was born after 1 April 2009 (after the previous RSV 
epidemic) and had at least 1 older sibling less than 13 years old. Deep nasopharyngeal 
swab (NPS) samples were collected every 3-4 days regardless of symptoms, together 
with a record of clinical illness.  The samples were tested for RSV antigen using an in-
house real-time multiplex polymerase chain reaction (PCR) assay. A sample was 
considered antigen positive if the PCR cycle threshold (Ct) value was 35.0 or below. 
Positive Ct values were then converted to viral load (log10 RNA equivalent). A 
household was defined as a group of individuals living in the same compound and who 
eat together. The data contain information from 493 individuals spread across 47 
households whose dates of data collection span 180 days. The household sizes range 
from 4 to 37 occupants with a median of 8 members.  
 
An RSV A/B shedding episode is defined as a period within which an individual 
provided PCR positive samples for RSV A/B that were no more than 14 days apart. A 
shedding episode is referred as symptomatic if within the window of virus shedding, 
there is at least one day where symptoms were recorded. The symptoms of interest 
are those of an acute respiratory illness (ARI), which are: cough, or nasal 
discharge/blockage, or difficulty breathing. Sampling of the study population was done 
in 3-4 day intervals, as such, complete duration of shedding and ARI episodes had to be 
imputed, and missing viral loads were linearly interpolated. Shedding durations were 
imputed first, after which, if there were any days of recorded ARI within shedding 
episodes, the total duration of the ARI was imputed based on the days of recorded 
symptoms. As such, the length of an ARI episode within a shedding episode can be ≤ 
length of related shedding episode. The start and end of a shedding and ARI episode 
were imputed rather than inferred through data augmentation to ensure consistency 
and hence comparability across studies that have used the same household data20,23,24. 
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During the sample-collection visits, if a household member was not present, they were 
recorded as being ‘away’ on that particular day. As with the shedding information, 
there was incomplete information on continuous periods of presence or absence from 
the household. This information was imputed using the same method that was applied 
to imputing complete shedding durations. There are some instances where an 
individual was present but not sampled, as such, presence could not purely be 
identified by the availability of NPS samples. Details of the imputation of shedding, ARI 
and presence/absence durations and interpolation of viral load can be found in the 
appendix section A2: Supplementary appendix for Paper 1. For the model, we will 
assume that all the cases were observed, and ignore the possibility of short duration 
shedding episodes that could have been missed by the sampling intervals.  
 
We categorized days of shedding according to viral load and symptoms into 4 
categories to compare infectiousness: low viral load and asymptomatic, high viral load 
and asymptomatic, low viral load and symptomatic and, high viral load and 
symptomatic. High viral load is defined as >6 log10 viral copy number (or a PCR Ct value 
<23.05). 
 
Transmission model 
We built a mechanistic model for RSV that tracks group-specific infection onset at the 
individual host level. The main aim is to determine the factors that influence infection 
onset in an individual, and this is the focus of the model formulation. At the start of 
the outbreak, we assume that everyone is susceptible to RSV infection, but the risk of 
infection is dependent on age. Once individuals have been exposed to infection, they 
enter a latency period that ranges between 2 to 5 days after which they become 
infectious. After the infectious period, individuals become susceptible to infection 
again, but the risk to subsequent infection is modified, i.e. RSV confers partial transient 
immunity that lasts as long as the outbreak is ongoing. This partial immunity is 
assumed to be different from heterologous group re-infection and homologous group 
re-infection. Having RSV infection risk altered by age and infection history implies the 
existence of long-term and short-term immunity. This has previously been explored by 
other modelling studies38,39. Individuals can get heterologous group co-infections, i.e. 
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we assume infection with RSV A is possible while shedding RSV B, and vice-versa. Per 
RSV group, our model formulation is similar to the Susceptible(S)-Exposed(E)-
Infectious(I)-Susceptible(S2) type model dynamics. 
 
The main assumptions about transmission are contained in the equation giving the per 
capita rate of exposure (to infection) per unit time, also known as the infection hazard, 
denoted 5(7). At its base:  
 
 5(7) = : ∗<=(7) 
 
In our model, a susceptible individual can get infected by someone they share a 
household with, or from a source outside of the household, splitting λ into two 
components: a within household exposure component and a community exposure 
component. 
 
 
5(7) = >: ∗ < =(7)?@ABC?@DE F + HI ∗ < =(7)J@KKALMNO P 
 
The number of infectious household contacts is observed in the data. Though there are 
cases from different households in the data, the sample in the study is small relative to 
the number of households in the community, as such the true number of infectious 
community contacts is unknown. We therefore cannot directly infer infectious 
community contacts and have to use a representative function instead. We do this 
using a bell-shaped curve that mimics the ongoing outbreak dynamics. We thus have: 
λ(t)	=	contact	rate	*	probability	of	transmission	give	contact	*	number	of	infectious	contacts(t)
=	baseline	rate	of	exposure	*	number	of	infectious	contacts(t)	
λ(t)	=	[baseline	household	rate	of	exposure	*	number	of	infectious	household	contacts(t)]
+	
[baseline	community	rate	of	exposure	*	number	of	infectious	community	contacts(t)]
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5(7) = >: ∗ < =(7)?@ABC?@DE F + QI ∗ R(7)S 
We extend this basic formulation to explore if factors such as household size, 
infectiousness (as determined by viral load and ARI symptoms) and age are 
determinants of exposure. Further details of each component are provided in the 
subsequent sections. The rate of exposure to a particular RSV group (index g) is given 
for a particular individual, (index i) from a given household (index h) at a given day 
(index t) and is specified by the notation 5M,?,T(7).  
 
Within household exposure: 
For an individual i, in household h, the rate of exposure at a given time t, is a 
summation of rates from all the infectious individuals in their household. The rate of 
exposure from a single infectious housemate (index j) is assumed to depend on the 
size of the household and the viral load and symptom status. We consider the 
household size effect as a binary variable where a house with >8 members is 
considered large. We consider viral load and symptom status as one variable with 4 
categories: low viral load and no symptoms, high viral load and no symptoms, low viral 
load and symptomatic, high viral load and symptomatic. The household rate of 
exposure from infectious individual j present in the household at time t to i is thus give 
as: 
 UU_WX7Y?,T,Z→M(7)= 	 :T × ]^(U_`aYℎ_cd_aefYM) × ]g,MLhQ=iRYj7eke7lZ,?,T(7)S × mZ,?(7) 
 :T is the baseline rate of exposure in the household which is estimated for each of the 
two RSV groups, RSV A and RSV B. ]^ is the coefficient modifying exposure in large 
household relative to small households and ]g,MLhis the coefficient modifying 
infectiousness based on viral load and symptom status. The within household rate of 
λ(t)		=	[baseline	household	exposure	rate	*	number	of	infectious	household	contacts(t)]
+	
[baseline	community	exposure	rate	*	background	community	function(t))]
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exposure only affects susceptible individuals who are present in the household, as 
such this rate is multiplied by a binary variable mM,?(7) =0 if i is not present in the 
household at time t and mM,?(7)=1 if i is present. 
 
Community exposure: 
For a susceptible individual i, this external to the household source of exposure is 
assumed to represent both sampled and unsampled cases from other households. 
Community exposure is assumed to depend on the age of the susceptible individual 
and time. Age is treated as a categorical variable. The community rate of exposure is 
thus given as:  
 n_oopqNCM,T(7) = IT 	×	RT(7) 	× 	]r,qTCQstY_tu_`vr,MS 
 IT is the baseline rate of exposure from the community, which is estimated for each of 
the two RSV groups. ]r,qTC  is the coefficient modifying the rate of community 
exposure by age. For each RSV group, we have RT(7), a time-unit dependent curve that 
modifies the community rate of exposure over time, in this case the time period of 
interest is the duration of the study. We wanted this curve to represent the 
background epidemic dynamics in the local zone from which the data was collected; as 
such we proceeded to use the same household dataset to generate it.  
The data are calibrated in days and are at the individual level, but to obtain the 
background community rate, we assumed that this background rate is scalable from 
the weekly household-level rate of primary incidence, denoted 5^^(7w). The 
household level rate of primary incidence is the rate at which a household (rather than 
a single member of a household) acquires the first episode/outbreak in the ongoing 
RSV season. A household outbreak is a period within which at any given time, at least 
one household member is shedding RSV. If we treat 5^^(7w) as the hazard rate in a 
probability distribution, we can estimate it using the following model: =J(7w) = x^^ y1 −	Y|v}∫ ÄÄ(B)ÅÇÉ Ñ	 		=(7w) = =J(7w) − =J(7w − 1)	 
Where 
NHH = Total number of households in the study 
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I(7w) = Average weekly household-level incidence of primary infection  
IC(7w) = Weekly cumulative household-level incidence of primary infection 
We further assumed that 5^^(7w) = X.Y|v}yÅÇÖÜáàá Ñâ, giving it a bell-shape, and 
estimated {a1, b1, c1} using maximum likelihood assuming Poisson distributed data.  
Once 5^^(7w) was estimated for each RSV group, it was scaled such that it ranges 
between 0 and 1 using the formula äMãJqDCE = åç}éèê	({å})éìî({å})}éèê	({å}). As such, 
 RT(7w) = ÄÄ(NÇ)}éèê	({ÄÄ(.),ÄÄ(ï)…ÄÄ(NÇ)})éìî({ÄÄ(.),ÄÄ(ï)…ÄÄ(NÇ)})}éèê	({ÄÄ(.),ÄÄ(ï)…ÄÄ(NÇ)}). To turn RT(7w) into 
a daily scale, the value for a given week were assumed to be the values for every day 
of that week. The resultant background community curves for RSV A and B are shown 
in Figure 3. 1. 
 
 
Figure 3. 1:  Establishing the background community rate function.  
The figures in the top row show a comparison of data and model fit of the weekly 
household-level rate of primary incidence that was used to derive the background 
community rate function. Top left: RSV A data and model fit; Top right: RSV B data and 
model fit; Bottom: Comparing the estimated background community rate function for 
RSV A and RSV B. 
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Finally, we assume that susceptibility can be modified according to an individual’s 
infection history within the same epidemic, and their age. These two components are 
combined into an equation representing relative susceptibility to infection as shown 
below  
 óM,T(7) = exp yõú,?MBNQ=iRYj7e_i_Uea7_ulM(7)S +	õå,qTCQstY_tu_`vã,MSÑ 
 õå,qTCis the coefficient modifying susceptibility by age. We categorized infection 
history into four groups: no previous infection, recovered from an RSV A infection, 
recovered from an RSV B infection, recovered from both RSV A and B. 	ϕû,üè†° is the 
coefficient modifying susceptibility to a particular RSV group depending on infection 
history in the following three ways: by Y|v¢£,§•¶  if an individual has previously 
experienced and recovered from infection by the same group (homologous infection), Y|v¢£,§ßÅ  if the individual has previously experienced and recovered from infection by 
a different group (heterologous infection) and by	Y|v(¢£,§•¶®¢£,§ßÅ) if an individual has 
previously experienced and recovered from both RSV A and RSV B infection. This 
mechanism of interaction between RSV A and B is similar to that applied in a 
compartmental model used to analyse data from the UK and Finland 27.  
In combination, all the above assumptions result in the rate of exposure equation 
shown below 5M,?,T(7) = Rate of exposure of individual i in household h with RSV group g at 
time t. 
5M,?,T(7) = óM,T(7)
⎣⎢⎢
⎢⎢⎡mM,?(7) < UUpqNC?,T,Z→M(7)Z¨M,	Z	ML	M≠B	?@ABC?@DE
+ n_oopqNCM,T(7)⎦⎥⎥
⎥⎥⎤ … (±≤	3.1) 
The assumption of how age and infection history modify the rate of exposure is similar 
to the assumptions made in a proportional hazards model.  
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Additional details on the data variables and parameters are given in Table 3. 1.  
 
Table 3. 1: Model Notation 
Symbol Name Type Description 
i   Index Index of individual 
h  Index Index of household 
g  Index Index of RSV group type, either A or B 
t   Index Index of time in days ¥µ,∂,∑(∏) Infectivity Data* Categorical data variable for infectious 
individuals indicating level of infectivity 
categorized by viral load and symptom status 
at time t. The categories are: low viral load 
and asymptomatic (reference group), high 
viral load and asymptomatic, low viral load 
and symptomatic and, high viral load and 
symptomatic. High viral load is defined as >6 
log10 viral copy number. π∫(∏) Infection_
history 
Data Variable indicating if an individual has 
experienced and recovered from an infection 
by a particular RSV group in the current 
epidemic at time t. ª∫ Age_grou
pS 
Data§ Categorical data variable indicating the 
susceptibility age group of an individual. The 
age groups are <1 year (reference group), 1-4 
years, 5-14 years and ≥15 years. º∫,∂(∏)  Data Binary data variable indicating if an individual 
is present in the household at time t. 
Absence from the household means that an 
individual was not present at the point of 
sample collection and thus in the model they 
can only get infection from a community 
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source and not from an infectious housemate 
(not sampled and not at household risk). 
Individuals who were present but not 
sampled are exposed to both household and 
community source transmission in the 
models (not sampled but at household risk).  Ω∫ Household
_size 
Data* Binary data variable indicating whether the 
individual lives in a large or small household. 
A small household (reference group) has <8 
individuals. æ∫ Age_grou
pE 
Data§ Categorical data variable indicating the 
community exposure age group of an 
individual. The age groups are <1 year 
(reference group), 1-4 years and ≥5 years. øª,¿∑¡ Sus.age.2 
Sus.age.3 
Sus.age.4 
Parameter Coefficients modifying susceptibility to RSV 
depending on age, applied to the age group 
covariate Xi. Sus.age.2 estimates the effect 
being in age group 1-4 years, Sus.age.3 the 
effect of group 5-15 and Sus.age.4 of group 
≥15 relative to group <1 year.  øπ,∂∫¬∏ 
 
Prev.hom 
Prev.het 
Parameter Coefficients modifying susceptibility to 
infection by a particular RSV group 
depending on infection history. Prev.hom 
estimates the effect of a previous 
homologous group infection, while Prev.het 
estimates the effect of a previous 
heterologous group infection. Applied to the 
categorical covariate Yi(t). √Ω HH.size Parameter Coefficient modifying the amount of within 
household exposure by household size. 
HH.size estimates the effect of being in a 
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large household relative to a small one. 
Applied to covariate Hi. ƒ∑ HH.rsv.a 
HH.rsv.b 
Parameter Baseline rate of within household exposure 
by RSV group √¥,∫≈∆ High.Asym 
Low.Sym 
High.Sym 
Parameter Coefficients modifying infectiousness by viral 
load and symptom status. Relative to 
shedding low viral load and being 
asymptomatic, High.Asym estimates the 
effect of shedding high viral load and being 
asymptomatic, Low.Sym the effect of 
shedding low viral load and being 
symptomatic and High.Sym the effect of 
shedding high viral load and being 
symptomatic. Applied to the infectivity 
covariate ¥µ,∂,∑(∏). √æ,¿∑¡ 
 
Exp.age.2 
Exp.age.3 
Parameter Coefficients modifying the rate of community 
exposure by age group. Exp.age.2 estimates 
the effect being in age group 1-4 years and 
Exp.age.3 the effect of group ≥5, relative to 
the <1-year age group. Applied to the age 
group covariate Ei «∑ 
 
Comm.rsv.
a 
Comm.rsv.
b 
Parameter Community transmission coefficient by RSV 
group 
∆∑(∏)  Estimated  RSV group specific, time-dependent curve 
modifying the rate of community exposure.  »∫,∂,∑  Data Set of all days where individual i has an onset 
of infection with RSV group g. Only includes 
the first day of shedding for each infection 
episode. 
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…∫,∂,∑  Data Set of all the days where individual i is at risk 
of infection with RSV group g, i.e. they are 
not currently shedding g. 
* The choice of cut-off for high viral load and large households was based on initial 
runs of the inference algorithm that explored different cut-offs for each. The choice of 
6 log10 copy number for high viral load and 8 persons for large households led to the 
best convergence. §The decision to have different age groups for susceptibility and 
community exposure was based on initial model runs where the 4th community 
exposure age group effect (>15 years) was poorly estimated and as such was 
uninformative. Consequently, this group was merged with the 3rd group. 
 
Following on from the rate of exposure equation are two additional nested equations 
that make up the model. 
  M,?,T(7) = Probability of infection following exposure per day i.e. individual 
enters the latent phase  M,?,T(7) = Q1 − Y|v}ç,§,À(N)S			…		(±≤	3.2) vM,?,T(7) = Probability of starting to shed i.e. individual enters the infectious 
phase at time t given they did not shed until t.  
vM,?,T(7) = <ÕD M,?,T(7 − c)ŒDœ– 			…		(±≤	3.3) 
Where L is the maximum latent period and ÕD  is the probability that the latent 
period is exactly c days. For c = {0,1,2,3,4,5} days, we have the following 
probabilities [0,0,4,4,3,1]/12= [0, 0,0.33,0.33,0.25,0.083] 40. The same latency 
distribution is used for RSV A and B.  
Since the model is focused on the determinants of infection onset process, the data 
whose likelihood we are interested in is the individual onset times. As such, we express 
the likelihood of an individuals observed days of onset as: —M= 	 “ [vu_‘X‘ece7l	_R	Xcc	_iaY7	dXla	Xid	i_i__iaY7	dXla	’e7ℎ	uea÷	_R	_iaY7|o_dYc]qDD	pãŸ	T⁄@A¤B  
We assume the data is binomially distributed and write the likelihood as: 
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—M = 	“‹ “ vM,?,T(`)A∈ﬁç,§,À “ Q1 − vM,?,T(`)SA∈ﬂç,§,À ‡T  
Where Ui,h,g is the set of days where individual i had an onset of RSV group g infection 
and Ai,h,g is the set of all days where i did not have an onset but was at risk of infection 
(i.e. not shedding RSV group g). 
 
The model as presented can be reduced to fit for a single RSV group or for RSV as a 
single pathogen with no distinction between RSV A and B. Attempts to model 
household size as a continuous variable were unsuccessful possibly due to our small 
sample size and hence we modelled transmission within the household as a density 
dependent process but identified households as either large or small and found that 
the cut-off between categories of 8 provided the best fit.   
 
Parameter inference 
We used Bayesian inference to obtain estimates of the parameters. Adaptive 
Metropolis Markov Chain Monte Carlo was used as implemented in the R software 
package fitR 41, function mcmcMH . The mcmcMH function can adapt the size of the 
proposal distribution, such that the acceptance rate is close to 23.4%, and the shape 
using the Adaptive metropolis algorithm as in 42; the difference in size and shape 
adaptation being in the scaling factor used. In brief, the method builds a Markov chain 
which allows us to sample from the posterior distribution P(φ|D) of the parameters 
given the data, where φ={õå,qTC,	õú,?MBN,	]^,	:T ,	]g,MLh,	]r,qTC,	IT }. Flat bounded 
priors were used for all the log of parameters. The limits on the parameters measuring 
relative effects was -10 to 10, while that on the transmission coefficients was -20 to 0. 
We initiated 3 chains and set the algorithm to start adapting the size of the proposal 
distribution after 1000 iterations and the shape after 500 accepted iterations.  
 
Burn-in was assessed visually after which the results of the three concurrent chains 
were combined to infer the posterior distribution. To obtain fairly accurate values for 
the 95% credible intervals, we ran the MCMC algorithm until the effective sample size 
(ESS) was ≥ 4000 43. The three chains were run for 250,000 iterations each and burn-in 
for each chain was 80,000, 90,000 and 80,000.  After burn-in the reminders of the 
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three chains were combined into a single chain with and overall acceptance rate of 
16.8%. The parameters were estimated on the log scale. All the computation was done 
using R software package (RStudio version 1.1.383 running R version 3.4.0 44). The 
code is freely available under the GNU Lesser General Public License v3.0 and can be 
found at https://github.com/Ikadzo/HH_Transmission_Model. 
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3.6. Results 
Table 3. 2 gives a summary of the shedding episodes in the data. This particular 
outbreak had more RSV B cases than RSV A, with a significant portion of cases being 
symptomatic both for RSV A and B. Eighty five percent of the households that were 
successfully followed up had an introduction of an RSV case. In addition to the 
information in Table 3. 2; 28 (13.5%) of the total 208 episodes were censored during 
imputation; of the A and B episodes, 14 (6.7%) were simultaneous RSV A and B 
shedding episodes, 7 (3.3%) of which had a simultaneous onset; of the 179 individuals 
who got infected 31 (17.3%) were <1 year old, 41 (22.9%) were 1-4 years, 66 (36.9%) 
were 5-14 years and 41 (22.9%) ≥15 years old. Of the symptomatic infected individuals, 
28 (25.7%) were <1 year old, 35 (32.1%) were 1-4 years, 36 (33%) were 5-14 years and 
10 (9.2%) ≥15 years old. A detailed analysis of these shedding patterns has been 
published elsewhere 24. Figure 3. 2 shows the shedding pattern for all 179 people who 
had a shedding episode. Figure A2. 3 and Figure A2. 4 in appendix A2 shows the 
shedding and ARI patterns for RSV A and B respectively. 
 
Table 3. 2: Summary of shedding episodes 
 
RSV A RSV B All RSV 
Number of episodes 97 125 208 
Number of symptomatic episodes 59 69 119 
Number of people infected 88 113 179 
Number of people with symptomatic 
episodes 
54 67 109 
Number of people with repeat infections 8 12 27 
Number of households infected 
(percentage of total) 
25 (53.2%) 34 (72.3%) 40 (85.1%) 
Total percentage of household occupants 
that were infected (total number of 
occupants) *  
30.0% (293) 28.5% (396) 40.5% (442) 
* The total number of infected individuals out of the total number of individuals that 
occupy the infected households.   
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Figure 3. 2: Shedding patterns for each of the 179 individuals who experienced at 
least one RSV shedding episode.  
The y-axis shows the household, time is on the x-axis with zero indicating the day 
before the first sample was collected. The grey dots show RSV A shedding, dark pink 
show RSV B and blue shows days of co-shedding. The horizontal grey lines separate the 
data by household. The study initially recruited 60 households but 13 were lost to 
follow-up, hence the numbering of the households goes beyond 47.  
 
Transmission model parameter inference 
The trace plots used to assess convergence of the three chains are shown in Figure A2. 
5 in appendix A2. The resulting parameters estimates are given in Error! Reference 
source not found. and Figure A2. 6. 
 85 
 
Table 3. 3: Results of fitting the transmission model.   
Median and 95% credible intervals (CrI) are given for the 15 parameters of interest. 
The posterior distribution for each parameter was obtained by running 3 MCMC chains 
for 250,000 iterations each. The burn-in for the three chains was 80,000, 90,000 and 
80,000 respectively. The reminders of the three chains were combined into a single 
chain with and overall acceptance rate of 16.8% 
 
Symbol Description Name Median (95% credible 
interval (CrI)) øª,¿∑¡ Coefficients modifying 
susceptibility to RSV by age. 
Sus.age.2 estimates modification 
to group 1-4 years, Sus.age.3 5-15 
years and Sus.age.4 ≥15 years 
relative to group <1 year.  
Sus.age.2 
Sus.age.3 
Sus.age.4 
0.924 (0.483, 1.87) 
0.267 (0.142, 0.537) 
0.155 (0.0825, 0.316) 
øπ,∂∫¬∏ 
 
Coefficients modifying 
susceptibility to infection by a 
particular RSV group depending 
on infection history. Prev.hom 
estimates the effect of a previous 
homologous group infection, and 
Prev.het the effect of a previous 
heterologous group infection.  
Prev.hom 
Prev.het 
0.530 (0.316, 0.833) 
0.607 (0.306, 1.08) 
√Ω Coefficient modifying the amount 
of within household exposure by 
household size for households of 
8 or more relative to <8.  
HH.size 0.424 (0.265, 0.702) 
ƒ∑ Baseline rate of within household 
exposure by RSV group 
HH.rsv.a 
HH.rsv.b 
0.0188 (0.00734, 0.0401) 
0.015 (0.00578, 0.033) √¥,∫≈∆ Coefficients modifying 
infectiousness by viral load and 
High.Asym 
Low.Sym 
0.0704 (0.0000692, 3.15) 
2.48 (1.22, 5.57) 
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symptom status. Relative to 
shedding low viral load and being 
asymptomatic, High.Asym 
estimates the effect of shedding 
high viral load and being 
asymptomatic, Low.Sym the 
effect of shedding low viral load 
and being symptomatic and 
High.Sym the effect of shedding 
high viral load and being 
symptomatic.  
High.Sym 6.7 (2.56, 16.0) 
√æ,¿∑¡ 
 
Coefficients modifying the rate of 
community exposure by age 
group. Exp.age.2 estimates the 
effect being in age group 1-4 
years and Exp.age.3 the effect of 
group ≥5, relative to the <1-year 
age group.  
Exp.age.2 
Exp.age.3 
0.563 (0.206, 1.45) 
1.87 (0.788, 4.26) 
«∑ 
 
Community transmission 
coefficient by RSV group 
Comm.rsv.a 
Comm.rsv.b 
0.00338 (0.00203, 0.00530) 
0.00615 (0.00388, 0.00926) 
 
In short, susceptibility to infection was reduced by previous infection whether these 
infections were homologous (Prev.hom = 0.53 (0.32 - 0.83)) or heterologous (Prev.het 
= 0.61 (0.3 - 1.1)). Increasing age also reduces susceptibility with ages 1-4 years old 
having an estimated 8% reduction  (Sus.age.2 = 0.92 (0.48 - 1.9)), ages 5-15 years a 
73% reduction (Sus.age.3 = 0.27 (0.14 - 0.53)) and ages ≥15 years an 84% reduction 
(Sus.age.4 = 0.16 (0.08 - 0.32)). The within household transmission coefficients 
(HH.rsv.a = 0.019 (0.0073 – 0.04) and HH.rsv.b =0.015 (0.0058 – 0.033)) are estimated 
higher than the community transmission coefficients (Comm.rsv.a = 0.0034 (0.002 – 
0.0053) and Comm.rsv.b = 0.0062 (0.0039 – 0.0093)). The coefficient modifying within 
household exposure by size (HH.size = 0.42 (0.27 – 0.7)) suggests that larger 
households have less risk of pair-wise within household transmission 
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(UU. Wea÷?,T,Z→M(7)) than smaller households. However the total risk of household 
transmission (∑ UU. Wea÷?,T,Z→M(7)Z¨M ) can conceptually be higher than that in smaller 
households if there are 20 or more infectious household members at a single time 
point, this is illustrated in Figure A2. 7. However, it should be noted that in this study, 
the highest number of simultaneously infectious individuals in large households was 
14.  
 
Although there is suggestion that pre-school individuals are the least likely to acquire 
infection from the community, and school-age individuals and older are the most likely 
to acquire community infection, the evidence is very weak: the relative estimate for 
age groups 1-4 years is Exp.age.2 = 0.56 (0.21 – 1.5) while for age group ≥5 years is 
Exp.age.3 = 1.9 (0.78 – 4.2). Symptomatic individuals are more infectious than 
asymptomatic individuals, more so those with high viral load, the relative estimate for 
high viral load symptomatic shedders is given as High.Sym=6.7 (2.6 – 16). However, 
there are not enough instances where individuals have high viral load and are 
asymptomatic to quantify the relative infectiousness of this specific combination, the 
relative estimate for high viral load asymptomatic shedders, High.Asym, has a very 
wide 95% CrI. Given 71132 person days of observation (493 individuals * 180 days of 
data, minus days individuals were away), 1021 had RSV A shedding, of which 49 were 
asymptomatic high viral load shedding days, and 1227 had RSV B shedding with 49 
days of asymptomatic high viral load shedding. Given the inability to distinguish 
between the infectiousness of high versus low viral load asymptomatic shedders, we 
will not make this distinction in subsequent results and instead just refer to 
asymptomatic shedders in general. 
 
For a better understanding of the within household and community transmission 
coefficient parameters, we calculated the different rates of exposure and plotted them 
as shown in Figure 3. 3. 
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Figure 3. 3: Comparing the range of within household exposure rate and community 
exposure rate for a single susceptible individual given different heterogeneities in 
exposure and infectiousness.   
Top row: The box plots show the 0.025, 0.25, 0.5, 0.75 and 0.975 percentiles for the 
rate of exposure per person per day between a single susceptible and a single 
infectious housemateyUU_Wea÷?,T,Z→M(7)Ñ for RSV A (I) and RSV B (II). The 
distributions of rate are categorized by household size and the infectiousness based on 
viral load and symptom status (see text). Note: outliers have been removed from the 
box plots for better visualization. Bottom row: The shaded graphs show the range of 
values over time for the rate of exposure from the community to a single susceptible 
individualyn_oo_Wea÷M,T(7)Ñ for RSV A (III) and RSV B (IV). The graphs are color-
coded by the age group of the susceptible individual. The ranges for each age group 
are determined by the 95% CrI of the parameters that go into the calculations, hence 
the shaded regions show 95% CrI of the community exposure rate. 
 
Given two competing sources of infection, an infectious housemate and a source 
outside of the household, a susceptible individual is more likely to get infected within 
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the household rather than from the community. There is a suggestion that RSV A has a 
higher transmission potential at the household level relative to RSV B, while the 
situation is reversed at the community level. However, there is considerable overlap 
between the distributions of within household transmission coefficient for RSV A and 
that for RSV B as seen in Figure A2. 6, which shows the distribution of the parameters 
on the log scale, which is mirrored in the rate of household exposure shown in Figure 
3. 3. 
 
We observed some correlations in the estimated parameters. In particular there were 
strong positive correlations within the relative susceptibility by age parameters. The 
within household transmission coefficient for RSV A was strongly positively correlated 
with the within household transmission coefficient for RSV B. The age effects of 
susceptibility were strongly negatively correlated with the age effects on community 
exposure. Figure A2. 8 in the supplementary index shows all the pairwise correlation 
patterns.  
 
Given the posterior densities for the parameters, we calculated the source with the 
highest likelihood for each infection. While respecting the correlation patterns 
observed in Figure A2. 8, we sampled 10 different parameter sets and for each, we 
calculated the proportion of cases whose most likely source was an infectious 
housemate. The changes made to the likelihood equation to allow for this calculation 
are described in the appendix A2. For all the infection cases, 32-53% of them were 
attributed to transmission within the household. For RSV A, this range was 40-59%, 
while for RSV B it was 26-48%.  
 
To check if any information is lost when we have less data, we refitted the data in 
three additional ways: RSV A alone, RSV B alone and RSV with no distinction between 
groups. The results are shown in Table A. 1 in the supplementary index. In reducing the 
data used to infer parameters we notice that more posterior densities for the relative 
effect parameters now include 1 in their 95% credible interval, as can be expected. In 
general, the trends with age, household size and relative infectiousness, as seen in 
Figure A2. 6, are maintained. However, when RSV is treated as one entity, the 
protective effect of previous infection is reduced, symptomatic cases are more 
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infectious, and the estimate of the community transmission coefficient is increased. 
This suggests that misclassification of viruses disrupts the ability of the model to track 
transmission patterns, resulting in a greater propensity to account for infections as 
spontaneous.  
 
Model validation and sensitivity analysis 
To validate the model, we checked to see that the range of simulated epidemics 
contained the real data; then we chose a single simulation with known parameters and 
re-estimated to see if the posterior distribution contained the known values. Details of 
this process can be found in the appendix A2, but in general, we were satisfied that the 
model was working as expected. Figure 3. 4 shows multiple simulated epidemics for 
different parameter sets relative to the real data. From this we see that as with the 
real data, the simulations show the RSV B epidemic taking off earlier than the RSV A 
epidemic. There is a tendency for simulate epidemics to be larger than that observed 
in terms of total number of cases (Figure A2. 23). 
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Figure 3. 4: A comparison between the simulated data and real epidemics using 
simulations from 5 different parameter sets estimated from the full model (row 1 to 
5).  
First column: RSV A simulated epidemics (grey lines) compared to real data (thick black 
line). Second column: RSV B simulated epidemics (light blue lines) compared to real 
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data (thick blue line). Third column: RSV simulated epidemics (orange lines) compared 
to real data (thick green lines). 
We performed a sensitivity analysis to check the robustness of our results to the 
background community density function. We used 3 additional background functions 
and found that despite a change in summary values for the parameters, in general the 
trends were maintained. These results are shown in the appendix A2. They show that 
the results are robust to the choice in the shape of background community density 
function. 
 
Finally, we removed the largest household (which had a very large RSV A outbreak but 
only a single RSV B case) from the data to check if this would change the patterns of 
the within household transmission coefficients. The results, shown in the appendix A2, 
were robust to these changes. 
 
Following the validation of the model, we simulated epidemics altering the degree of 
infectiousness. Initially we reduced the infectiousness of symptomatic individuals to 
predict the effect of reducing RSV related ARI; then we assumed that asymptomatic 
individuals are not infectious in order to quantify the contribution of asymptomatic 
infections to transmission. The results show that reducing infectiousness of 
symptomatic individuals to the level of asymptomatic individuals lowers the 
distribution of total number infected. Assuming that asymptomatic individuals are not 
infectious also tends to decrease the total number infected (see Figure A2. 23 in 
appendix A2).  We also removed the asymptomatic shedding episodes from the data 
and re-estimated the parameters to check what the effect of only having sampled 
symptomatic individuals would be. We found that we lose precision in the estimates of 
the relative infectiousness parameters, previous infection is estimated as being more 
protective as is being ≥15 years old (Figure A2. 24 and Figure A2. 25). 
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3.7. Discussion 
We developed an individual based approach to make Bayesian based inference on 
transmission parameters using MCMC. We set out to better understand RSV 
transmission within a household setting using cohort data collected with 
unprecedented detail during the course of a single RSV epidemic in a rural coastal 
community in Kenya.  
 
Older individuals are less susceptible to detectable infection, presumably due to 
immunity acquired in previous epidemics. We found strong evidence of partial 
immunity to homologous re-infection within the same epidemic for the RSV groups. 
The effect of previous infections is captured in two different ways in our model. Age 
(Sus.age parameters) captures the combined effect of age and experience of 
epidemics prior to the one under study, while the estimates for the effect of previous 
observed infections (Prev.hom parameter), captures effect of infections in the current 
epidemic. It is therefore implicit that immunity to RSV is built up in the long term, from 
one epidemic to the next and in the short term from one infection to the next. The 
evidence for cross-immunity between RSV A and B was weaker, which presumably 
allowed the two virus groups to co-circulate in this epidemic. However, typically, RSV 
epidemics are dominated by one or other of group A or B and so the particular 
circumstances of this epidemic might not always hold. It remains to be explored how 
this individual level parameter estimate is translated into population dynamics.  
 
We found some evidence that individuals aged ≥5 years were the most likely to get 
infection from a community source (less likely to get infected during a household 
outbreak). This means that given our assumption of latent periods between 2-5 days, 
which forms the temporal link between cases, individuals ≥5 years were the most 
often identified as index cases in a household outbreak relative to the younger age 
groups. We have not considered an age-dependent latent period and estimating the 
latent period from these data is a future goal. The ≥5 years age group contains school 
going children and our result is in line with those of Munywoki et al 20, based on a 
different analysis of the same study, who found that school-going children were often 
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initiating household outbreaks. Establishing transmission chains using genomic 
information could strengthen this result. 
 
We have assumed that the community risk of infection changes smoothly over time 
and is homogeneous apart from an age effect. These assumptions are necessary as 
community infections are not completely observed. We are confident that these 
assumptions do not have significant influence on our estimates of within-household 
transmission (which is fully observed), but may result in an over-estimate of 
community exposure, which will be more heterogeneous than we have assumed. 
Consequently, the simulated epidemics are larger in total numbers than that observed, 
Figure 3. 4, and our results of up to one half of infections arising from within the 
household are likely to be a minimum. Data on genetic relatedness between viral 
isolates will clarify the extent to which individuals are infected from the community 
during a household outbreak.  
 
By separating RSV A and RSV B we find that RSV B has a higher rate of introduction into 
the household, and RSV A is more transmissible once in the household, an observation 
also made by 36 from a phylogenetic analysis of RSV A sequences. This, together with 
the fact that RSV A had a larger proportion of cases attributed to within household 
transmission, suggests that there might be some niche separation, explaining how and 
why these two different groups are able to co-exist and remain separate. It should be 
noted however that the difference in the distribution of the within household 
transmission coefficient between the RSV groups is not large, there is a substantial 
overlap of credible intervals. As such, whatever advantage RSV A might have over RSV 
B at the household level is small in terms of transmission but might be larger in terms 
of interaction with other respiratory viruses, and small differences in individual based 
parameters might translate into large population effects. In the present epidemic, the 
RSV B epidemic takes off earlier than the RSV A epidemic despite the first case being 
RSV A (Figure 3. 2). In addition to which, we see that despite RSV B infecting more 
households than RSV A, RSV A infects a larger proportion of household members 
(Error! Reference source not found.). An examination of the comparative dynamics of 
RSV A and B within epidemics might be a good way to understand how they interact. 
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With the definition of a household as a group of individuals living in the same 
compound and eating food from the same kitchen, we found that the pairwise rate of 
within household transmission is higher in small households than large ones. The 
relationship between household size and pair-wise rate of transmission has been 
observed before for Influenza, 11,12,14,15, however going a step further we show that if 
households are structured such that they can have at least 20 simultaneously 
infectious occupants (possible if several members of an extended family live in the 
same household as is the case in the present study) then larger households will tend to 
contribute more to transmission than smaller households.  
 
We looked at a combination of presence of symptoms and viral load to infer 
infectiousness. We found that being symptomatic is of key importance. In general, 
symptomatic individuals were more infectious, particularly if shedding large amounts 
of virus. Though this result is not surprising it has an important implication on vaccine 
effectiveness. If an RSV vaccine works by reducing or preventing disease in the form of 
an ARI, this will in turn have an impact on transmission potential and we should expect 
to see reduced morbidity and infection. To check what that potential impact of such a 
vaccine would be, we simulated epidemics where the infectiousness of symptomatic 
individuals was equal to that of asymptomatic individuals and we found a significant 
shift in the overall distribution of simulated case towards smaller total numbers 
infected. The shift was more for ages between 1 and 15 years, given that this group 
also had the larger fraction of symptomatic cases, the observation from simulations 
with reduced infectiousness suggests largely assortative mixing within this group, 
which in turn means largely assortative transmission. The number of cases in the <1 
year age group is not greatly altered by reducing the infectiousness of symptomatic 
individuals, implying that there are several sources of infection to the infant and 
reducing or removing only one has little impact Figure A2. 23.  
 
We reduced the model complexity to look at RSV as a single pathogen without 
distinguishing between groups. This resulted in skewing the parameter estimates away 
from within household transmission and towards spontaneous infection from external 
sources, as a result of introductions due to RSV A and RSV B being treated as multiple 
introduction of the same pathogen thus compounding the effect of community 
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transmission. This, in addition to the reduced protective effect of previous infection 
due to misclassification of re-infections, led to the within household transmission 
parameter being underestimated in order for the model to account for the observed 
number of infections. In addition, temporally linking RSV A and B cases as a result of 
misclassification also led to the effect of symptoms on transmission being 
overestimated. This suggests that the estimates obtained in the present analysis are 
likely to change if we further classified the cases into RSV subgroups. This goes to 
illustrate the importance of making distinctions between pathogens in order to obtain 
accurate estimates of transmission parameters. At any given moment multiple 
pathogens are co-circulating in a host population, this household study alone had 
multiple viruses spreading in large numbers during the time of data collection 45. How 
these pathogens interact could have dramatic implications for parameter estimates, 
and ultimately on how control strategies are implemented. We have seen the effect of 
the pneumococcal vaccine on the non-vaccine serotypes and how it might mitigate 
vaccine effectiveness 46 and a study on influenza has shown evidence of its controlling 
effect on other pathogens 47. There is an increasing call from such observations to 
understand how multiple pathogens interact at the host population level.  
 
Our study is not without limitations. The households in the study were selected based 
on the presence of an infant born after the previous RSV epidemic and older siblings to 
the infant in order to determine who infects the infant. As such the sample is not 
random and this might introduce bias in the parameter estimates, the extent of which 
we are uncertain. Relative to other studies, our sample size in terms of number of 
households is small. However, the intensive sampling regardless of symptoms means 
we had less biased observation of infections relative to index-case ascertained 
household studies that rely on symptom reporting by household contacts. In our study 
we had 47.2% of RSV A and 40.2% of RSV B positive samples that were symptomatic, 
60.8% of RSV A and 55.2% of RSV B episodes were symptomatic. Estimation of 
parameters only using data from symptomatic episodes shows similar parameter 
estimates, although with loss of precision, especially in terms of differential 
infectiousness Figure A2. 24. In addition, sampling was done every 3 or 4 days, which 
means that short duration infections might have been missed, and we do not have 
serological data to complement the PCR results. There were 14 instances of RSV A and 
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RSV B co-infections, 7 of these were apparent co-onset shedding episodes. Our 
method of imputing the start of a shedding episode is based on the gap between the 
last negative sample before the first positive sample of the episode, and the first 
positive sample of the episode. For the co-onset cases, this gap ranged between 3-4 
days, and the start of onset was imputed as being halfway between the gap. These 
may or may not be true co-onset cases, it would require the existence of daily 
sampling to confirm. Treating the start and end of a shedding episode as augmented 
data is an alternative to the mid-point estimation, if applied that could lead to 
different onset days being inferred.   
  
The present analysis could be extended in several ways. We used interpolated 
shedding durations; it would be an added advantage to use the data to estimate a 
distribution of shedding durations that could potentially be more generalizable. The 
inclusion of other sources of information into the analysis could improve parameter 
inference, as was the case with Li et al and the inclusion of genetic data 48. The 
inference made on within-household transmission compared to community 
transmission is based on the latency distribution that links onset of cases. This is a 
temporal linking of cases that is not always correct. A combination of temporal and 
genetic distance would allow better inference on linked cases and consequently the 
competition between within-household and community source transmission. Finally, 
the RSV A and B model could be used to look at other pathogen interactions and 
perhaps incorporate more than two pathogens. 
 
In conclusion, our analysis presents the first transmission modelling of cohort data for 
RSV and we find that it is important to factor in household size and social structuring – 
such as the tendency for households to contain several members of the extended 
family – when modelling transmission. It is also important to model competing risks of 
infection from within the household and the community. There are questions on the 
mechanisms that allow co-existence of RSV groups temporally and geographically. The 
weak cross immunity between RSV groups demonstrated by our analysis and the 
possibility of different transmission niches could form part of the explanation for the 
co-existence.   
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4. Paper 2: Integrating epidemiological and genetic data with 
different sampling densities into a dynamic model of RSV 
transmission. 
4.1. Overview  
This chapter was written in fulfilment of the second part of the second objective, and 
the third objective. It is an extension of the methods developed in the previous 
chapter. As with the previous chapter, this chapter is written in the format of a 
publication and we intend to submit it to a journal with the running title: Integrating 
epidemiological and genetic data with different sampling densities into a dynamic 
model of RSV transmission.  
4.2. Role of candidate  
I formulated the problem, conducted the numerical analysis and wrote the first draft 
of the chapter. Revisions were made with feedback, input and guidance from my 
supervisors Graham F. Medley and D. James Nokes, and advisor Marc Baguelin.   
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4.3. Abstract 
Respiratory syncytial virus (RSV) is responsible for a significant burden of respiratory 
illness in children under 5 years old. A maternal vaccination against RSV disease has 
recently completed phase III trials where it was reported as being modestly efficacious. 
Prior to rolling out any vaccination program, a clear understanding of the transmission 
dynamics in necessary in order predict which vaccination strategies would be the most 
effective. We built a dynamic model calibrated at the individual host level that 
integrated social-temporal data on shedding patterns and genetic clustering patterns 
derived from a phylogenetic analysis. Through aggregating the genetic information 
into clusters and the use of data augmentation, we were able to integrate data types 
of different sampling densities into a single framework. In this study population of 493 
individual with 55 infants under the age of 1 year distributed across 47 households, we 
found that 52% of RSV B and 60% of RSV A cases arise from infection within the 
household.  Fifty-five percent of infant RSV A infections occur in the household, as do 
36% of infant RSV B. Frequently the source of infant infection is a child aged between 2 
and 13 years living in the same household at the infant. These results further highlight 
the importance of school-aged children in RSV transmission, particularly the role they 
play in directly infecting the infant at the household level. This age group could provide 
an alternative vaccination target group. 
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4.4. Introduction 
Ever since the term phylodynamics first came into use in 2004 1 there has been an 
increasing interest to analyse genetic sequences of pathogens while accounting for the 
epidemiology of the infection: the main question being, how do the pathogen’s 
transmission dynamics shape the observed genetic relationships and conversely, how 
does the evolution of the pathogen influence how it is transmitted? Developing the 
methodology that accurately captures both the epidemiological and evolutionary 
processes, and that is computationally tractable is challenging. The field of 
phylodynamics has grown to include other multiple data types, more so to determine 
transmission chains during an outbreak2–4. A range of methods have been developed 
with variations observed in the nature of sequence data (single 2,3,5,6 versus multiple 7,8 
sequences per infected host ); complexity of genetic model (coalescent 7,9,10 versus 
simple genetic distance models5); complexity of transmission model (dynamic 
transmission models 2,11,12 versus simple temporal distance models4,5); generalizability 
across pathogens (often available in packages such as SCOTTI7, Outbreaker5,6, 
PhyDyn13, TransPhylo14); types of data (sequences and collection dates5,7,12; sequences, 
collection dates and location of host3,4; sequences, collection dates and contact data2) 
and ability to account for unsampled cases 5,7,12,14. A recent attempt has been made to 
compare the utility of several methods, and though only 9 published models were 
used, the authors came to the conclusion that “Each model had its own strengths 
related to the purpose for which it was developed, and limitations related to its 
assumptions” 15. It is therefore crucial for investigators to bear in mind their specific 
study design in choosing a method to adopt. 
 
Despite the existence of a wide assortment of methods for integrated epidemiological 
and evolutionary analyses, most of them use data types that are at the same sampling 
density, meaning there usually are as many cases as are identified by the generated 
sequences. To account for there being cases without sequences, some methods 
estimate or fix the fraction of the outbreak that is unobserved5–7,12,14. Uniquely, the 
method developed by Lau et al can explicitly model confirmed cases that do not have 
sequence data since the method imputes missing sequences12. There have been great 
advancements in the generation of pathogen genetic sequences, however, whole 
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genome sequencing is not always successful, more so when the pathogen is present at 
low loads within the host. Given that it might not always be possible to generate 
genetic sequences for a majority of samples from an outbreak, it would be useful if an 
analysis technique can simultaneously make use of the sequence data where available, 
and more readily available spatial or social-temporal shedding patterns to make 
inferences on transmission characteristics. In this article, we model social-temporal 
data from an outbreak of respiratory syncytial virus (RSV) and genetic data that covers 
~50% of the observed cases to infer the determinants of transmission within a group 
of households over a 6-month follow-up period.  
 
Respiratory syncytial virus infects all age groups but causes a significant lower 
respiratory disease burden in children <5 years old, more so in < 6 months old, and the 
elderly 16–18. RSV virus is a negative stranded RNA virus (length ~15,200 bases) that 
exists in two antigenically and genetically distinct groups estimated to have diverged 
350 years ago 19. It spreads in seasonal patterns with most places experiencing annual 
cycles 20–23. Phylogenetic analysis of RSV whole genome sequences from different 
countries that span several years have estimated mutation rates between 6 × 10}‰ 
and 7 × 10}‰ substitutions/site/year 24–26. These studies found that the clustering 
pattern of RSV sequences in the long term is more temporal than geographical. In the 
short term, changes in the dominant transmitting genotype have been used to 
understand transmission patterns, as has been the case with studies looking at the 
distribution of the RSV A ON1 genotype 27–29. Genotype replacement from one RSV 
season to the next is common 23,30,31, however short term changes to the genome over 
the course of a single epidemic could help to determine transmission chains across a 
limited geographical space. It is such short-term changes observed in the RSV genome 
that we exploited in the analysis presented here. 
 
The model we use is an extension of our previous work where we successfully used 
social-temporal patterns of shedding coupled with demographic information on the 
host to identify symptom status and virus load, household size, age and recent 
infection history as determinants of transmission at the individual level. In addition, by 
virtue of RSV A having slightly higher estimates of the parameter quantifying within 
household transmission relative to RSV B, we hypothesized that RSV A having might 
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have a transmission niche at the household level 32. The question we aim to answer is 
whether increased resolution in pathogen identification improves inference on 
transmission characteristics; do weak signals in previously inferred parameters, e.g. a 
slight difference in the within-household transmission coefficient for RSV A relative to 
RSV B, become clearer? The easiest place to start would be to build on an existing tool 
for data integration. The ‘Outbreaker’ model 5,6 takes a modular approach by 
establishing a model for the epidemiological data (epidemiological likelihood) and 
another for the genetic data (genetic likelihood) and then combines these into a single 
likelihood for inference on parameters and transmission pairs given genetic sequences 
and their dates of collection. This modular approach can be used with different data 
types; temporal (sampling times or exposure data), genetic and spatial 3,4,12. An 
alternative, more classical phylodynamics approach, would be to link the equations of 
the epidemiological model to the rate of coalescence of the model of evolution and 
estimate parameters based on the genetic sequences as was the case in the Li et al 
model 33. Joint inference of epidemiological and genetic characteristics would be ideal, 
however writing down a likelihood and developing an inference technique given 
different data densities is not straightforward, as demonstrated by Lau et al 12 and, 
depending on what fraction of the outbreak is missing genetic information, an attempt 
at joint inference can lead to significant inaccuracies even for fairly sophisticated 
methods15. Instead, we will take the two-staged approach of first ‘learning’ from the 
sequence data and then using the inferred traits within the epidemiological model, 
similar to14,34–37.The aim of our analysis is therefore to attempt to enrich the densely 
sampled epidemiological data with the genetic data that is available at a lower 
sampling density.  
  
 109 
4.5. Methods 
The model that we extended for this analysis is an individual level transmission model 
that is calibrated by day and individual host (see Chapter 3). The individuals 
represented in the data are grouped into households according to the demographic 
information provided. Individuals can get infected within the household from a 
sampled infectious individual or from an unsampled infectious individual outside of the 
household represented by a background community rate. Distinctions are made 
between RSV A and RSV B group infections and interaction between the two groups is 
modelled through modified susceptibility to heterologous group reinfection. Further 
details can be found in 32.    
 
The data used in the present analysis consists of shedding durations imputed from the 
results of samples collected every 3-4 days, information on symptom status and 
information on presence or absence from the household.  Given the discontinuity in 
the sampling, complete shedding, ARI and presence/absence durations had to be 
imputed. This imputation process has been described in detail in A2: Supplementary 
appendix for Paper 1. In brief, an RSV A/B shedding episode is defined as a period 
within which an individual provided PCR positive samples for RSV A/B that were no 
more than 14 days apart. A shedding episode is referred as symptomatic if within the 
window of virus shedding, there is at least one day where symptoms were recorded. 
The symptoms of interest are those of an acute respiratory illness (ARI), which are: 
cough, or nasal discharge/blockage, or difficulty breathing. Individuals are assumed to 
start shedding halfway between the last negative sample and the first positive sample 
of the episode, and they stop shedding halfway in between the last positive sample of 
the episode and the first negative sample. In the same way, complete ARI durations 
are imputed within shedding episodes and complete presence/absence durations are 
imputed for all the days of data available for a particular individual. There are some 
instances where an individual was present but not sampled, as such, presence could 
not purely be identified by the availability of NPS samples. Imputation was chosen over 
data augmentation to ensure consistency across studies analysing the same household 
dataset38–40. 
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In the same way that a shedding episode can be identified as RSV A or RSV B, we used 
the sequence data to further classify shedding episodes into genetic clusters.  These 
genetic clusters are then treated in the same way as genetic groups in the model. 
Transmission is allowed between members of the same cluster but between clusters 
transmission is not. Figure 4. 1 illustrates how cases can become disconnected with 
addition of genetic information. If all the cases are identified at the pathogen level 
(i.e., all infecting viruses are alike), then the timing of cases is the only thing that 
informs possible transmission clusters. With information on RSV group, one knows 
that there are at least 2 transmission clusters since an RSV A case could only have been 
infected by another RSV A case, and so forth with the genetic clusters.   
 
 
Figure 4. 1: Illustration of how cases become disconnected with added pathogen 
information 
 
The sequences available from the outbreak are grouped into clusters according to a 
combination of criteria based on: nucleotide distance cut-off, clustering patterns on 
the global RSV phylogenetic tree and the inferred date of sequence divergence. Details 
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of this phylogenetic analysis can be found in 41. Figure 4. 2, part of Figure 2 in the 
original paper, shows the time-resolved maximum likelihood phylogenetic trees for 
RSV A and RSV B showing the estimated node edges and assigned clades and sub-
clades. RSV A clustered into one clade with 5 sub-clades while RSV B clustered into 5 
clades, two of which had two sub-clades each. For our analysis we do not make a 
distinction between clades and sub-clades as such we use 5 clusters for RSV A and 7 
for RSV B.  
 
 
Figure 4. 2: Time-resolved maximum likelihood phylogenetic trees for RSV A and RSV 
B from the Agoti et al 41phylogenetic analysis.  
 
4.5.1. Imputing missing genetic information 
We did not have whole genome sequences for all the positive samples and as such, we 
needed to impute information where it is lacking. We decided to impute cluster 
identity rather than sequences, choosing to look at genetic clusters as a way to 
aggregate genetic information. Augmenting sequences has previously been done by 
Lau et al 42,  but we proposed to use a simpler approach which does not need any 
assumptions on sequence evolution. Within a given RSV group, infection by a 
particular cluster is assumed to be a mutually exclusive process, an individual can only 
shed one cluster type at a time. The genetic data available is consensus whole genome 
sequences as such, only one cluster can be identified from a single sample. There are 
two levels of missing sequence data: - Partially missing. Where only some of the positive samples in an episode have 
sequences.  
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- Completely missing. None of the positive samples in an episode have 
sequences 
 
Partially missing 
If all the sequences within a particular shedding episode belong to the same genetic 
cluster, then this cluster id is assigned to every day of the shedding episode. If the 
sequences belong to multiple clusters say C1 and C2, the duration of shedding each is 
divided such that the first day of shedding up to and including the last day where C1 
appeared are assigned cluster C1, subsequent days are assigned C2 up until the end of 
shedding, and so forth for >2 cluster identities. 
 
Completely missing  
Here we make a further distinction between cases that are part of a household 
outbreak that has some genetic information, and those that are not. Cases in a 
household will be assumed to be in the same outbreak if, either there is an overlap in 
shedding period, or the time between end of shedding of one case and onset in 
another is ≤5 days. Cluster assignment will proceed as follows: 
 
• Cluster assignment for cases that are part of a household outbreak with at least 
one sequence will depend on the identity of the closest temporal known 
cluster in the household outbreak. If there is more than one cluster option, this 
case is left unassigned. The assignment is done sequentially beginning with the 
case with the earliest onset. Given that this is a deterministic process, these 
assignments are maintained throughout the fitting process.  
 
• Cluster assignment for cases that are part of a household outbreak with no 
sequence information. For such cases, the cluster assigned to the entire 
outbreak is inferred along with model parameters. The option of possible 
cluster assignment is chosen from the pool of possible clusters. Cases left 
unassigned by the previous step also have their cluster identity inferred.  
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A spatial-temporal clustering algorithm was attempted using a distance metric similar 
to 43. To validate the algorithm, we blinded the algorithm from known clusters, and 
had it impute them. Over 50% of the time, the algorithm failed.  
 
We also investigated if within cluster variation is informative of transmission events. 
There is evidence that the clustering pattern mimics closely the household structure41 
and in such a case, the model might not learn much from the genetic clustering alone. 
We therefore derived genetic distances between cases in the same cluster, which were 
used to weight the transmission link between said cases.  
 
4.5.2. Deriving genetic distances between cases 
Consider a case i who had an onset after case j, both of whom have sequences. The 
genetic distance between case i  and j is obtained by comparing the first sequence 
available from case i and any sequence from j whose sampling time is closest to the 
first sequence from i. In the illustration below, this would mean comparing sequence 
Si,1 to Sj,2 to obtain genetic distance dgen(i,j). The phylogenetic analysis of Agoti et al 41 
found that long shedding episodes do not have drastically differing genetic sequences 
(<6 SNPs) as such it should not make a significant difference whether we compare 
sequences forward (Si,1 to Sj,2) or backward (Si,1 to Sj,1) in time. 
 
 
If either one or both of the cases do not have sequences, then the genetic distance is 
obtained from randomly sampling from the set of all pair-wise genetic distances from 
the specific genetic cluster. For cases with sequence data, dgen(i,j) is fixed, but for cases 
where one or both is missing sequences, dgen(i,j) changes every time the likelihood is 
calculated to reflect uncertainty. In this way only pairs of cases with sequence data 
Time	
Case	j	
Case	i	
t1	 t2	
Sj,1	 Sj,2	
Si,1	 Si,3	Si,2	
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contribute definitive genetic information to the parameter inference algorithm while 
the rest will not. We use nucleotide differences as the distance dgen(i,j). 
 
Once we have dgen(i,j), we then use this to obtain a genetic weight for the probability 
of a transmission event given by ÊZ→M = Y|v}EÀßÁ(M,Z)∗Ë where È is the rate of 
exponential decay and is estimated along with other model parameters. This function 
form results in a negative exponential relationship between the genetic weight and the 
genetic distance between a pair of cases. As part of uncertainty analysis, we will 
explore an additional function form where ÊZ→M  is a step-function such that ÊZ→M =1	eR	dTCL(e, Í) 	≤ È, 0	_7ℎYu’eaY, where È now becomes a nucleotide distance cut-off 
for within cluster transmission that is estimated along with other model parameters.  
4.5.3. The transmission model 
We extend the model in Chapter 3 to track cluster-specific infection onset at the 
individual host level. We create 3 levels of hierarchy in pathogen identification within 
the model. At the top level of the structure is identification by pathogen type, at the 
second level is identification by RSV groups and at the third level is identification by 
genetic clusters within groups. This hierarchy is in place to allow estimation of some 
parameters at the pathogen level and others at the group level while identifying the 
infecting pathogen at the cluster level. The model in Chapter 3 had 2 levels of 
hierarchy.  
 
Similar to the previous model, everyone is assumed to be susceptible to RSV infection 
at the start of the outbreak, but the risk of infection is dependent on age. Once 
individuals have been exposed to infection, they enter a latency period that ranges 
between 2 to 5 days after which they become infectious. After the infectious period, 
individuals become susceptible to infection again, but the risk to subsequent infection 
is modified, i.e. RSV confers partial transient immunity that lasts as long as the 
outbreak is ongoing. This partial immunity is assumed to be different for heterologous 
group re-infection and homologous group re-infection. Individuals can get 
heterologous group co-infections, however, different from the model in the previous 
chapter, we explore if susceptibility to infection by RSV A is modified if an individual is 
currently shedding RSV B, and vice-versa.  
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Let’s denote the rate at which individuals get exposed to infection (rate of exposure) 
as 5. In our model, an individual can get infected by someone they share a household 
with or from a source outside the household, resulting in a two-component rate of 
exposure. In a simplified form, we have:  
 
 
5(7) = >: ∗ < =(7)?@ABC?@DE F + HI ∗ < =(7)J@KKALMNO P 
In the previous model, we represented infectious community contacts using a bell-
shaped curve that mimicked ongoing transmission dynamics. In this chapter, two 
changes are made to the community rate of exposure. First, we explore the possibility 
of transmission between sampled households by introducing a term in the rate of 
exposure representing risk from sampled neighbours. The risk from sampled 
neighbours is weighted by a spatial distance kernel which modifies the risk based on 
the spatial distance between individuals. Second, because we are now modelling the 
rate of exposure to a specific RSV cluster, deriving a bell-shaped curve to mimic 
outbreak dynamics for specific clusters is no longer appropriate due to the low number 
of some cluster specific cases that resulted in unexpected curve shapes. Details of the 
new formulation of the background cluster-specific community function can be found 
in the subsequent section. The rate of exposure now takes the form: 
 
 
5(7) = Ï: ∗ < =(7)?@ABC?@DEJ@LNqJN Ì + I ∗ ⎝⎜⎜
⎛
⎝⎜
⎛ < =(7)BqK¤DCELCMT?Ò@A⁄ ⎠⎟
⎞ + R(7)⎠⎟⎟
⎞
 
λ(t)	=	[baseline	household	rate	of	exposure	*	number	of	infectious	household	contacts(t)]
+	
[baseline	community	rate	of	exposure	*	number	of	infectious	community	contacts(t)]
λ(t)	=	{baseline	household	rate	of	exposure	*	number	of	infectious	household	contacts(t)}
+	
{baseline	community	rate	of	exposure	*	[number	of	infectious	neighbour contacts(t))	+	
background	community	function(t)]}
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In detail, we present the model by specifying the rate of exposure to a particular RSV 
cluster c acting on a susceptible person i from household h at time t, denoted 5M,?,J(7) 
as:  
 
5M,?,J(7) = óM,T(7) ‹mM,?(7)<UU_WX7Y?,J,Z→M(7)Z¨M
+	n_oo_WX7YM,J(7)‡										…		(±≤	4.1) 
Where: óM,T(7) is the factor modifying exposure by recent group specific infection history, age 
and group specific shedding status at time t given by: 
 óM,T(7) = exp yõú,?MBNQ=iRYj7e_i_Uea7_ulM(7)S +	õå,qTCQstY_tu_`vã,MS+ õˆ,JA⁄⁄QóℎYddeit_a7X7`aM(7)SÑ 
 UU_WX7Y?,J,Z→M(7) is the cluster specific within household exposure rate from 
infectious individual j present in the household at time t, and is given by:  
 UU_WX7Y?,J,Z→M(7)= 	 :T 	× 	]^(U_`aYℎ_cd_aefYM) 	× 	]g,MLhQ=iRYj7eke7lZ,?,J(7)S 	× 	mZ,?(7) 
 n_oo_WX7YM,J(7) is the cluster specific community (external to the household) 
exposure rate given by: 
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n_oo_Wea÷M,J(7)= It 	
× 	]r,qTCQstY_tu_`vr,MS⎝⎜⎜
⎛
⎝⎜
⎛me,ℎ(7) < óXovcYd_xYetℎ‘_`u_Wea÷?,J,Z→M(7)Í≠e,			Í	i_7	ei	e′a	ℎ_`aY ⎠⎟
⎞	
+	Rj(7)⎠⎟⎟
⎞
 
Where: óXovcYd_xYetℎ‘_`u_Wea÷?,J,Z→M(7) is the cluster specific exposure rate from 
sampled infectious individual j present in a neighbouring household at time t, and is 
given by: óXovcYd_xYetℎ‘_`u_Wea÷?,J,Z→M(7)= ]g,MLhQ=iRYj7eke7lZ,?,J(7)S 	× 	¯Qde,Í, ˘S 	× 	mÍ,ℎ(7) 
The parameter ˘  is the rate of exponential decay for the spatial distance kernel given 
by ¯QdM,˙, ˘S = 	 Y}˚∗Eç,¸. 
 
The background community function  
We define a background cluster-specific rate of exposure, RJ(7), which affects 
susceptible individuals outside their household. This background function allows for 
introduction of new transmission clusters. The function form for a cluster c at time t is 
given as  RJ(7) = ˝ + < YQN}˛ç,àSˇM	B?CEEMLTpãŸ	JDABNC⁄	J  
Where ˝ is the basic risk prior to any observed onsets and ! is the rate of exponential 
decay related to the time since onset of a case shedding cluster type c, ! is a measure 
of the rate at which the cluster might disappear from the community and "M,J  is the 
onset time of RSV cluster type c by person i. The parameters ˝ and ! are not cluster or 
group specific. The sum of the cluster specific curves has to add up to the group 
specific curve, otherwise using clusters could lead to an over or under representation 
of the background community exposure rate. To ensure that ∑RJ(7) = RT(7) we need 
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to normalize the cluster level curves such that their sum adds up to the group level 
curve.  A description of how this was done can be found in the appendix section A3: 
Supplementary appendix for Paper 2. 
 
Table 4. 1 lists all the parameters in the model and gives a brief description. Despite 
identifying the infection pathogen at the cluster level, we do not have any cluster-
specific parameters in the model. 
 
Table 4. 1: Model parameters and their descriptions 
Parameter 
(symbol) 
Parameter 
(name) 
Description 
øπ Prev.hom, 
Prev.het 
Coefficients modifying susceptibility to infection by a 
particular RSV group depending on infection history. 
Prev.hom estimates the effect of a previous homologous 
group infection, while Prev.het estimates the effect of a 
previous heterologous group infection øª Sus.age.2, 
Sus.age.3, 
Sus.age.4 
Coefficients modifying susceptibility to RSV depending 
on age. Sus.age.2 estimates the effect being in age 
group 1-4 years, Sus.age.3 the effect of group 5-15 and 
Sus.age.4 of group ≥15 relative to group <1 year. ø# Curr.het Coefficient modifying susceptibility to a particular RSV 
group based on shedding status of the heterologous 
group type ƒ∑ HH.rsv.a, 
HH.rsv.b 
Baseline rate of within household exposure by RSV 
group, per person per day.  √Ω HH.size Coefficient modifying the amount of within household 
exposure by household size. HH.size estimates the 
effect of being in a large household(>8 inhabitants) 
relative to a small one $ Gen.rate For ÊZ→M = Y|v}EÀßÁ(M,Z)∗Ë the genetic distance kernel 
giving the genetic weight on probability of transmission, 
Gen.rate is the rate of exponential decay.  
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√¥ Low.Sym 
High.Sym 
Coefficients modifying infectiousness by viral load and 
symptom status. Relative to being asymptomatic, 
Low.Sym estimates the effect of shedding low viral load 
and being symptomatic and High.Sym the effect of 
shedding high viral load and being symptomatic «∑ Comm.rsv.a 
Comm.rsv.b 
Baseline rate of community exposure by RSV group, per 
person per day. √æ Exp.age.2 
Exp.age.3 
Coefficients modifying the rate of community exposure 
by age group. Exp.age.2 estimates the effect being in 
age group 1-4 years and Exp.age.3 the effect of group 
≥5, relative to the <1-year age group % Dist.rate The rate of exponential decay for the spatial distance 
kernel given by ¯QdM,˙, ˘S = 	 Y}˚∗Eç,¸ 		 2,& Delta, 
Beta 
For the cluster specific background community function 
given by  RJ(7) = ˝ + < YQN}˛ç,àSˇM	B?CEEMLTpãŸ	JDABNC⁄	J  
Delta(˝) is the basic risk and Beta(!) is the rate of 
exponential decay related to the time since onset of a 
case shedding cluster type c. 
 
Following from the rate of exposure is the probability of exposure to cluster c given an 
exposure event has occurred, expressed as: 
Probability of exposure = prob(any exposure event) * prob(exposure to cluster c)  M,?,J(7) = Q1 − Y|v}∑ ç,§,à(N)'≠ S ∗ ( 5M,?,J(7)∑ 5M,?,J(7))≠ * 										…		(±≤	4.2) 
 
Where n+is the set of all clusters in a given RSV group. 
This formulation factors in the fact that on any given day, an individual can only be 
shedding virus from a single cluster, in the respective group, this can be seen in the 
shedding patterns shown in Figure 4. 5. The clusters are therefore competing for 
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susceptible hosts. Exposure events are mutually exclusive and distributed according to 
a multinomial distribution. We thus have  ,vu_‘(i_	Y|v_a`uY) + < vu_‘(Y|v_a`uY	7_	jc`a7Yu	j)ﬂDD	JDABNC⁄B - = 1 
 
 
Assuming that the duration of latency can range from 0 to 5 days with probabilities [0, 
0,0.33,0.33,0.25,0.083] 44, we then have the following probability of onset at time t 
given no onsets or shedding until t: 
vM,?,J(7) =<ÕD M,?,J(7 − c)ŒDœ–  
Where L is the maximum latency period and ÕD  is the probability that the latency 
period is exactly c days. In this way, the genetic clusters are used together with the 
spatial/social clusters (households) and the latency distribution (which implicitly works 
based on temporal clusters) to make joint inference on transmission parameters. 
 
The likelihood  
Since the model is focused on the determinants of infection onset process, the data 
whose likelihood we are interested in is the onset data. Given the model described, 
the likelihood of an individual’s observed cluster c data is the probability of all the 
onsets, and days of no onsets where the individual was at risk of infection, i.e. not 
shedding RSV cluster c. For a particular cluster, this follows a Bernoulli distribution 
with probability vM,?,J(`). 
 
For i with no onset of type c: 
—M,J = 	“.1 − vM,?,J(7)/0Nœ.  
Where T is the end of the observation period.  
For i with an onset of type c, the likelihood is give as: 
—M,J = ‹H “ vM,?,J(`)A∈1LBCNBç,§,à P ∗ H “ y1 − vM,?,J(X)Ñq∈ﬂN2ç34ç,§,à P‡ 
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In this instance, to factor in the genetic data we modify the rate of exposure given in 
(Eq 4.1) such that: UU_Wea÷?,J,Z→M(7)= 	 :T 	× 	]^(U_`aYℎ_cd_aefYM) 	× 	ÊZ→M 	× 	]g,MLhQ=iRYj7eke7lZ,?,J(7)S 	× 	 	mZ,?(7) 
 óXovcYd_xYetℎ‘_`u_Wea÷?,J,Z→M(7) = ÊZ→M × ]=,j,Í(7) 	× 	¯Qde,Í, ˘S 	× 	mÍ,ℎ(7) 
With this formulation, the genetic components of the model are dependent on the 
epidemiological in that they are not expressed independently in the likelihood function 
as is the case with modular approaches such as the kind implemented in the 
Outbreaker package5,6. We introduce ÊZ→M  into the rate of exposure equation as 
opposed to directly into the likelihood because for a given case, we are not making 
direct inference on the source of infection or the exact date of exposure: we consider 
all likely dates and sources given the latency distribution. 
 
The total likelihood is thus given by the product of —M,J  over all the genetic clusters and 
individuals in the data 
 
— = 	“‹“‹H “ vM,?,J(`)A∈1LBCNBç,§,à P ∗ H “ y1 − vM,?,J(X)Ñq∈ﬂN2ç34ç,§,à P‡J ‡M  
4.5.4. Inference of model parameters and augmented data 
We used Bayesian inference to obtain estimates of the model parameters j= 
{Prev.hom, Prev.het, Sus.age.2, Sus.age.3, Sus.age.4, Curr.het, HH.rsv.a, HH.rsv.b, 
HH.size, Gen.rate, Low.Sym, High.Sym, Comm.rsv.a, Comm.rsv.b, Exp.age.2,Exp.age.3, 
Dist.rate, Delta, Beta} and the augmented data DA given the observed data D. In brief:, 
Bayesian inference results in an updated distribution of the parameter of interest 
(posterior distribution) given prior assumptions/knowledge of the parameter (prior 
distribution) and an expression giving the probability of a parameter value given data 
(likelihood) i.e. Ê(5|6,6ﬂ) ∝ Ê(5) × 	—(5|6,6ﬂ).  
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The adaptive MH-MCMC algorithm is a popular first step for a situation where the 
target distribution is not simple, and the dimension of the parameters is not small. As 
we have a total of 19 parameters this seemed a natural starting point. We assume that 
all the cases were observed but that for some of the cases, there is no information on 
the cluster id of the shedding episode, as such, the augmented data is the set of all 
shedding episodes whose cluster id was left unassigned by the imputation process 
previously described. These include cases that are part of household outbreaks with no 
genetic information and cases that are part of household outbreaks with more than 
one possible genetic cluster id. For cases that are part of an outbreak with no genetic 
information, a single cluster id is inferred for all the cases in the household outbreak. 
For a brief explanation of our implementation of MH-MCMC, see appendix section A3.  
 
We initiated 3 chains and set the algorithm to start adapting the proposal distribution 
based on accepted parameters after 10000, 15000 and 10000 iterations respectively. 
Burn-in was assessed visually after which the results of the three concurrent chains 
were combined to infer the posterior distribution. The three chains were run for 
250,000 iterations each. The parameters were estimated on the log scale. All the 
computation was done using the julia language45 (version 1.1) 46. The code is freely 
available under the GNU Lesser General Public License v3.0 and can be found at 
https://github.com/Ikadzo/HH_Transmission_Model. 
 
4.5.5. Highest probability transmission source 
Following the estimation of the posterior parameter distribution, we randomly 
selected a subset to determine infection sources for very case.  For every case 
observed in the data we identified the transmission source that had the highest 
likelihood given the data and a parameter set 5∗ sampled from the joint parameter 
posterior distribution (highest probability transmission source: HPTS). Consider a case i 
,with onset date TM1. Given our assumption of a maximum latency duration of 5 days, 
we define a time window where potential infection could have occurred. For each day 
in the time window, potential sources of infection are {ΩM.,ΩMï …ΩML} . An infection 
source is assigned if it gives the highest value of i's likelihood defined as “ the 
likelihood of i's onset date, infection date and infection source given sample 
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parameter set 5∗.  Further details of the likelihood function used to identify the HPTS 
can be found in appendix section A3.  A hundred parameter sets were sampled and the 
HPTS for each case established for each sample. From the distribution of 100 HPTS, the 
one with the highest frequency was selected as the source of transmission.  
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4.6. Results 
4.6.1. The data 
Prior to model fitting, we look at the patterns of the sequence data. The table below 
quantifies the missing data problem by giving the number of sequences available by 
RSV group, shedding episode, person and household. 
 
Table 4. 2: A summary of the distribution of sequences 
  RSV A RSV B 
No. Samples 250 306 
No. Samples with sequences 103 (41.2%) 88 (28.8%) 
No. Episodes 97 125 
No. Episodes with sequences 54 (55.6%) 54 (43.2%) 
No. People infected 88 113 
No. People infected with sequences 50 (56.8%) 53 (46.9%) 
No. Households 25 34 
No. Households with sequences 9 (36%) 15 (44.1%) 
 
Given the genetic clusters imported from the clades and sub-clades of Agoti et al 41,  
Figure 4. 3 and Figure 4. 4 show the distribution of pair-wise nucleotide difference 
between sequences in the same genetic cluster for RSV A and RSV B respectively.  
Figure 4. 5 shows the distribution of sequences across the temporal shedding patterns 
and the results of the cluster duration imputation previously described. 
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Figure 4. 3: Distribution of pair-wise nucleotide distances between RSV A sequences. 
Top row, the first distribution shows all the pair-wise distances, the subsequent figures 
show the distances by cluster.  
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Figure 4. 4: Distribution of pair-wise nucleotide distances between RSV B sequences.  
Top row, the first distribution shows all the pair-wise distances, the subsequent figures 
show the distances by cluster.  
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Figure 4. 5: Distribution of available sequences across shedding episodes (left) and 
the results of imputation of cluster durations (right).  
RSV A data is shown in the top row shows and RSV B is shown at the bottom. 
Imputation of cluster shedding durations was done for episodes that had at least one 
sequence, and for episodes with no sequences but that were part of a household 
outbreak with at least one sequence. 
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4.6.2. Inference on model parameters 
The median and 95% credible intervals of the 19 parameters inferred using the model 
and data with three levels of hierarchy in pathogen identification are shown in Table 4. 
3. The trace plots showing the results of the MCMC algorithm are given in A3: 
Supplementary appendix for Paper 2. Convergence was assessed visually and 
confirmed using the Gelman-Rubin-Brooks (GRB) statictic47.  
 
Table 4. 3: Median and 95% credible intervals for parameters estimated using the 
model with sequence data. 
Symbol Description Name Median (95% 
Credible interval) øπ Coefficients 
modifying 
susceptibility to 
infection by a 
particular RSV 
group depending 
on infection 
history. Prev.hom 
estimates the 
effect of a previous 
homologous group 
infection, and 
Prev.het the effect 
of a previous 
heterologous 
infection 
Prev.hom 
 
Prev.het 
0.4328 (0.2665, 
0.6727) 
0.5126 (0.2601, 
0.8985) 
ø# Coefficient 
modifying 
susceptibility to a 
particular RSV 
group based on 
Curr.het 0.9520 (0.2494, 
2.262) 
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shedding status of 
the heterologous 
group type øª Coefficients 
modifying 
susceptibility to 
RSV by age. 
Sus.age.2 
estimates 
modification to 
group 1-4 years, 
Sus.age.3 5-15 
years and 
Sus.age.4 ≥15 
years relative to 
group <1 year. 
Sus.age.2 
 
Sus.age.3 
 
Sus.age.4 
0.8804 (0.4997, 
1.616) 
0.2741 (0.1591, 
0.4946) 
0.1562 (0.08867, 
0.2852) 
ƒ∑ Baseline rate of 
within household 
exposure by RSV 
group, per person 
per day. 
HH.rsv.a 
 
HH.rsv.b 
0.02360 (0.0119, 
0.04361) 
0.02272 (0.01120, 
0.04196) 
√Ω Coefficient 
modifying the 
amount of within 
household 
exposure by 
household size for 
households of 8 or 
more relative to 
<8. 
HH.size 0.4457 (0.2892, 
0.6843) 
√¥ Coefficients 
modifying 
Low.Sym 
High.Sym 
2.1 (1.214, 3.67) 
4.437 (1.8, 8.959) 
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infectiousness by 
viral load and 
symptom status. 
Relative to being 
asymptomatic, 
Low.Sym estimates 
the effect of 
shedding low viral 
load and being 
symptomatic and 
High.Sym the 
effect of shedding 
high viral load and 
being symptomatic % The rate of 
exponential decay 
on the spatial 
distance kernel 
Dist.rate 207.7  (7.819, 
169100) 
$ The rate of 
exponential decay 
on the genetic 
weight function.  
Gen.rate* 0.0002631 
(0.000001027, 
0.003817) 
«∑ Baseline rate of 
community 
exposure by RSV 
group, per person 
per day. 
Comm.rsv.a 
 
 
Comm.rsv.b 
0.0003091 
(0.0001198, 
0.0008682) 
0.0003849 
(0.0001525, 
0.001072) √æ Coefficients 
modifying the rate 
of community 
exposure by age 
Exp.age.2 
 
Exp.age.3 
0.5311 (0.2179, 
1.221) 
1.64 (0.7705, 
3.386) 
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group. Exp.age.2 
for 1-4 years and 
Exp.age.3 for ≥5 
years, relative <1 
year  2,& Parameters for the 
cluster specific 
background 
community 
function.  
Delta 
 
Beta 
1.58 (0.5466, 
4.693) 
0.1929 (0.08315, 
0.7321) 
* Here Gen.rate is the rate of exponential decay. 
 
Previous infection reduces the risk of re-infection in the same outbreak by ~50% based 
on the estimates of Prev.hom and Prev.het parameters which measure the relative 
reduction in susceptibility to infection by a particular RSV group given previous 
homologous or heterologous group infection, respectively. Estimates of Sus.age.2, 
Sus.age.3 and Sus.age.4 imply an inverse relationship between age and susceptibility 
to infection. Households of 8 or more individuals have ~55% reduction in pair-wise rate 
of exposure within the household relative to smaller households, HH.size= 0.4457 
(0.2892, 0.6843). Symptomatic cases are 2-4 times more infectious than asymptomatic 
cases, Low.Sym = 2.1 (1.214, 3.67) and High.Sym = 4.437 (1.8, 8.959). The high 
estimate for the rate of exponential decrease in probability of transmission with 
increasing distance between households, Dist.rate = 207.7  (7.819, 169100), means 
that transmission between household for this study population is unlikely to have 
occurred, although the large credibility interval suggests that there is limited 
information for this parameter. Estimates of the rate of exponential decrease in 
transmission probability with increasing genetic distance (Gen.rate) parameter imply 
that within cluster transmission was nearly 100% likely regardless of the pair-wise 
nucleotide distances.  The uncertainty analysis where a genetic cut-off for transmission 
was estimated rather than a rate of exponential decay resulted in the same outcome 
(results not shown). Age is unlikely to affect the rate of exposure to infection from 
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sources outside of the household, Exp.age.2 and Exp.age.3, were estimated with 
credible intervals including 1.  
 
To validate the model, we simulated multiple epidemics and checked to see if the 
observed epidemic was captured by the range of simulated dynamics. Details of the 
simulation algorithm can be found in A3: Supplementary appendix for Paper 2. We 
sampled 12 sets of parameters from the posterior distribution, and for each set, 
simulated 100 epidemics. The results of these simulations are shown in Figure 4. 6 for 
RSV A and Figure 4. 7 for RSV B. In addition to comparing the time course of cases, we 
also looked at the total number of cases in an epidemic, the proportion of individuals 
with multiple onsets and the number of cases in the first and last week of the time 
period. These values from the data were compared to the range of simulated values to 
check that key aspects of the epidemic were being reproduced by the simulations. 
These results are shown in A3: Supplementary appendix for Paper 2. From these 
results, we concluded that the model sufficiently captured key aspects of the 
epidemic.   
 
 
 
Figure 4. 6: A comparison of simulated and observed data for RSV A.   
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Each panel shows the results of 100 simulations from a single parameter set. The grey 
lines show the simulated data while the black lines show the observed data. Time is 
shown on the x-axis while the y-axis shows the total number of people who are 
shedding at a given point in time.  
 
Figure 4. 7: A comparison of simulated and observed data for RSV B.   
Each panel shows the results of 100 simulations from a single parameter set. The light 
blue lines show the simulated data while the dark blue lines show the observed data. 
Time is shown on the x-axis while the y-axis shows the total number of people who are 
shedding at a given point in time.  
 
 
To assess the impact of increased resolution in pathogen identification on estimated 
parameters we compared the distributions of parameters estimated using RSV cases 
identified at the pathogen level, group level and cluster level. Figure 4. 8 shows the 
density plots comparing these distributions, details of the model modifications to 
allow fitting of group level data are given in appendix section A3. This figure shows 17 
of the 19 parameters in the model with genetic clusters, parameters Dist.rate and 
Gen.rate are not included. For parameters that are present in the model with group 
and cluster level identification but not in the model with pathogen level identification, 
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e.g. Prev.het, we used the corresponding parameter assumption, i.e. Prev.het = 
Prev.hom. 
 
 
Figure 4. 8: A comparison of the parameter distributions obtained from the model 
using different resolutions in pathogen identification.  
The green curves show the results using data at the pathogen level, the blue curves 
shows the group level and the pink curves show the cluster level. Each panel shows 1 
one of 17 shared parameters. 
 
The results show that for most of the parameters, the estimated distributions do not 
differ by the resolution in pathogen identification. The parameters measuring the 
effect of viral load and symptoms on infectiousness (Low.Sym and High.Sym) are 
estimated with increased precision when pathogen resolution is increased. The 
0.3 0.4 0.5 0.6 0.7
0
1
2
3
4
Prev.hom
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.434
Median = 0.453
Median = 0.457
0.2 0.4 0.6 0.8
0
1
2
3
4
Prev.het
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.509
Median = 0.474
Median = 0.457
0.5 1.0 1.5 2.0
0.
0
0.
2
0.
4
0.
6
0.
8
Curr.het
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.994
Median = 0.951
Median = 0
0.5 1.0 1.5 2.0
0.
0
0.
5
1.
0
1.
5
Sus.age.2
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.908
Median = 0.996
Median = 0.982
0.1 0.2 0.3 0.4 0.5 0.6 0.7
0
1
2
3
4
5
Sus.age.3
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.282
Median = 0.287
Median = 0.298
0.10 0.15 0.20 0.25 0.30 0.35
0
2
4
6
8
Sus.age.4
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.16
Median = 0.164
Median = 0.159
0.01 0.02 0.03 0.04
0
20
40
60
80
HH.rsv.a
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.0231
Median = 0.0173
Median = 0.0123
0.01 0.02 0.03 0.04
0
20
40
60
80
HH.rsv.b
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.022
Median = 0.0141
Median = 0.0123
0.3 0.4 0.5 0.6 0.7 0.8
0
1
2
3
4
HH.size
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.447
Median = 0.43
Median = 0.445
1 2 3 4 5 6 7 8
0.
0
0.
2
0.
4
0.
6
0.
8
Low.Sym
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 2.1
Median = 2.67
Median = 2.59
5 10 15 20 25
0.
00
0.
10
0.
20
High.Sym
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 4.41
Median = 6.38
Median = 9.61
2e−04 4e−04 6e−04 8e−04
0
10
00
20
00
30
00
Comm.rsv.a
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.000313
Median = 0.000317
Median = 0.000397
0.0002 0.0004 0.0006 0.0008 0.0010 0.0012
0
50
0
15
00
25
00
Comm.rsv.b
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.000392
Median = 0.000413
Median = 0.000397
0.5 1.0 1.5
0.
0
0.
5
1.
0
1.
5
2.
0
Exp.age.2
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.501
Median = 0.482
Median = 0.511
1 2 3 4
0.
0
0.
2
0.
4
0.
6
0.
8
Exp.age.3
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 1.58
Median = 1.57
Median = 1.62
0 1 2 3 4 5
0.
0
0.
2
0.
4
0.
6
0.
8
Delta
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 1.56
Median = 1.08
Median = 1.25
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
0
2
4
6
8
Beta
De
ns
ity
Resolution at cluster level Resolution at group level Resolution at pathogen level
Median = 0.194
Median = 0.152
Median = 0.142
 135 
distribution of the within household transmission coefficients shift slightly towards 
higher values with increased resolution both for RSV A and B (HH.rsva and HH.rsv.b) 
while the community transmission coefficient for RSV A (Comm.rsv.a) has a slight shift 
towards lower values. 
 
4.6.3. Highest Probability transmission source 
For each case in the data, we established the HPTS given a particular set of parameters 
and matching augmented data. For a particular case, the frequency of each HPTS 
across the sample was recorded and only the most frequent HPTS is show in the 
transmission networks in Figure 4. 9. Table 4. 4 gives additional characteristics of the 
transmission networks. 
 
Table 4. 4: Characteristics of the transmission chains inferred. 
 RSV A RSV B 
Number of cases 97 125 
Number of introductions into households (index 
cases) 
39 60 
Number of introductions leading to onward 
transmission 
13 23 
Number of infant cases 20 22 
Number of non-index infant cases 11 8 
Number of household outbreaks initiated by an 
infant 
3 9 
 
Thirty-nine out of ninety-seven (40%) of the RSV A cases were from sources outside of 
the household, while for RSV B 60 (48%) cases were are result of non-household 
exposures; 33% (13/39) of RSV A introductions into the household led to infection of 
other household members, as did 38% (23/60) of RSV B introductions; 55% (11/20) 
infant, children <1 year old, RSV A infections were acquired within the household as 
were 36% (8/22) infant RSV B infections. Of the 11 infant RSV cases that were infected 
within the household, 8 were infected by children aged between 2 and 13 years, 1 was 
infected by another infant , 1 by a 16-year old and 1 by a 37-year old adult. Five out of 
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8 of the infant RSV B cases infected within the household were infected by children 
between 2 and 13 years, 2 were infected by a 16 and 18-year-old while one was most 
likely infected by a 49 year old. Table 4. 5 gives the age distribution of index cases that 
led to other infections in the household (HH outbreaks) compared to the age 
distribution of index cases that did not. Household outbreaks were, more often than 
not, initiated by children below 13 years old (31 out of 36 index cases).  
 
Table 4. 5: Age distribution of index cases of household outbreaks. 
Index cases are clustered into 3 age groups and according to whether they led to 
onward transmission in the household or not.   
Age Group No. index cases leading to 
onward transmission 
No. index cases NOT leading to 
onward transmission 
RSV A RSV B RSV A RSV B 
 < 1 3 9 6 5 
 1 − 13 8 11 13 19 
 ≥ 13 2 3 7 13 
Total 13 23 26 37 
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Figure 4. 9: Transmission networks showing the highest probability source of 
transmission given by our model results.  
Each vertex is an RSV case labelled by individual study number (top) and age in years 
(bottom) and color-coded by household. Cases that are <1 year old are represented by 
square shaped vertices.  The width of the connecting edge is proportional to the 
frequency at which the particular source was identified as the HPTS given different 
parameter set values. 
 
 
 
 
  
 139 
4.7. Discussion 
We carried out an analysis of data on the social-temporal and genetic pattern of 
spread of RSV in a group of households in rural Kenya followed up during a six-month 
study period covering the time frame of an entire RSV epidemic in the local area. 
Through systematically integrating all the available information of the infection 
episodes and host demographics, we were able to infer sources of infant infections. 
Fifty five percent of infant RSV A infections were acquired within the household, 
compared to 36% of infant RSV B infections. There were 8% more RSV B introductions 
into the household than RSV A, and a 5% difference in the proportion of introductions 
that led to onward within household transmission between the RSV groups. In this 
study population, there is evidence of differences in transmission dynamics between 
the two RSV groups, parts of which could be due to RSV B dominating in this particular 
outbreak. However, despite the seemingly slight transmission advantage of RSV B, a 
larger fraction of infant RSV A infections was acquired within the household. This 
points to the household not only being an important environment for RSV transmission 
in general, but possibly, more specifically, for infant RSV A transmission.  
 
This work is an extension of a previous analysis on social-temporal data32 that now 
incorporates the output of a phylogenetic analysis41 with the aim of utilizing all the 
available data from an outbreak to define transmission dynamics. In doing so, we also 
assessed the difference in model inference when different data resolutions were used 
for pathogen identification; resolution at the pathogen level (RSV), resolution at the 
group level (RSV A and RSV B), and resolution at the genetic cluster level (5 RSV A 
clusters and 7 RSV B clusters). We found that increased resolution did not dramatically 
change the distribution of estimated parameters. With resolution at the group level we 
had previously inferred possible niche separations between RSV A and RSV B based on 
the distribution of the transmission coefficients. The evidence of this was not 
overwhelming to begin with, and the slight change in parameter distributions as a 
result of increased resolution resulted in this line of evidence being lost. However, in 
both the present and previous analysis, a larger fraction of RSV A cases were acquired 
in the household relative to RSV B. In the present analysis, 60% of RSV A and 52% of 
RSV B infections occurred in the household. In the previous analysis, 40-59% of RSV A 
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and 26-48% of RSV B infection occurred in the household. As previously established in 
the social-temporal data analysis, households with less that 8 occupants had a higher 
pair-wise risk of exposure compared to larger household, increasing age had a 
protective effect on transmission as did previous infection in the same outbreak. 
Symptomatic cases with high viral load were more infectious than asymptomatic cases, 
the effect of which was inferred more precisely with the inclusion of genetic data.  We 
found that transmission between the households in this study was unlikely to have 
occurred, which is in line with the results of the phylogenetic analysis of Agoti et al41. 
Different resolutions of the data had different ways of suggesting a difference in 
transmission niche between RSV A and RSV A; the group data inferred overlapping but 
slightly different values for the transmission coefficients, the cluster resolution data 
inferred almost similar distributions for the transmission coefficients between RSV A 
and B, but RSV A was better transmitted to infants within the household. Respiratory 
syncytial virus is an important pathogen to the under 5 years olds, with <6 month olds 
experiencing the most severe disease burdens48. It is a ubiquitous pathogen that 
circulates in seasons which are not only characterized by a change in the dominant 
group type, but also changes to the genotype composition23,29. The slower mutation 
rates of RSV A49 could account for its niche being in young infection-naïve infants. In 
accord with this, White et al found evidence that RSV A is slightly more transmissible 
than RSV B50. Their study used a compartmental multi-strain model to fit data from the 
UK and Finland. From the household study that we analysed, we cannot state with 
certainty that there is a difference in transmission niche between the two groups, a 
study that incorporates information from different potential transmission hubs such as 
households, schools and workplaces would be better placed to do so.  
 
Increasing the resolution in pathogen identification did not have a drastic impact on 
estimated parameters; this could be due to the study design. Nasopharyngeal swab 
(NPS) samples to test for the presence of infection were collected twice a week every 
week for 6 months from all the participants present in the households at the time of 
the sample collection visits. This resulted in densely sampled detailed data that left 
little room for uncertainty in when individuals got infected. In addition, information on 
the social structuring of the population in the form of households provides information 
on some of the most frequent contacts each participant had. This level of detail is 
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likely why the addition of genetic information, whose clustering mimicked the 
household structure, did not lead to much further resolution on who might have 
acquired infection from whom, hence no significant changes in most of the inferred 
parameter distribution. This result should not have been surprising; Campbell et al in 
integrating genetic, temporal and contact data found that the contact data could 
replace the genetic data in a model trying to infer the transmission chains2. In their 
work, Kinyanjui et al highlighted the importance of mixing assumptions and social 
structure in models of RSV transmission51. This implies that good quality data on timing 
of cases and their most frequent contacts is key to be able to determine transmission 
characteristics of an infection. However, this could be limited to the type of infection 
under study and it should be borne in mind that contact data can be difficult to gather 
in the heat of an ongoing outbreak. In place of a detailed epidemiological study with 
dense sampling, integrating temporal and genetic data is the next best thing, 
particularly if the priority is transmission chain inference. A possible further analysis of 
these data would be to determine to what extent the genetic information can 
recapture the household clustering, i.e. to fit a model which does not include the 
household information. 
 
Through combining epidemiological and phylogenetic inference, our method was able 
to determine transmission chains within households with greater certainty than a 
preceding phylogenetic analysis by Agoti et al52. In general, the networks inferred from 
the present analysis did not contradict any of the inference from the phylogenetic 
analysis. However, for one of the infected infants the inferred source of transmission 
differed. We assigned individual 3806 as the source of infant 3801’s RSV B infection 
while Agoti assigned 3805. Both 3806 and 3805 were children of school going age and 
both had sequences that were 3 nucleotides apart from the closet temporal sequence 
from 3801. In addition to considering the social grouping, infection window and 
genetic cluster, our approach also considers the infectiousness of a potential source. In 
this case, 3806 had symptoms and a high viral load in the three days preceding 
shedding onset in 3801, while 3805 did not. Our model assigned 3806 as the infection 
source due to their higher infectiousness relative to 3805. Such an example highlights 
the strength in our technique in being able to incorporate all possible determinants of 
a transmission event. Despite the marked improvement in transmission chain 
 142 
inference when combining an epidemiological and phylogenetic analysis, we did notice 
that our method has a propensity to infer super-spreaders, examples are infant 504 
who was implicated in infecting 10 household cohabitants and 3821 who seeded 7 
other infections. Though there might be some truth to these dynamics, based on the 
roles of the different members of the household, the model arrives at these networks 
based on the patterns in the available data. If all the criteria for a transmission event 
have been met, i.e. in the same genetic cluster, within a reasonable infection window, 
in the same household, a highly infectious potential source, then the model will create 
a link between cases. To tease apart true super-speared events from “convenience” 
networks, additional data on within household contacts would be needed to inform 
the model, data such as the kind collected by Kiti and colleagues53.  
 
This study is not without its limitations. Similar to previous work14,35,37, we used a two-
step approach in our application of phylodynamics.  This has the potential to lead to 
inconsistencies that would otherwise not occur with simultaneous inference of the 
evolutionary and epidemiological dynamics. However, given that we only used 
aggregated results of the phylogenetic analysis, in the form of clusters, and raw 
nucleotide distances as opposed to phylogenetic tree distances, we do not heavily rely 
on the exact results of the independent phylogenetic analysis. Using genetic clusters 
provides the advantage of being able to identify obvious separate introductions, a 
characteristic that can be difficult to account for in the models of simultaneous 
inference. In addition, given that the genetic clusters were generated using a 
combination of criteria makes it less likely that the wrong clustering pattern was 
inferred. As with previous work14, our two-step approach is more computationally 
tractable than a simultaneous-inference version of it would have been. We were able 
to include data from individuals who did not have genetic sequences and use a non-
trivial epidemiological model.  
 
Despite the fact that sequence data did not make a significant change in understanding 
overall transmission patterns for RSV in this study, we believe that there is still a lot of 
potential for phylodynamics in RSV. At a larger geographical scale, say country level, 
sequences collected over several months coupled with a stochastic transmission model 
of RSV could be used to determine patterns of spread within the country; answering 
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questions such as where are new strains of RSV introduced, how quickly to they spread 
across the country and what are the drivers of the spread. Sequences collected over 
several years coupled with a transmission model and social-demographic data on the 
host population could help determine what drives the replacement of RSV genotypes 
and what allows the co-existence of RSV groups; potentially giving a more definitive 
answer as to whether immune pressure plays a role in changes to the RSV genome in 
the short term. RSV has already been shows to have geographically different 
transmission patterns and potential drivers of seasonality 21,54, if a phylodynamics 
analysis reveals that there are also geographically different drivers of genotype 
replacement, this could have significant implications to vaccine development and 
effectiveness. Finally, improved surveillance is needed in order to get better data on 
RSV outbreaks. There is currently a spatial bias in the RSV sequences available in 
GenBank as Giallonardo et al reported 25, however, there is an ongoing WHO effort to 
develop a global RSV surveillance strategy55. 
 
In conclusion, we were able to integrate the results of a phylogenetic analysis with 
epidemiological data to infer that nearly half of the RSV infections in this study were 
acquired within the household. A significant portion of infant RSV infections occur in 
the household, more so for RSV A than RSV B, and a majority of these are a result of 
transmission from children aged between 2 and 13 years old. Vaccination of this age 
group would therefore provide indirect protection to the infant.  
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5. Paper 3: A multi-pathogen model of infection investigating 
potential interactions between respiratory syncytial virus 
and coronavirus. 
5.1. Overview  
This chapter presents an analysis based on an extension of the model first introduced 
in Chapter 3. As with the previous chapter, this chapter is written in the format of a 
publication and we intend to submit it to a journal with the running title: A multi-
pathogen model of infection investigating potential interactions between respiratory 
syncytial virus and coronavirus. 
5.2. Role of candidate  
I formulated the problem, conducted the numerical analysis and wrote the first draft 
of the chapter. Revisions were made with feedback, input and guidance from my 
supervisors Graham F. Medley and D. James Nokes and advisor Marc Baguelin.   
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5.3. Abstract 
Respiratory syncytial virus (RSV) is a common viral pathogen that causes a significant 
burden of respiratory disease in children. RSV circulates in seasonal patterns and has 
often been observed to co-circulate with other viral pathogens such as influenza, 
human coronavirus, rhinovirus etc. Often, viral pathogens are assumed to be 
circulating independently, ignoring any possible interactions between pathogens in the 
same ecological system. This could lead to a miss-representation of the true disease 
burden attributed to a particular pathogen and ill-informed projections of the effect of 
an intervention targeted at a single pathogen. In light of this, we extended a previously 
developed multi-strain model of RSV to include data on RSV and human coronavirus in 
order to investigate potential interactions at the individual host level and extend these 
to infer transmission dynamics of the two pathogens in a small population of hosts. We 
found that interactions between the two pathogens are specific to particular groups. 
RSV B interacted with coronavirus OC43 through increased susceptibility to 
heterologous pathogen infection, where the susceptibility to corona OC43 was 
increased by about 81% (95% CrI: 40%, 134%) following an RSV B infection. Though the 
results of this study are based on a small population of hosts, the inferred interactions 
imply that a vaccine that reduces the transmission of RSV would also reduce the 
transmission of coronavirus OC43 and its associated disease burden. Further studies 
are warranted to explore these and other interactions between RSV and other 
pathogens at a larger geographical and temporal scale.   
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5.4. Introduction 
Respiratory syncytial virus (RSV) is recognized as a major cause of respiratory disease 
in children less than 5 years old1–3. RSV has clear epidemic patterns that coincide with 
winter seasons in temperate countries, but has less definitive correlates of seasonality 
in the tropics4. Co-circulation of RSV with other pathogens is common especially 
adenovirus and rhinovirus, both of which tend to be year-round as opposed to 
seasonal 5–10. However, RSV and influenza have been shown to have similar epidemic 
timings during winter in temperate regions 8,9,11–13. In the tropics, it is not as clear 
which pathogens share similar epidemic timings with RSV, but observations have been 
made on co-circulation with human coronaviruses (HCoVs) and human 
metapneumovirus (HMPV)6,14–18.  
 
Given the ubiquitous nature of RSV and other respiratory pathogens, co-infections are 
common. In studies looking at the distribution of pathogens present in cases of 
respiratory illness, RSV-virus or RSV-bacteria co-infected samples represent a 
significant fraction of the total RSV samples5,7,10,15,19,20. The effects of viral co-infections 
in general are not clear. Some studies report co-infections being associated with 
increased disease risk10,21,22, others do not find any associations 23,24, while some have 
found an association with decreased disease risk25. Viral-bacterial co-infections do 
have a clearer pattern of increased disease risk or severity26. Cases of respiratory 
illness co-infected with RSV and a bacterial pathogen have been associated with 
increase disease severity27–29. More specifically, when looking at Streptococcus 
pneumonia, Greenberg et al found that RSV more commonly occurs with non-invasive 
serotypes than invasive serotypes, hypothesizing that non-invasive serotypes do not 
typically cause disease unless there is a viral co-infection30. Further evidence of a 
facilitative relationship between RSV and bacterial pathogens has been found31–33. 
RSV-virus co-infections have been associated with increased disease risk or longer 
duration of hospital stay in some instances10,15,21,34–36, which could also be indicative of 
facilitation, but further evidence is warranted.  
 
Competitive relationships between RSV and other viruses have been proposed as 
explanations for the observed associations in data. Greer et al looked at data from 
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cases presenting with ARTI at hospitals and found an association between detection of 
RSV, rhino and HMPV and decreased detection of other viruses, implying 
competition37. The cases from this study were mostly children. Martin et al followed 
children in day-care for two years and characterized respiratory illness. Though 
adenovirus, human bocavirus (HBoV), HCoVs, HMPV and rhinovirus often occurred 
together, RSV and rhinovirus occurred together less frequently than would happen by 
chance, a signal of competition between the two38. Bhattacharyya et al found evidence 
of cross-immunity between paramyxoviruses, more so an immunizing effect of RSV, 
the strength of which increased with decreasing phylogenetic distance between 
viruses39. At a cellular level, Shinjoh et al showed competition between RSV and 
influenza38.  
 
Facilitative or competitive pathogen interactions can occur at a cellular and/or host 
and/or population level. Despite the biological and epidemiological evidence of RSV 
interacting with other pathogens, many mathematical models of RSV do not account 
for it. In fact, pathogen interactions are rarely accounted for in most studies of viral 
transmission dynamics, yet if there are important pathogen interactions that affect 
population level dynamics, models that do not take this into account could be 
erroneous in their analysis of individual viruses. Mechanistic mathematical models are 
powerful tools for gaining a better understanding of disease transmission. They can be 
used not only to investigate and quantify mechanisms of pathogen interactions, but 
also to predict the population level impact of an intervention against one pathogen 
that interacts with other pathogens in the same host population40. Multiple-pathogen 
models, in general, are not common. Statistical models that take into account co-
circulation of pathogens have been used to assign causality to cases of respiratory 
disease3,41. Asten et al looked at data on influenza like illness (ILI) spanning 10 years 
from the Netherlands and were able to establish, through regression, that a change in 
shift in the influenza A epidemic resulted in changes to the epidemics of other 
pathogens that usually circulate around the same time. When influenza A outbreaks 
occurred earlier, RSV outbreaks were delayed, and coronavirus outbreaks were 
intensified. RSV outbreaks in this dataset tended to start earlier than influenza 
outbreaks, as such when the influenza outbreaks were early and the RSV outbreaks 
late, they overlapped more42. In a recent systematic analysis of data from multiple 
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sites distributed across the globe, Li et al found that the global seasonal trend of RSV 
and influenza differed by both timing and length and despite RSV and HMPV having 
similar epidemic durations, they did not co-circulate in most countries, an observation 
which led to the hypothesis of a potential competitive interaction between RSV and 
HMPV. This analysis had the strong advantage of more study sites, hence more 
geographically representative data11. Merler et al used a simple compartmental model 
with homogenous mixing to explore the hypothesis that co-infection with an acute 
respiratory infection increased the transmissibility of pandemic influenza, leading to 
multiple waves of cases during an outbreak. Their model, which had no seasonal 
forcing, was able to produce output that was in agreement with data showing multiple 
waves of the 1918 Spanish flu43. Velasco-Hernández et al used a deterministic 
compartmental model to explore a hypothesis of a competitive interaction between 
RSV and influenza through super-infection, where influenza was treated as the 
superior pathogen capable of infecting hosts already infected with RSV. Their 
hypothesis was partially validated, using data from children <5 years old seeking 
treatment at a hospital in Mexico, despite that fact that their model needed further 
complexities to be more realistic44. Pinky et al built an ODE model to explore RSV and 
influenza viral kinetics at a cellular level. In the model, within a co-infected host, RSV 
and influenza were competing to infect cells in the respiratory tract. The model was fit 
to data of in vitro co-infection and then used to determine that the virus with the 
highest growth-rate will outcompete other co-infecting viruses and infect more cells, 
however, this competitive advantage could be surpassed if the slower virus had a 
higher initial inoculum or an earlier infection time. Single pathogen in vitro and in vivo 
models comparing influenza and RSV found that indeed RSV had a slower rate of 
spread from cell to cell and hence viral titres increased at a slower rate. In addition, 
the infectious cell lifespan was shorter for RSV than influenza 45,46. Multi-strain models 
are much more common with a huge volume of literature around models of 
influenza47. Models that look at the interactions between RSV groups are few and far 
between48. In a recent review, Opatowskia et al highlighted the importance of multi-
pathogen mechanistic models. They argue that once pathogen interactions have been 
adequately accounted for, then a more accurate picture of disease burden can be 
established and intervention programs can be better optimized40.  
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In studying the interaction between species, the level of the data is critical. Most of the 
previous studies have either been at the population level (looking at population level 
patterns) or the within-individual level. The data from the HH study enable us to look 
in detail at the individual level, i.e. the simultaneous exposure and transmission 
patterns in co-circulating viruses. In this study, we propose to use a mechanistic 
mathematical model that tracks infection at the individual host level to investigate 
interactions between different strains (groups) of RSV and endemic strains of human 
coronavirus (HCoV). This choice of pathogens was based on the fact that RSV and HCoV 
were the only pathogens whose identification was also at a group level for all the 
observed cases. Rhinovirus was typed in only 5 of the 47 households, while no typing 
was carried out for adenovirus. The most frequently circulating strains of HCoV are 
HCoV-OC43, HCoV-NL63, HCoV-229E and HCoV-HKU149. The four groups cause mild to 
severe disease and have often been observed to co-circulate6,14,50–52. As with RSV, 
children and the elderly are at an increased risk of symptomatic infection53,54. There is 
evidence that the strains differ by host age group55, symptoms56 and seasonality56. 
Repeat infections with HCoV are common6 and a recent phylogenetic analysis found 
evidence that changes to the HCoV-NL63 genome are not immune driven57. Similar to 
RSV, HCoV-NL63 has been shown to have a facilitative interaction with Streptococcus 
pneumoniae through enhancing its cell adherence58.  
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5.5. Methods 
5.5.1. Data 
We use data on RSV and human coronavirus (hCoV) shedding patterns collected from a 
household cohort study conducted in rural coastal Kenya within the Kilifi Health and 
Demographic Surveillance System (KHDSS) during the 2009/2010 RSV epidemic. A 
household was defined as a group of individuals living in the same compound who 
share a kitchen. Details of the study have been published elsewhere 6,59–62. In brief, the 
infant-centric study recruited household members using the criteria that the infant 
was born after 1 April 2009 (after the previous RSV epidemic) and had at least 1 older 
sibling less than 13 years old. Deep nasopharyngeal swab (NPS) samples were collected 
every 3-4 days regardless of symptoms, together with a record of clinical illness. The 
focus of the study was to investigate who infects the infant with RSV, however, three 
other pathogens were identified as frequently circulating in the study participants: 
rhinoviruses, adenoviruses and human coronaviruses with coronavirus further 
classified by group into 229E, OC43 and NL63. We did not include adenovirus and 
rhinovirus in the present analysis due to the lack of information on infecting virus 
species. This resulted in the observation of some shedding durations being as long as 
>60 days, which were probably re-infections by different species. Test runs were 
conducted with adenovirus and rhinovirus data in the model, but each time the 
inference algorithm failed to converge. Details of all the pathogens identified from the 
household study can be found in6. The data contain information from 493 individuals 
spread across 47 households whose dates of data collection span 180 days. 
 
In addition to the data on shedding and symptom status, there is information on 
presence or absence from the household. Given the discontinuity in the sampling, 
complete shedding, and presence/absence durations had to be imputed. This 
imputation process has been described in detail in A2: Supplementary appendix for 
Paper 1. In brief, a virus shedding episode is defined as a period within which an 
individual provided PCR positive samples for the virus that were no more than 14 days 
apart. Individuals are assumed to start shedding halfway between the last negative 
sample and the first positive sample of the episode, and they stop shedding halfway in 
between the last positive sample of the episode and the first negative sample. In the 
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same way, complete presence/absence durations are imputed for all the days of data 
available for a particular individual. There are some instances where an individual was 
present but not sampled, as such, presence could not purely be identified by the 
availability of NPS samples. Imputation was chosen over data augmentation to ensure 
consistency across studies analysing the same household59,61,63. 
5.5.2. Transmission model 
To interrogate the data on any possible interactions between pathogens, we built a 
model that tracks infection with RSV and coronavirus at the individual host level. This 
model is a modified version of an earlier model that was used to analyse RSV A and 
RSV B data 64. We extend the logic applied to modelling multiple groups/strains of RSV 
to model multiple groups/strains of multiple pathogens interacting through modified 
susceptibility. Every group within a pathogen is treated independently, so for RSV with 
two groups, we treat RSV A and RSV B as distinct infectious agents and look for an 
interaction. In the case where we have RSV and coronaviruses, we have a total of 5 
infectious agents: RSV A, RSV B, corona 229E, corona OC43 and corona NL63. An 
individual is either susceptible to, or infected with, a particular infectious agent.  An 
individual who is currently not shedding any of the infectious agents is considered 
susceptible to all of them, if they are shedding one, say RSV A, then they are 
susceptible to the other 4, RSV B, corona 229E, corona OC43 and corona NL63. For a 
single infectious agent, we assume SEIS2 type dynamics where an individual is initially 
susceptible, they get exposed and go through a period of latency prior to onset of 
infectiousness after which they become susceptible again, but the susceptibility is 
modified as a result of having experienced an infection. Unlike in the previous models 
in Chapter 3 and 4. We do not assume an age effect on susceptibility, this is purely for 
computational reasons in order to reduce the dimension of the parameter vector. Also 
different from the models in the previous chapter is that fact that we do not fix the 
latency distribution. We assume that every pathogen has a gamma latency distribution 
with a specific mean and standard deviation (SD). The pathogen-specific mean and SD 
for these distributions are estimated along with other model parameters. 
 
We model the rate at which an individual i, is getting exposed to infection by infectious 
agent v at time t, denoted 5M,?,<(7). Individuals can get infected by someone they share 
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a household with or from a source outside of the household, resulting, as in previous 
model versions, in a two-part rate of exposure equation.  
 5(7) = >: ∗ < =(7)?@ABC?@DE F + QI ∗ R(7)S 
The number of infectious household contacts is observed in the data while infectious 
contacts from the community are represented using a derived function. We use the 
same function form that was used in Chapter 4, We define an infectious-agent specific 
background rate of exposure, R<(7) given as  R<(7) = ˝ + ∑ YQN}˛ç,=SˇM	B?CEEMLT	MLhCJNM@L	<  is the basic risk prior to any observed onsets and ! is 
the rate of exponential decay related to the time since onset of a case shedding 
infectious agent v, ! is a measure of the rate at which the infectious agent might 
disappear from the community and "M  is the onset time by person i. The parameters ˝ 
and ! are not infectious-agent or pathogen specific. 
Where δ is the basic risk prior to any observed onsets and β is the rate of exponential 
decay related to the time since onset of a case shedding infectious agent v, ! is a 
measure of the rate at which the infectious agent might disappear from the 
community and τi,v is the onset time of infectious agent v by person i. 
 
Unlike in the previous model iterations, we do not include the effect of household size, 
viral load and ARI, or age in the rate of exposure. As with the removal of age effects on 
susceptibility, this was also done to reduce the dimension of the parameter vector. 
The main aim of this version of the model is to investigate possible pathogen 
interactions.  
 
We model pathogen interactions through parameters that modify susceptibility based 
on infection history and current infection status. The interactions are investigated in a 
pair-wise manner. Say we have three infectious agents in the data, V1, V2 and V3. 
Susceptibility to V1 is modified based on previous infection with: V1 indicated by the 
parameter (uea÷.>.. vuYk.>.), V2 indicated by the parameter (uea÷.>.. vuYk.>ï) and 
!(#)		= [baseline household exposure rate * number of infectious household contacts(t)]
+
[baseline community exposure rate * background community function(t)]
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V3 indicated by the parameter (uea÷.>.. vuYk.>?). The first modification is due to 
previous homologous infection while the second and third are due to previous 
heterologous infection. In addition, susceptibility to V1 is also modified if the individual 
is currently shedding V2 indicated by the parameter (uea÷.>.. j`uu.>ï) and V3 
indicated by the parameter (uea÷.>.. j`uu.>?). The same logic applies to modification 
of susceptibility to V2, V3 and V4. We assume that the modification to risk of V1 given 
previous or current infection with V2 = modification of risk to V2 given previous or 
current infection with V1, i.e. (uea÷.>.. vuYk.>ï) = (uea÷.>ï. vuYk.>.) and 	(uea÷.>.. j`uu.>ï) = (uea÷.>ï. j`uu.>.). This greatly reduces the number of 
interaction parameters to be estimated. The effect of multiple infections by different 
infectious agents is cumulative, if at time t an individual has experienced and 
recovered from infection by V2 and V3 then their susceptibility to V2 is modified by a 
factor = Y(⁄MB@.Ÿâ.¤⁄C<.Ÿâ®	⁄MB@.Ÿâ.¤⁄C<.ŸA). The rate of exposure to a particular infectious 
agent (index v) is given for a particular individual, (index i) from a given household 
(index h) at a given day (index t) and is specified by the notation 5M,?,<(7).  The rate of 
exposure is given in equation Eq.5.1 and the variables are described in Table 5. 1. 5M,?,<(7) = exp yõú(7) × BM,?,<(7)
+	õã × óM,?,<(7)Ñ ⎣⎢⎢
⎡
⎝⎛mM,?(7) 	× 	:< < yóZ,?,<(7) × mZ,?(7)ÑZ¨M,			Z	ML	M≠B	?@ABC?@DE ⎠⎞
+ QI< 	× 	R<(7)S⎦⎥⎥
⎤…		(±≤	5.1)	 
 
Table 5. 1: Description of variables in the model 
Symbol Type Description 
i  Index Index of individual 
h Index Index of household 
v Index Index of the type of infectious agent 
t  Index Index of time in days 
p Index Index of the type of pathogen 
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D∫,∂,E(∏) Data Binary data variable indicating if an individual i is shedding 
infectious agent v at time t π∫,∂,E(∏) Data Binary variable keeping track of an individual’s infection 
history with respect to infectious agent v by time t. º∫,∂(∏) Data Binary data variable indicating if an individual is present in 
the household at time t. Absence from the household 
means that an individual was not present at the point of 
sample collection and thus in the model, they can only get 
infection from a community source and not from an 
infectious housemate (not sampled and not at household 
risk). Individuals who were present but not sampled are 
exposed to both household and community source 
transmission in the models (not sampled but at household 
risk).  øπ 
 
Parameter Coefficients modifying susceptibility to infection by a 
particular infectious agent depending on infection history. 
The estimated effect could be due to previous 
homologous or previous heterologous infection. Applied 
to the categorical covariate Yi,h,v(t). The parameter name is 
risk.V1.prev.V2. øD Parameter Coefficients modifying susceptibility to infection by a 
particular infectious agent depending on shedding status. 
The estimated effect is due to heterologous infection. 
Applied to the categorical covariate Si,h,v(t). The parameter 
name is risk.V1.curr.V2. ƒE Parameter Baseline rate of within household exposure specific to the 
infectious agent. The parameter name is HH.V. «E 
 
Parameter Community transmission coefficient specific to the 
infectious agent. The parameter name is Comm.V. 2,& Parameters  For the infectious-agent specific background community 
function given by  
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R<(7) = ˝ + < YQN}˛ç,=SˇM	B?CEEMLTMLhCJNM@L	<  
Delta(˝) is the basic risk and Beta(!) is the rate of 
exponential decay related to the time since onset of a case 
shedding infectious agent v. The parameter names are 
Delta and Beta and they are not pathogen or infectious-
agent specific. FG,HG Parameters The mean I¤ and standard deviation J¤ of a pathogen 
specific gamma distribution used to approximate the 
distribution of latency durations. Different groups/species 
in a single pathogen are assumed to have the same 
latency distribution. Latency durations are used in 
calculating the probability of onset given exposure.  »∫,∂,E Data Set of all days where individual i has an onset of infection 
with infectious-agent v. Only includes the first day of 
shedding for each infection episode. …∫,∂,∑ Data Set of all the days where individual i is at risk of infection 
with infectious-agent v, i.e. they are not currently 
shedding v. 
 
Following on from the rate of exposure equation are two additional nested equations 
that make up the model. 
  M,?,<(7) = Probability of infection following exposure per day i.e. individual 
enters the latent phase  M,?,<(7) = Q1 − Y|v}ç,§,=(N)S			…		(±≤	5.2) ÊM,?,<(7) = Probability of starting to shed i.e. individual enters the infectious 
phase at time t given they did not shed until t. 
ÊM,?,<(7) =<ÕD,¤ M,?,<(7 − c)ŒDœ– 			…		(±≤	5.3) 
Where L is the maximum latent period and ÕD,¤ is the probability that the latent 
period is exactly c days. We assumed that the latency durations follow a 
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discretized gamma distribution truncated at 7 days. Given that incubation 
periods have been estimated to range from 2-5 days65, we chose 0 to 7 days for 
possible latency durations. The mean and standard deviation of the gamma 
distribution are estimated for every pathogen p.  
Since the model is focused on investigating if pathogen interactions determine the 
infection onset process, the data whose likelihood we are interested in is the onset 
data for the different infectious agents. As such, we express the likelihood of an 
individuals observed days of onset for all infectious agents as: 
—M = 	“‹ “ ÊM,?,<(`)A∈ﬁç,§,= “ Q1− ÊM,?,<(X)Sq∈ﬂç,§,= ‡<  
 
Where Ui,h,v is the set of days where individual i had an onset of infectious agent v  and 
Ai,h,g is the set of all days where i did not have an onset but was at risk of infection (i.e. 
not shedding infectious agent v). As with the previous iterations of the model, we 
assumed binomially distributed data. 
 
While fitting the data with the pathogens identified at the group level, the model has 
37 parameters, however, reducing the model to fit the data identified at the pathogen 
level results in 14 parameters. The parameters for the latency distribution 	I¤,J¤ were 
estimated once using the data identified at the pathogen level. The inferred values 
were then fixed for the model with pathogen identification at the group level.  
5.5.3. Parameter inference 
We used Bayesian inference to obtain estimates of the parameters. Adaptive 
Metropolis Markov Chain Monte Carlo was used to explore the parameter space 66. In 
brief, the method builds a Markov chain which allows us to sample from the posterior 
distribution P(φ|D) of the parameters given the data, where φ={	õú ,	õã,	:< ,	I<,	˝,!, I¤,J¤}. Normal distributions with large standard deviations were used as weakly 
informative priors for the log of all the parameters. The algorithm is initiated with 
narrow standard deviations in the joint parameter proposal distribution, which are 
adjusted after a specified number of accepted proposals.  
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We initiated 3 chains and set the algorithm to start adapting the proposal distribution 
based on accepted parameters after 25,000 iterations. Burn-in was assessed visually 
after which the results of the three concurrent chains were combined to infer the 
posterior distribution. The three chains were run for 250,000 iterations each. The 
parameters were estimated on the log scale All the computation was done using R 
software package (RStudio version 1.1.383 running R version 3.4.0 67). The code is 
freely available under the GNU Lesser General Public License v3.0 and can be found at 
https://github.com/Ikadzo/HH_Transmission_Model. 
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5.6. Results 
5.6.1. Data  
A summary of the distribution of cases by infectious agent is given in Table 5. 2. A 
majority of the onsets were due to coronaviruses with Corona OC43 having the highest 
number of onsets and Corona 229E the lowest. All the households in the study 
experienced at least one coronavirus infection, while 7 households did not get any RSV 
infections. There were some cases that experienced re-infections in each of the 5 
infectious agents considered. RSV A and RSV B had similar proportions of onsets that 
were re-infections (10.2% and 10.6% respectively), while of the coronaviruses, NL63 
had the highest proportion of re-infections (32.5%). RSV A had the highest proportion 
of onsets accompanied by an acute respiratory illness while HCoV 229E had the lowest, 
61% and 26% respectively. 
 
Table 5. 2: Summary of the data 
Infectious 
agent 
Number 
of onsets  
Number 
of onsets 
with an 
ARI 
Number of 
people 
infected 
Number of 
repeat 
infections 
Number of 
households 
infected 
RSV A 97 59  88 9 25 
RSV B 125 69  113 12 34 
RSV 208 119  179 29 40 
Corona-229E 133 34  119 14 30 
Corona-NL63 216 85  163 53 33 
Corona-
OC43 
260 118  215 45 44 
Corona 565 228 346 219 47 
 
 
Figure 5. 1 shows the temporal distribution of cases clustered by age group for ages <1 
year, 1-5 years, 5-15 years and >15 years. The number of individuals in the study in 
each age group increased by age, from 55 <1 year olds to 191 >15 year olds, however 
the number of onsets for each pathogen was highest in the 5-15 age group. Figure 5. 2 
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shows the distribution of shedding episodes for each individual that had a recorded 
onset. Despite the fact that there were hundreds of coronavirus cases, there were very 
few RSV-coronavirus co-infections. Figure A4. 1 in A4: Supplementary appendix for 
Paper 3. shows the distribution of shedding durations by infectious agent and 
pathogen.  
 
Figure 5. 1: Temporal distribution of cases for the 5 infectious agents clustered by 
age group.  
In each panel, the x-axis shows time in days while the y-axis shows the total number of 
infectious people. Top-left: The temporal distribution of all the cases in the data; Top-
centre: temporal distribution for all the cases <1 year old; Top-right: 1-5 year olds; 
Bottom-left: 5-15 year olds and Bottom-centre: > 15 year olds. 
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Figure 5. 2: Distribution of shedding episodes for coronavirus and RSV by household 
and time.  
The x-axis shows the time in days while the y-axis shows the individuals, where each 
notch is a single individual. The horizontal lines demarcate the different households. 
The labels on the y-axis are color-coded to separate the different households.   
 
5.6.2. Pathogen interactions 
This section of results aims to answer two questions: Are there interactions between 
RSV and coronavirus that can be detected from the data? Are these interactions 
detected at different scales of pathogen identification? To answer these questions, the 
data was fitted in two ways, first with identification of coronavirus and RSV at the 
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pathogen level, then at the group level. The comparable parameter densities that 
came out of this analysis are shown in Figure 5. 3 and Table A4. 1 in appendix A4. The 
trace plots showing the results of the MCMC algorithm are given in appendix A4. 
Convergence was assessed visually and confirmed using the Gelman-Rubin-Brooks 
(GRB) statistic 68. 
 
Starting from panel a) in the top row in Figure 5. 3, the risk of RSV infection given an 
individual has already experienced at least one other RSV infection in the present 
outbreak is reduced by about 40% compared to an individual who has no previous RSV 
infection. This reduction in susceptibility remains approximately unchanged whether 
infection is identified at a pathogen (solid black line) or group level (dashed coloured 
lines). However, the 95% Credible interval for the parameters estimated with the 
group level data now includes 1 on the fringes of the interval. The first interaction 
parameter in panel b) measures the reduce susceptibility to reinfection by a 
heterologous pathogen, i.e. risk of RSV given previous coronavirus and vice versa. Here 
there is a noticeable change in distribution when the pathogens are identified at a 
finer scale. When identification is at a pathogen level, the modified susceptibility is 
1.33 (95% CrI: 1.14, 1.57), which indicates and increased risk of infection. However, 
with identification at the group level, this effect is increased for an (RSV B - OC43) 
interaction to 1.81 (1.4, 2.34) and reduced for an (RSV A - 229E) interaction to 0.698 
(0.383, 1.17). These parameters are estimated such that the interactions are assumed 
to be symmetric, i.e. previous infection with RSV B increases the risk to subsequent 
infection with coronavirus OC43 and vice versa. However, the data shows that in 66% 
(40 out of 61) of the individuals who had an RSV B and OC43 infection, the RSV B 
infection preceded the OC43 infection. In individuals who had an RSV A and 229E 
infection, 59% (10 out of 17) of them had the coronavirus infection prior to the RSV 
infection. These shedding patterns are shown in  Figure 5. 2 and Figure A4. 2, Figure 
A4. 3, Figure A4. 4 and Figure A4. 5 in appendix A4. The other group level interactions 
have their distributions centred closer to 1, which implies no effect. The risk of 
infection with HCoV is modified given previous infection within the same epidemic, 
however, unlike with RSV, the direction of effect is not as clear, panel c). Previous 
infection reduces susceptibility to homologous group infection for OC43 
(risk.oc43.prev.oc43=0.58 (0.413, 0.79)) and NL63 (risk.nl63.prev.nl63=0.617 (0.438, 
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0.844)). The interaction between NL63 and the other HCoV groups appears to be of 
increased susceptibility, as the medians of the distributions are above 1, however, the 
95% Credible intervals do include one so the effect cannot be stated with significance 
(risk.229e.prev.nl63=1.1 (0.806, 1.46) and risk.nl63.prev.oc43=1.16 (0.914, 1.48)). 
 
 
The other interaction between RSV and coronavirus measured by the susceptibility to 
co-infection (risk.rsv.curr.corona) shown in panel d) does not have a strong signal 
regardless of the level of pathogen identification, the distribution of the estimated 
parameters are either centred around 1 or have a wide credible interval. The values of 
the within household transmission coefficients are dependent on the level of pathogen 
identification. For RSV (HHrsv) shown in panel e), when identification is at the 
pathogen level, the value is 0.0038 (0.00291, 0.00508) while identification at the group 
level increases the within household coefficient for RSV A to 0.00544 (0.00379, 
0.00758). The change in distributions with increased pathogen resolution is also 
observed when looking at the coronavirus within household transmission coefficient 
(HH.corona) shown in panel f). In general, coronaviruses had higher values for the 
within household transmission coefficient than RSV (HH.229e=0.00795 (0.00577, 
0.0108), HH.nl63 = 0.0117 (0.00939, 0.0145) and HH.oc43 = 0.00547 (0.00428, 
0.00681), compared to HH.rsva = 0.00544 (0.00379, 0.00758) and HH.rsvb = 0.00408 
(0.00282, 0.00555)). The distributions of the community transmission coefficients have 
a narrower credible interval when identification of the pathogen is at the group level; 
however, the distributions of the individual groups are not too different from each 
other whether looking at RSV (Comm.rsva = 0.000186 (0.000101, 0.000317) and 
Comm.rsvb = 0.000217 (0.00012, 0.000357)) shown in panel g), or coronavirus 
(Comm.229e = 0.000242 (0.000132, 0.000398), Comm.nl63 = 0.000181 (0.0000996, 
0.000297) and Comm.oc43 = 0.000297 (0.000167, 0.000485)) shown in panel h). The 
parameters for the background community function are not significantly altered by the 
resolution of pathogen identification (Delta and Beta) shown in panel i) and j) 
respectively. 
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Figure 5. 3: Comparing parameter densities obtained from fitting the data at the pathogen level (solid black lines) to the 
densities obtained from fitting data at the group level (dashed coloured lines). 
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Estimates of the mean and standard deviation of latency distribution were derived for 
RSV and coronavirus. RSV had a mean latency distribution of 3.05 days (2.19, 3.7) and 
standard deviation of 0.683 (0.323, 1.21); coronavirus had a mean of 2.95 days (2.4, 
3.62) and standard deviation of 0.712 (0.518, 0.938).  
 
5.6.3. Modified pathogen inference 
This section of results compares the pathogen specific parameters estimated when 
independently fitting the pathogen (either RSV or coronavirus) to parameters 
estimated when fitting multiple pathogens (RSV and coronavirus). The results are 
shown in Figure 5. 4 for RSV and Error! Reference source not found. for coronavirus. 
The trace plots showing the results of the MCMC algorithm are given in appendix A4.  
For RSV, there are slight shifts in the distributions of the parameters for RSV B within 
household transmission coefficients (towards smaller values), and RSV A community 
transmission coefficients (towards larger values) when going from a single-pathogen fit 
to a multi-pathogen fit.  The shift observed in the parameters of the background 
community function (Delta and Beta) imply that when considering multiple interacting 
pathogens in a model, the basic risk prior to any observed onsets is higher and the rate 
of exponential decay of risk following observed onsets is much faster. The rates of 
exposure from within the household and from the community need to balance out in a 
way that explains the timing of the cases. Since Delta and Beta are not pathogen 
specific, the shift was probably necessary in order to explain the number of observed 
RSV and HCoV index cases in the data and subsequent cases in the same time window 
that were likely part of the same transmission chain as the index cases.  
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Figure 5. 4: Comparison of the RSV specific parameters obtained from fitting a single 
pathogen model (blue line) to those obtained from fitting a multi-pathogen model 
(black line). 
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become better defined. Noticeably, when fitting HCoV as a single pathogen the 
distributions for Comm.229e, Comm.nl63, Comm.oc43 and Beta appear to be bimodal. 
It is worth noting however that the model with HCoV data took a lot longer to 
converge relative to the version with RSV data. Increasing the number of iterations to 
400,000 resulted in an increase in the effective sample sizes, however it did not 
resolve the bimodal distributions observed for these parameters as seen in Figure 5. 5. 
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Figure 5. 5: Comparison of the coronavirus specific parameters obtained from fitting 
a single pathogen model (pink line) to those obtained from fitting a multi-pathogen 
model (black line). 
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5.7. Discussion 
We extended a multi-strain individual level transmission model of RSV to be able to fit 
data from multiple pathogens and investigated the interactions between RSV and 
coronavirus. The two pathogens interacted through modified susceptibility and we 
found evidence that RSV and HCoV interacted through increased susceptibility to 
heterologous pathogen re-infection. With increased resolution at the group level, this 
effect was only significant for the interaction between RSV B and OC43 where previous 
infection with RSV B increased an individual’s susceptibility to coronavirus OC43 by 
about 81% (95% CrI: 40%, 134%). Though the modification to susceptibility was 
assumed to be symmetric, i.e. modified susceptibility to RSV B given previous OC43 
equals modified susceptibility to OC43 given previous RSV B, the pattern in the data 
was such that RSV B infections preceded OC43 infections 66% of the time. The exact 
mechanism of this facilitative interaction between RSV B and HCoV OC43 is unknown; 
differences in target host cells, immune response to infection or modification in host 
behaviour following infection could play a role in the observed dynamics. In vitro and 
in vivo infection studies coupled with models of viral kinetics would provide more data 
at different levels of interaction45,46.In addition to investigating interactions, we 
compared inference made when fitting data from a single pathogen to fitting data 
from multiple pathogens and found that though there were no drastic changes to the 
pathogen specific parameters, fitting more data did lead to better resolution in some 
of the parameter distributions, more so for HCoV. 
 
The data used in this study showed that 26-45% of coronavirus onsets were 
accompanied by an acute respiratory illness, with OC43 having the higher case-disease 
ratio. Though this is not as high as for RSV, 55% for RSV B and 61% for RSV A, it is still 
significant evidence of the importance of coronaviruses as contributors to respiratory 
illness. Given our inferred interaction between RSV B and coronavirus OC43, it follows 
that if a vaccine against RSV was introduced leading to a reduction in RSV transmission, 
it could also lead to a reduction in coronavirus OC43 transmission and associated 
disease. Since there is no clear evidence of competition between the coronavirus 
groups, a reduction in OC43 transmission is unlikely to result in its replacement in 
dominance by the other coronavirus groups. In this case, the inferred pathogen 
interaction would lead to a positive unintended effect of RSV vaccination against 
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coronavirus. Such a scenario would not be novel. It has been shown that the effect of 
the measles mumps and rubella (MMR) vaccine has had an impact on measles related 
cases and non-measles related deaths. This is as a result of preventing measles 
infections which lead to immunomodulation making the host more susceptible to 
infections for up to 3 years after the measles infection 69. This is one significant 
example of how complex pathogen interactions can be, necessitating the need to 
consider viruses as potentially being linked to each other in order to fully understand 
their epidemiology.   
 
Previously, a different version of the model used in the present analysis was used to fit 
RSV data identified up to the level of genetic clusters (see Chapter 4). This analysis 
found evidence of an interaction between RSV A and RSV B where previous infection 
with either RSV A or RSV B reduced the risk of heterologous group re-infection by 
49%(95% CrI: 10%-74%). In the present analysis, this effect was not as clear as the 
estimates for the modified susceptibility included one. This could be a result of a 
difference in model assumptions or due to the increased resolution in pathogen 
identification. Even with such detailed data, the more pathogens that are considered 
together in the same system, the more interaction parameters are needed leading to a 
decrease in statistical power to make inference and an increase in computational 
demands. In moving from the model in Chapter 4 to the model presented here, 
parameters quantifying the effect of age, household size and viral load were forgone in 
order to estimate parameters that would allow inference on potential interactions.  
 
The results of this analysis must be considered along with its limitations. Interaction 
between the infectious agents was through modified susceptibility to heterologous re-
infections or co-infections. Other potential mechanisms of interaction such as modified 
infectiousness, modified duration of infection or ecological interference by way of 
modified behaviour following infection, were not explored. Ecological interference is 
unlikely to have a significant effect when considering transmission events within 
households70. Modified susceptibility is a common place to begin when investigating 
pathogen interactions39,48,71. While it is plausible that a combination of modifications 
could be contributing to observed pathogen dynamics, including all possible 
interactions could quickly lead to an intractable model, as such choices have to be 
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made on the system being represented by the model and conclusions should be drawn 
in light of the simplifying assumptions72. There is however evidence from this data set 
that pathogens could be interacting through modified duration of infection. Previous 
infection with other viruses was found to be associated with shorter RSV shedding 
episodes while co-infections were associated with longer shedding episodes61. It was 
assumed that the interactions between the pathogens were symmetric, effectively 
ignoring the order of infection events within a single individual. Though this is also 
assumed when using compartmental models that are fitted to data that span larger 
geographical and temporal scales39,48,71, it is often done due to a lack of suitable data 
to determine the order of infection with multiple pathogens. That is not the case with 
the household data used in the present analysis, as a first step to extend this analysis 
in preparation for publication, the symmetry assumption will be relaxed. It was also 
assumed that immunity following exposure to multiple pathogens is built up 
geometrically, i.e. if previous infection with pathogen X reduces susceptibility to 
infection by Y by a factor of 0.7 and previous infection with Z reduces susceptibility to 
Y by a factor of 0.5, then previous infection by X and Z reduced susceptibility to Y by a 
factor of 0.35. Making such an assumption for pathogens that appear to co-circulate is 
reasonable since the data has a record of infection history during the epidemic period. 
However, were it clear that one of the pathogens is significantly out of sync with the 
rest, then this assumption would not be appropriate. Instead, the model could be 
formulated such that only the most recent infection contributes to modified 
susceptibility72.  
 
The data spanned a relatively short temporal period of 6 months bringing into 
question whether the observations are generalizable across epidemics. However, the 
detailed nature of the data that captured repeat infections with different pathogens is 
a great advantage relative to cross-sectional studies that mostly capture single onsets 
making it difficult to explore pathogen relationships at the host level. Cross-sectional 
studies often have the advantage of capturing transmission dynamics at a larger 
temporal and geographical scale, such data is available from the same local area as the 
household data and has previously been used to fit a compartmental model73. A multi-
scale model that combines the individual level dynamics and extrapolates these to the 
population level would elucidate if the pathogen interactions observed at the 
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individual host level significantly impact transmission at the population level. The 
model was only fit to data from RSV and coronavirus onsets but there are other viral 
pathogens in circulation, most notably rhinovirus and adenovirus, both of which could 
have potential interactions with RSV, as well as unobserved bacterial infections. The 
choice in which pathogen to fit was based on the availability of pathogen identification 
at a finer scale. Rhinovirus has over 100 serotypes as such, treating it as a single 
homogenous pathogen is likely to lead to incorrect inference. All the households in the 
data experience at least one rhinovirus introduction, but only 5 of the 47 households 
in the data had the rhinoviruses typed74. In preparing this analysis for publication, a 
sub-analysis of 5 households will be included where three pathogens with 
identification at the group level are used to fit the model, RSV, HCoV and rhinovirus. 
Due to the relatively short study period, the circulation of other pathogens might have 
been missed, in particular the HMPV epidemic. Susceptibility to HMPV has been shown 
to be altered by an RSV infection39 which could explain why the epidemics were not 
observed to overlap. Such potentially competitive interactions warrant further 
exploration and extrapolation to a larger population of hosts. 
 
In conclusion, this study, to the best of our knowledge, presents the first dynamic 
multi-pathogen model of RSV and coronavirus group specific data. We show that 
interactions between the two pathogens are group specific, which could explain the 
contradictory observations from previous studies on the effect of RSV infection on 
other respiratory pathogens. Quantifying the level of interaction between pathogens 
and understanding how this influences the transmission dynamics of each could help 
to design optimized control strategies. Future studies should look at pathogen 
interactions at multiple levels such as cellular, individual host, etc., identifying 
parameters that could then be used in mechanistic population models of transmission. 
Most models assume viruses are independent, a factor that is unlikely to be true. 
There are challenges in determining the level and extent of interactions; however, 
pathogen interactions could shed light on long standing issues such as drivers of 
seasonality and pathogenicity.  
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6. Discussion 
Recognizing the importance of understanding the transmission dynamics of RSV, this 
PhD project was conceptualized with an aim to use an integrated data analysis to 
identify transmission chains within a household setting. The idea was to use all the 
data available on the shedding episodes and host social-demographic factors within a 
single modelling framework. A key determinant of the methodology that could be 
applied was the availability of genetic data. Naturally, this called for an investigation 
into the field of phylodynamics1,2. A review of the methods available revealed that 
applying any of the pre-existing methods that simultaneously infer ecological and 
evolutionary dynamics would be challenging due to the nature of the data. The genetic 
sequences were available at about half the sampling density of the pathogen-positive 
samples. It was therefore decided that a two-part analysis of the data would be more 
suitable beginning with the epidemiological data, then extending the model to include 
genetic information, similar to previous work3,4. 
 
The epidemiological data, consisting of timings of positive samples, viral load and 
symptom status, was modelled using a dynamic transmission model calibrated at the 
individual host level and time in days. RSV cases were identified by group either as RSV 
A or RSV B. The results of this primary analysis revealed that during the course of a 
single epidemic, individuals acquire partial immunity that is stronger against 
homologous group re-infection than heterologous. The existence of re-infections 
within the same epidemic is evidence that even in the short-term, immunity to RSV 
infection is not complete and this incompleteness was quantified as a 47% (95% CrI: 
17%-68%) reduction in susceptibility to homologous re-infection and 39% (95%CrI: -
8%-69%) reduction to heterologous.  An effect of increasing age on susceptibility was 
also inferred. Older individuals were less susceptible to RSV infection. This could be 
indicative of a lifelong partial immunity that builds up with repeated exposure, a 
mechanism previously explored by Weber et al5 and Kinyanjui et al6. However, it was 
assumed that exposure and hence infectious contacts occurred homogeneously with 
respect to age. This is not necessarily the case, as a recent study on household contact 
revealed7, as such the estimated age effects on susceptibility could include effects of 
age related contacts within the household. Nonetheless, these results imply that there 
are short-term and long-term immune dynamics against RSV. If vaccinations are timed 
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according to the seasonal patterns, models assessing the impact of such strategies will 
need to account for both the short and long-term dynamics. Individuals who were 
shedding large quantities of virus and had ARI symptoms, characteristics which have 
been found to be correlated8, were estimated as being more infectious than their 
asymptomatic low viral load counterparts. Simulations were run to assess the impact 
of a vaccine that worked by eliminating symptoms. These showed that such a vaccine 
would reduce the projected number of cases significantly. It has previously been 
shown that a vaccine that worked by reducing infectiousness and duration of shedding 
would have the highest impact9. Two unique findings came out of this analysis: firstly, 
households of less than 8 occupants were inferred as having an increased pair-wise 
risk of transmission; secondly, there was evidence that RSV A had a slight transmission 
advantage over RSV B in the household. The first observation could be the result of 
smaller households, as defined in this setting, being more likely to have fewer 
structures and as such members come into contact more freely, and therefore are 
more likely to infect each other. If so, then this means that social structuring needs to 
be considered when modelling transmission, or at a minimum, population density. 
High population density has already been linked to the generation of new RSV viral 
variants10 and household structure has been included in a dynamic model used to 
explore a joint maternal and cocoon vaccination strategy11. The second observation is 
not completely new; other studies have found evidence that RSV A is more 
transmissible than RSV B12,13, perhaps providing an explanation for RSV A dominating 
most outbreaks. Finding some evidence that RSV A and RSV B might have different 
transmission niches could point more to the ecology of the two groups and the 
mechanisms by which they manage to co-exist. 
 
The genetic information was included into the model by allowing further classification 
of the infecting virus into genetic clusters. These clusters were derived from a separate 
phylogenetic analysis14 and were used to create mutually exclusive pathogen 
identities. The model and inference technique were then adapted to include the 
genetic cluster information where available and infer it where it was not. Increased 
resolution in pathogen identification did not result in significant shifts in the 
distribution of estimated parameters, however, the weak signal of there being 
separate transmission niches for RSV A and B transmission inferred though differences 
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in the distribution of the group-specific transmission coefficients was lost. In inferring 
the transmission networks, which were refined by the pathogen resolution, I did find 
that despite RSV B being the dominant pathogen in circulation, RSV A was more 
successfully transmitted to infants in the household.  It was also shown that when 
infants were infected within the household, it was by a child under the age of 13 years 
which is supported by a household contact study that showed that children 6-14 years 
old frequently contacted children 0-5 years old in the same household7. Infants were 
also frequently found to be index cases in household outbreaks, this result taken 
together with observations from the previously mentioned household contact study 
that found children 0-5 years old were frequently contacted by adults outside of their 
households7, could point to childcare practices that are important in determining the 
source of infant infections.  Since the analysis by White et al15, there aren’t other 
publications that look into quantifying the interaction between RSV groups and 
inferring what such interactions mean for transmission dynamics.  Such studies could 
aid in gaining a better understanding of why the RSV groups manage to co-exist with 
RSV A being the more dominant pathogen. Why does RSV A not replace RSV B? 
Interactions between the RSV groups could be ecological and/or immunological, and 
disentangling these effects would result in a better understanding of transmission 
drivers thereby allow more effective control16. 
 
Following the results above, there was increased interest in identifying if RSV 
interactions within the household also occur with other pathogens. The model was 
adapted to fit data from two different pathogens, RSV and human coronavirus (HCoV), 
each identified at the group level. Coronavirus was classified as corona-229E, corona-
NL63 or corona-OC43. Given how frequently individuals in the study were infected 
with HCoVs, it was surprising that the frequency of RSV-HCoV co-infections was not 
more common than what was observed. Whether this frequency was less than what 
would be expected to occur if the pathogens were independent was investigated by 
estimating if susceptibility to RSV infection is modified if one is currently shedding 
HCoV, and vice versa. Whether susceptibility was altered depended on the level of 
pathogen identification. If all RSV shedding episodes were treated homogeneously and 
all the HCoV episodes were also treated homogenously, it was inferred that 
susceptibility was not altered; implying the lack of frequent co-infections was to be 
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expected. However, with pathogen identification at the group level, there was a 
combination of effects, with some pathogen group pairs showing reduced 
susceptibility and others showing increased. A similar effect was observed when 
attempts to infer if susceptibility to one pathogen was altered by previous infection to 
another. Interactions with RSV A seemed to result in reduced susceptibility while 
interactions with RSV B resulted in increased susceptibility. These observations could 
form part of the explanation as to why epidemiological studies investigating the effect 
of viral co-infections find conflicting interactions, with some reporting increased 
disease risk17–19 and other not20–22. However, these results should be interpreted with 
caution. A strong assumption was made by treating the interactions as symmetric, i.e. 
the effect of say previous RSV A infection on susceptibility to HCoV-OC43 was the same 
as the effect of previous HCoV-OC43 infection on susceptibility to RSV A. This 
assumption was made to reduce the dimensions of the parameters being estimated 
for computational efficiency and ease of interpretation. However, the results suggest 
that this should be challenged, and asymmetric relationships explored. Asymmetric 
fitting is beyond the scope of this thesis, however since the results of the multi-
pathogen fitting are intended for publication, this will be done prior to submitting to a 
journal. The analysis we presented in Chapter 5 only begins to scratch the surface of 
possible interaction mechanisms that could be driving patterns of pathogen 
transmission observed at the host level. A majority of models treat pathogens as 
existing independently, an assumption which has already been challenged by studies 
showing RSV replacement as a disease causing agent in the face of prophylactic 
treatment23, competitive interactions between RSV and influenza24,25, competitive 
interactions between RSV and human metapneumovirus (HMPV)16,26, and facilitative 
interactions between viruses and bacteria27–29. It is increasingly crucial for investigators 
to begin to consider multi-pathogen interactions even if the focus is just on one 
particular pathogen30. The challenge for such studies will be in determining the level 
and extent of these interactions. Models would become increasingly intractable with 
increase in the number of pathogens being considered. The resolution with which 
these pathogens are identified will also play a role in the consistency of inferred 
interactions. All these factors mean that a lot of data is required at different potential 
levels of interactions, within the host, individual host level and between host level.  
 189 
The table below gives a summary of the three versions of the individual level dynamic model used in Chapter 3, 4 and 5.  
 
Table 6. 1: A summary of the three variants of the individual level model used to investigate transmission dynamics of RSV.  
The models are named according to the chapter in which they were presented.  
 Chapter 3 Chapter 4 Chapter 5 
Data • Social-temporal RSV shedding 
patterns where shedding episodes 
are identified by RSV group. 
• Individual’s demographics e.g. age 
• Social-temporal RSV shedding 
patterns. 
• Individual’s demographics e.g. 
age 
• Viral genetic sequence data in 
the form of genetic clusters used 
to further classify shedding 
episodes 
Social-temporal RSV and hCoV 
shedding patterns 
Analysis 
objectives 
To define transmission patterns for 
RSV  
• To define transmission patterns 
for RSV  
• To identify transmission chains 
and source of infant infections 
To investigate possible pathogen 
interactions between RSV and hCoV 
at the individual host level 
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Assumptions • Susceptible-Exposed-Infected-
Susceptible (SEIS2) RSV natural 
history 
• Infection from household and 
external unknown sources 
(community exposure) 
• Group-specific community 
exposure to infection can be 
represented by a bell-shaped 
curve estimated from household 
level incidence 
• Age, household size, viral load and 
symptom might affect 
transmission 
• Latency period ranges between 2-
5 days 
• Transmission between households 
in the study not explicitly 
modelled 
• Susceptible-Exposed-Infected-
Susceptible (SEIS2) RSV natural 
history 
• Infection from household and 
external unknown sources 
(community exposure) 
• Cluster-specific community 
exposure to infection can be 
represented by adding up an 
exponential function relating the 
rate of exposure to time since 
onset in every case. 
• Age, household size, viral load 
and symptom might affect 
transmission 
• Latency period ranges between 
2-5 days 
• Possible transmission between 
households in the study 
• Susceptible-Exposed-Infected-
Susceptible (SEIS2) RSV and 
hCoV natural history 
• Infection from household and 
external unknown sources 
(community exposure) 
• pathogen-specific community 
exposure to infection can be 
represented by adding up an 
exponential function relating 
the rate of exposure to time 
since onset in every case. 
• Pathogen-specific latency 
durations gamma distributed 
with mean and SD estimated 
from the data 
• Transmission between 
households in the study not 
explicitly modelled 
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Findings • Smaller households have a higher 
pairwise rate of exposure. 
• Increasing age estimated to 
reduce susceptibility to infection. 
• RSV confers partial short-term 
immunity more so against 
homologous group re-infections.  
• A vaccine that works to eliminate 
symptoms would have an impact 
on overall transmission 
• Estimates of the baseline rates of 
exposure within the household 
and at the community level for 
RSV A and B suggest a possible 
transmission niche for RSV A 
within the household. 
• Estimated 40-59% of RSV A and 
26-48% of RSV B cases occurred in 
the HH 
• Smaller households have a 
higher pairwise rate of exposure. 
• As with model in Chapter 3, age 
estimated to affect susceptibility 
and RSV infection estimated to 
confer short-term immunity 
• Inclusion of genetic data in the 
model resulted in slight shifts in 
the distributions of the baseline 
rates of exposure for RSV A and 
B, resulting in the evidence of a 
transmission niche from the 
previous model being lost 
• Increased precision in infection 
source attribution, estimated 
60% of RSV A cases from the HH, 
while 52% of RSV B were from 
the HH.  
• Pathogen interactions become 
cleared with increased 
resolution of pathogen 
identification, which could 
explain conflicting evidence of 
how RSV interacts with other 
pathogens from other studies. 
 
• RSV B and hCoV OC43 estimated 
to have a facilitative interaction 
where previous infection with 
one increases susceptibility to 
the other.  
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 • Over half of infant RSV A 
infections contracted within the 
household, less so for RSV B 
• Where infant infections occurred 
in the household, often the 
source of infection was a child 
between the ages of 2 and 13.  
• Transmission between 
households in the study unlikely 
to have occurred.  
Limitations • Small sample size  
• Sampling frequency means short 
duration episodes might have 
been missed 
Used two-step approach in data 
integration which could introduce 
inconsistency in inferred dynamics 
• Assumed symmetry in pathogen 
interactions 
• Only used data from 2 
pathogens 
• Data represents short temporal 
window  
Recommendations Inclusion of other data types such as 
genetic data to further elucidate 
• Targeting school-aged children 
for vaccination would result in an 
• Pathogen interactions should 
not be ignored if we are to fully 
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transmission chains and clarify 
hypothesis of transmission niche. 
indirect protective effect on the 
infant 
• Though genetic data did not lead 
to a drastic change in the 
inferred transmission dynamics, 
its utility should not be ruled out 
in future studies conducted at a 
broader temporal and 
geographical scale 
• Inferred interactions between 
RSV A and B, and differences in 
transmission such as the 
observation that more RSV A 
infections occur in the household 
relative to RSV, warrant further 
investigations. 
understand their pathogen 
transmission dynamics. 
 
• Evidence of an interaction 
between RSV and hCoV 
warrants further investigation  
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In all the three main analyses presented in this thesis, it was considered that infection 
can occur within a household, through contact with an infectious household 
cohabitant, or outside the household (community level). The possibility of between 
household transmission as a source of community infection was considered in the 
model in Chapter 4, however there were numerous households in the study area that 
were not recruited, making the possibility of direct transmission occurring between 
the few that were sampled unlikely. It was therefore necessary to find a way to 
account for community exposure in order to allow introductions into the households. 
Two different approaches to account for this were implemented. In Chapter 3, a bell-
shaped incidence curve was fitted to primary onsets of household outbreaks and used 
as a proxy for the background community rate. This background function was derived 
at the RSV group level. In Chapter 4, it was no longer feasible to use this function with 
the identification of genetic clusters. This was because some clusters had such a low 
representation in the population of infected households that the background curves 
derived in this way took unexpected shapes. As such, a new function form was 
adopted that was based on the timings of cases infected with a particular cluster. The 
‘signal’ of the cluster in the broader community was assumed to wane exponential 
from the time of onset in an individual. Signals from all the individuals with onsets to a 
particular cluster were added up to give the total background community function. 
Though this formulation worked, it requires further validation. Accounting for 
exposure from sources outside of the household is crucial, if one community exposure 
can lead to a household member getting infected, it would be wrong to assume that 
this external exposure is not competing with exposure at the household level once 
infection is introduced. However, throughout all the analyses, the inferred pair-wise 
rate of within household exposure was much higher than the community rate of 
exposure. 
 
Depending on the definition of RSV disease, the efficacy and effectiveness of 
preventive measures may vary and be affected by population characteristics (genetic 
or otherwise) and circulation patterns31,32. This necessitates the understanding of RSV 
transmission dynamics at geographical scales that have generalizable seasonality, 
population demographics and infrastructure for implementation of vaccine policy. 
Kenya is a lower middle-income country in the tropical eastern coast of the African 
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continent. As with other tropical locations, the seasonality drivers of RSV are not well 
understood, however, the burden of disease due to RSV has been shown to be 
significant33–38, making a vaccine against RSV a subject of national interest. Though the 
results of this study are based on a small number of individuals, the characterization of 
the ecology of RSV calls for further investigations to determine the role of pathogen 
interactions and social-demographic characteristics in driving the observed viral 
seasonality patterns. Would an RSV vaccine need to be such that it prevents disease 
without disrupting the viral ecology so as not to elicit pathogen replacement?  
 
All the inference made in this work is based on data collected from a small fraction of 
the population. Due to the intense sampling of the individuals in the study, it was not 
feasible to extend follow-up to large groups of individuals due to constraints, the least 
of which is logistics. The results presented here must therefore be taken with the 
knowledge that it was not possible to characterize what was not observed, and 
transmission in a majority of the local area was largely unobserved.  In addition to the 
data being limited in geographical scale, there are also temporal limits to bear in mind. 
Data collection only covered six months of the year, meaning seasonality of viruses 
such as HMPV were missed, (which could also be another indicator of competition 
between RSV and HMPV). The strengths of such study designs are being able to 
observe infection dynamics at the individual host level, picking up on repeat infections, 
co-infections, asymptomatic infections and variations in the infecting pathogen. On the 
opposite end of the spectrum are studies such as those conducted by Li and colleagues 
that collated data from different sources to come up with a global picture of pathogen 
dynamics spanning several years26. Such studies are useful in being able to compare 
and contrast seasonality and therefore infer potential drivers, however, it is too course 
to infer factors such as the role of repeat infections. Depending on the purpose of a 
study, a balance must be found between the number of samples and the information 
content of each sample.  
  
In the analyses presented in this thesis, individual level dynamics were used to predict 
population level transmission dynamics, albeit in a small population. Due to the size of 
the population, it was possible to use individual-level mathematical models. Such 
models can become increasingly complicated and computationally intensive when they 
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are used to represent large heterogeneous populations. At which point a popular 
alternative is compartmental models that group hosts into several states. As a middle 
ground, multi-scale models are used to link individual level dynamics such as variation 
in infectiousness based on age of infection, to populations level transmission 
dynamics39. As more data on the characteristics of individual infections are becoming 
available, especially genetic data, such multi-scale models should concurrently 
increase in frequency. This naturally might mean an increase in complexity of the 
inference technique, requiring the use of advanced techniques such as particle filter 
MCMC40.  
 
This PhD project was conceptualized with a broad aim of gaining a better 
understanding of RSV transmission dynamics by interrogating different data types 
collected from a longitudinal household study. Specifically, I had four main objectives. 
The first was simply to conduct a review of the literature and identify the best way to 
integrate different data types into a single modelling framework. This review, 
presented in Chapter 2, was successful in identifying that the choice of method should 
be data driven, thus given the unique nature of the data, it was decided that the model 
will be focused on representing short-term (6 months) infection dynamics at the 
individual host. The model also focused on the most abundant type of data, social-
temporal shedding patterns, and used any other data types as enhancements. The 
second objective was to use all the available genetic data and epidemiological data to 
infer transmission dynamics and transmission chains within and possibly between 
households. The model was built-up in stages, first using the epidemiological (social-
temporal) data to infer transmission characteristics and then extending the model to 
include genetic data as a way to further clarify transmission clusters. These two 
versions of the model are presented in Chapter 3 and 4 respectively. Including genetic 
data in the model did not result in a drastic change in the inferred dynamics, possibly 
due to the study design, as discussed in Chapter 4. Despite the hypothesis of a 
difference in transmission niche between RSV A and B inferred in Chapter 3 from the 
distribution of parameters being nullified in Chapter 4, there was consistency in the 
fact that more of the RSV A cases were attributed to within household transmission 
than RSV B. The evidence for the existence of a transmission niche might not be clear, 
but the differences inferred between the two groups warrant further investigation. 
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The third objective was to identify the added benefit of viral genetic sequence data 
and provide advice on data collection for future studies. The use of genetic clusters in 
the model increased the certainty with which transmission clusters were inferred, 
therefore allowing more precision in some of the epidemiological parameters. 
However, given the relatively smaller sampling density of the genetic data compared 
to the social-temporal data, the utility of the former was not greatly observed in the 
model inference. However, I do not dismiss how informative viral genetic sequences 
can be and argue that at a larger temporal and geographical scale the insights gained 
from integrating genetic data with epidemiological data will be much more impactful. 
Finally, the integrated data framework was to be used to explore vaccination strategies 
and give information on target population, timing and frequency. Though I did not 
explicitly model vaccination, I did infer that targeting school going children would lead 
to indirect protection of the infant and that a vaccine would have an overall effect on 
transmission even if it only worked to eliminate symptomatic infections. The inference 
from the analyses presented in this thesis could be used in multi-scale model of 
vaccination that aims to translate individual level dynamics onto population level 
effects. Though it was not part of the main objectives, Chapter 5 presents the results 
of extending the model in Chapter 3 to fit data from multiple pathogens. The need to 
do so arose after the observations of the interactions between RSV A and B. Though 
the analysis had numerous simplifying assumptions, it was able to highlight the need 
to not only consider group/species interactions of the same pathogen, but also 
between pathogen interactions as they could have an impact on how effective and 
intervention will be.  
 
In conclusion, this thesis presents the progression of a data driven analysis that began 
with an aim of simply inferring transmission dynamics through integrating genetic 
sequence data and epidemiological data. Though this target was met, inference on the 
ecological dynamics of RSV groups and RSV with other pathogens was made. Evidently, 
there is an interaction between the two RSV groups and possible differences in 
transmission propensity within the household that require further investigation. 
Signals of possible multi-pathogen interactions also warrant further investigations and 
should serve as a precaution for future studies that treat RSV as a homogenous 
independent pathogen. During vaccine trials, samples should be taken to consider the 
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potential enhanced or reduced impact of a reduction in RSV transmission. Extensions 
of this analysis are possible on two fronts. First, integration of epidemiological and 
genetic data could be done at larger temporal and geographical scales to reveal 
interactions between ecological and evolutionary dynamics. The approach taken here 
was two-staged, avoiding simultaneous inference of the epidemiological and genetic 
models for computational reasons and due to restrictions in the data brought about by 
differences in sampling densities. However, much insight can be gained through 
simultaneous phylodynamic inference.  Second, future models of RSV could aim to be 
a combination of inference on the longitudinal short-term host dynamics, such as the 
kind inferred here in Chapter 4, and population level long-term dynamics such as the 
kind inferred by Kinyanjui et al6. Such models would not only be able to make better 
inference on interactions between RSV groups, but also interactions between different 
pathogens, and in doing so, be better placed to make predictions on the impact of an 
intervention strategy against one or more pathogens30.  
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A2: Supplementary appendix for Paper 1. 
A2.1. Imputing shedding durations, symptomatic episodes and viral loads 
 
An RSV A/B shedding episode is defined as a period within which an individual 
provided PCR positive samples for RSV A/B that were no more than 14 days apart. 
Sampling of the study population was done in intervals, as such, complete shedding 
episodes had to be imputed using the mid-point method described.  Shedding was 
assumed to start mid-way between the last negative sample and the first positive 
sample, and it ended midway between the last positive sample and the first negative 
sample of an episode. This is illustrated below: 
 
                   
 
Filled circles are positive samples in a single episode, empty circle are negative. t1, t2, t3 
and t4 are dates of sample collection. 
 
For (t4-t3) and (t2-t1) ≤7 days !"#$%&'( = *%+ + -%. − %+ 21 23 − *%4 − -%4 − %5 21 23  
For (t4-t3)>7 !"#$%&'( = 6%+ + 78 21 9: − *%4 − -%4 − %5 21 23 : Right censoring 
For (t2-t1) >7 !"#$%&'( = *%+ + -%. − %+ 21 23 − 6%4 + 78 21 9: : Left censoring 
Where x=mean of sampling intervals for samples in an episode, which was found to be 
3.45 days.  
Any negative samples (Ct >35 or Ct=0) in between a shedding episode were ignored, 
i.e. were not treated like true end of shedding. Figure A2. 1 shows the distribution of 
imputed shedding durations for RSV A and RSV B episodes. 
 
L=t4 J=t3 I=t2 K=t1 
Time 
       L=t4 J=t3 I=t2 K=t1 
Time 
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Figure A2. 1: Distributions of imputed shedding durations for RSV A (left) and RSV 
(right)  
 
In order to include information of the amount of virus shed by an infected person into 
the transmission model, the Ct value need to be converted to log10 RNA copy number 
which is a more direct measure of viral load. The formula used to convert Ct values to 
their log10 RNA equivalent was y= -3.308x + 42.9, where y=Ct values and x=log10 RNA 
copy number[1,2]. 
Following conversion of the PCR Ct values to viral load, we proceeded to interpolate 
the viral loads for days in an episode that did not have data. Linear interpolation was 
used for all the shedding episodes. It was assumed that the starting and ending 
sample, if data was missing, had a viral load of 2.388 log10 RNA (baseline positive Ct 
value converted to viral load). For two samples of viral load Va and Vb at times ta and 
tb, tb > ta, the gap in between is filled out as follows:  
For tb – ta =n, viral load Vj at time point tj for j=1…(n-1) is given by 
 ;< = ;= + <	(@AB@C)E  
Viral loads lower than 2.388 log10 RNA in between an episode were not included in the 
interpolation. Figure A2. 2 shows histograms of interpolated viral loads for RSV A and 
RSV B. 
 208 
 
 
Figure A2. 2: Histograms of interpolated viral loads for RSV A (left) and RSV B (right). 
 
We define symptomatic as having an acute respiratory illness (ARI), which is defined as 
having at least one of three traits: cough or nasal discharge/ blockage or difficulty 
breathing. Within virus shedding episodes, we imputed complete ARI episodes from 
intervals of recorded ARI. A virus shedding episode that had no day where an ARI was 
reported was assumed to be asymptomatic. For a virus shedding episode with at least 
one day of recoded ARI, the duration of symptoms was imputed using the midpoint 
method described for shedding episodes. This is illustrated below: 
 
Green open circles are reported ARI symptoms (ARI positive) within the shedding 
episode and black open circles are confirmed absence of ARI (ARI negative). τ1, τ2, τ3 
and τ4 are days within the shedding episode where information on symptoms was 
collected. 
In this case, the mean sampling interval for ARI ‘samples’ within an episode was 3.78 
days. This was obtained from all ARI episodes not just the ones within shedding 
	-	o	-	-	o	-	-	o	-	-	o	-	-		
τ1	 τ4	τ2	 τ3	
Imputed	Shedding	duration	
Imputed	ARI	duration	
Time	
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episodes. Figure A2. 3 and Figure A2. 4 show the shedding patterns by RSV group and 
ARI status. 
 
 
Figure A2. 3: Shedding and ARI patterns for each of the 88 individuals who 
experienced at least one RSV A shedding episode.  
The y-axis shows the individuals with labels color-coded by household, time is on the x-
axis with zero indicating the day before the first sample was collected. The green dots 
show virus shedding and orange dots show the virus shedding days that were 
accompanied by an ARI. 
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Figure A2. 4: Shedding and ARI patterns for each of the 113 individuals who 
experienced at least one RSV B shedding episode.  
The y-axis shows the individuals with labels color-coded by household, time is on the x-
axis with zero indicating the day before the first sample was collected. The green dots 
show virus shedding and orange dots show the virus shedding days that were 
accompanied by an ARI. 
 
The imputation of continuous periods of presence or absence from the household was 
done similar to the imputation of shedding durations, however, there was no left or 
right censoring. Each participant had a set of days of recorded data, these days were 
either marked as ‘away’ or ‘present’ in the household, e.g. a participant might have 
data on days {32, 36, 39, 43, 46, 50, 53, 57} with status {away, away, present, away, 
present, present, away, present}. Since no data is available for this individual before 
day 32 and after day 57, no imputation is done outside this time window. For the days 
within the window, imputation is done as illustrated below: 
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Filled circles are days when the participant was recorded as being present while open 
ones is when they were away. The present period starts halfway between the last ‘away’ 
and first ‘present’ and ends halfway between the last ‘present’ and first ‘away’. 
A2.2. Extra results 
This section shows some additional results that are mentioned in the main text. 
Three chains with different starting points were used to generate the parameter 
estimates. The trace plots are shown in Figure A.5. Chain 3 was run in three parts each 
with a length of 50000, 100000 and 100000 respectively. The starting point of the 
second part was the end point of the first part, and so on for the third part. This was 
done in an attempt to reduce total computation time. The model runs were 
implemented on a cluster computer that appeared to be slowing down tasks that were 
taking up a lot of time and resources, as such, to try and work around this, the long 
chains were split up to give the impression of a new task. The Final results given after a 
burn-in of 80000 iterations exclude the re-start period seen between iteration 150000 
and 175000. However, including it does not make a significant difference to the 
inferred posterior distributions. 
t=32 t=36 t=39 t=43 t=46 t=50 t=53 t=57
Time
Present Present Present
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Figure A2. 5: Trace plots showing convergence for the 15 parameters of interest.  
Three chains with different starting points were used.  
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Figure A2. 6: Caterpillar plot of estimated parameters.  
The 15 parameters estimated, and their respective effective sample sizes are shown. 
Points represent posterior medians, the thick lines represent 50% credible region and 
the thin lines represent 95% credible region. Except ηA	and	ηB	(within	household	transmission	coefficients)	εA,	and	εB	(community transmission coefficients 
respectively) all the other parameters represent relative effects where a reference 
group exists. If a relative effect parameter is equal to 1(0 on the log scale) then the 
group it represents, and the reference group are not different. ESS is the effective 
sample size 
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Figure A2. 7: Comparing the total household rate of exposure 7∑ GG.IJKLM,O,P→J(R)PSJ 9 between small and large households.  
Each panel shows violin plots (combination of box plots and density plots) giving the 
distribution of the total household rate of exposure by total number of people 
infectious in the household at a given time point. The x-axis shows the total number 
infectious and the y-axis shows the value of the total household rate of exposure. The 
top row shows the linear relationship between total number of infectious individuals 
and total rate of within household exposure inferred from the parameter estimates for 
small households (left panel) and large household (right panel). The bottom row shows 
the same linear relationship, but with actual observed number of infectious household 
members. In this data set, small households had at most 6 simultaneously infectious 
household members while large household had 14.  
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Figure A2. 8: Correlation patterns of the different parameters obtained from fitting 
to the observed data.  
 
Table A2. 1: Results of fitting a reduced version of the model.  
We reduced the model such that there are no interactions between different RSV 
groups and refit the data in three additional ways: RSV A alone, RSV B alone and RSV 
with no distinction between groups. 
 
Parameter 
symbol 
Parameter 
name 
RSV A  RSV B  RSV 
 TU,MVW Prev.hom 0.444 (0.0194, 
0.963) 
0.547 (0.276, 
0.983) 
0.643 (0.423, 
0.978) 
 TXY	 Sus.age.2 1.01 (0.436, 
3.16) 
0.773 (0.263, 
2.99) 
0.919 (0.456, 2) 
 TXZ Sus.age.3 0.293 (0.134, 
0.821) 
0.234 (0.0866, 
0.859) 
0.294 (0.154, 
0.63) 
 TX[ Sus.age.4 0.187 (0.0829, 
0.534) 
0.129 (0.047, 
0.494) 
0.159 (0.0811, 
0.343) 
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η HH.rsv 0.021 (0.00544, 
0.0561) 
0.0101 
(0.000453, 
0.0343) 
0.0133 (0.00457, 
0.0311) 
 TG	 HH.size 0.337 (0.184, 
0.659) 
0.606 (0.285   
1.52) 
0.467 (0.277, 
0.847) 
 T\Y High.Asym 0.0401 
(0.0000626, 
1.72) 
0.243 
(0.0000662, 
18.1) 
1.03 (0.000126, 
6.36) 
 T\Z Low.Sym 1.91 (0.711, 
6.36) 
3.39 (1.20, 71.1) 2.17 (0.931, 
5.93) 
 T\[ High.Sym 7.28 (0.701, 
25.4) 
6.31 (0.885, 158) 8.76 (3.72, 23.5) 
ε Comm.rsv 0.00328 
(0.00159, 
0.00594) 
0.006 (0.00339, 
0.0096) 
0.00939 
(0.00588, 0.014) 
 T]Y	 Exp.age.2 0.335 (0.0745, 
1.46) 
0.815 (0.16, 
3.44) 
0.574 (0.187, 
1.65) 
 T]Z Exp.age.3 1.73 (0.548, 
5.26) 
2.13 (0.484, 7.6) 1.81 (0.712, 4.4) 
 
A2.3. Modification of the likelihood to establish the most likely infection 
source for every case. 
 
The rate of exposure in the model is give as: 
^_,`,a(%) = b_,a(%) cd_,`(%)eff_h&ij`,a,<→_(%)<S_ +	k'll_h&ij_,a(%)m 
This can be expanded to show all the variables and parameters as shown: 
^_,`,a(%) = exp7qr,`_st(%) +	qu,=av9 cd_,`(%)e7wa ∗ yz 	∗ 	y{,_E|9<S_
+ 7}a ∗ ~a(%) ∗ y,=av9m																				(1) 
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For a given case i, in order to be able to calculate the likelihood of infection from a 
particular source Ω_, either a sampled housemate or an unknown community source, 
we need to formulate the probability of transmission from said source at time t. This is 
given by:  Ç#ÉÑ→_,`,a(%) = ^ÉÑ→_,`,a(%)^_,`,a(%) 															(2) 
For Ω_  in the same household as i, the rate of exposure is given by  ^ÉÑ→_,`,a(%) = exp -qÖ,ℎ&i%(%) +	qá,$àâ2 äd&,ℎ(%)wày&,fyÉÑ,ã,&(~(%)dÉÑ,ℎ(%)å 
 
For Ω_  an unknown source external to the household, the rate of exposure is given by 
 ^ÉÑ→_,`,a(%) = exp -qÖ,ℎ&i%(%) +	qá,$àâ2 6	}a ∗ ~a(%) ∗ y,=av: 
 
The likelihood function 
The probability given in (2) is calculated for a time point t = exposure time of individual 
i, %_. This is not observed in the data, however, given our assumption on the latency 
duration, we can define a 6-day window of possibility. If case i had a shedding onset at 
time ç_é, then the window for transmission is from day 7ç_é − 59 to 7ç_é − 09. For 
each day in the window, potential sources are identified based on shedding status and 
for each combination of infection source Ω_  and exposure date %_, the likelihood is 
calculated using the formula below:  
 ë(íì{ç_ï, %_, Ω_})
= -1 − âBóÑ,ò,ô7tÑö92 ∗ õú âBóÑ,ò,ô(tÑ)tÑStÑö ù ∗ -ûü(ç_ï − %_)2∗ †^ÉÑ→_,`,a(%_)^_,`,a(%_) ° 
 
The first part of the product is the probability of infection at time %_, the second part is 
the probability of escaping infection at any time %_ ≠ %_, the third is the probability of 
 218 
a latency duration of length (ç_ï − %_)	and the last term is the probability of 
transmission from source Ω_  to i. 
 
Given the likelihood, the highest-probability-source is chosen as the infection source 
that give the highest value of the likelihood.  
A2.4. Model validation  
This is a two part process: first we check if the parameters estimated can reproduce 
the results (or something similar) by simulation; then we check if given simulated data, 
we can re-estimate parameters that are similar to the ones used to simulate the data. 
This process is illustrated in the flow chart below. 
 
 
Figure A2. 9: Flow chart showing validation process 
 
Given a set of parameter values, the simulation pseudo code per simulation is as 
follows:  
 
1. Initiate system such that everyone one is susceptible to RSV A and RSV B.  
2. At every time step keep track of:  
a. Susceptibility status of every individual 
b. Exposure status 
c. Infectious status (viral load and infectivity group) 
Data	
Likelihood	of	model	
given	data	
Simulate	epidemics		using	
set	of	parameter	values	
from	the	posterior	(θ)	
Posterior	distribution	
of	parameters	
Model	building	
MCMC	
Compare	to	
data	
Sample	set	of	
parameters	from	
posterior	(θ*)	
Simulate	epidemic	
Estimate	parameters	
(θ’)	
Compare	θ’	
to	θ*	
Part	1	 Part	2	
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d. Infection history 
3. At every time step: 
a. Determine number of transmission events using  
∆§ = Ç'&ii'(õe(1 − âB•=tvö,Ñ)_∈ßö ù ΔE =	number	of	events	of	type	E	at	a	given	time	point	
CE	=	set	of	all	individuals	capable	of	experiencing	event	E.	
rateE,i		=	rate	of	occurrence	of	event	E	on	person	i.		 
b. Determine who experiences each event. For a given event, order 
individuals capable of experiencing the event. For a given person p to 
experience the event, the following inequality has to be satisfied. 
 
e Ç,__®©B5_™5 	< õh¨≠!	 × e Ç,__	∈ßö ù 	≤ 	eÇ,_
_®©
_™5  
Where Ç,_ = 1 − âB•=tvö,Ñ  = probability of person i experiencing event 
E. RAND = a random number between (but not including) 0 and 1. This is 
illustrated in the figure below. 
 
 
Repeat this until the required number of events 
 
c. For each individual experiencing a transmission event, assign a latency 
duration and shedding profile by sampling from the relevant empirical 
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distributions. The empirical latency distribution is the same as was used 
in estimating the parameters and is homogeneous for every individual. 
The shedding profiles are grouped by age in the following 4 groups <1,1-
5, 5-15 and ≥15 years (see Figure A2. 10 and Figure A2. 11 for age 
grouped shedding profiles). An assigned shedding profile is a 
combination of duration of shedding, viral loads and symptom status. 
Once latency durations and shedding profiles have been assigned, the 
state variables for each individual are updated accordingly.  
d. Update rate of exposure.  
The rate of exposure/transmission for susceptible individuals changes 
according to  
^_`a(%) = exp	(quá_ + qraÖ_a(%)) cd_`(%)wa	qzf_eq{ã<`a(%)<S_ +	q§_}a~a(%)m 
Figure A2. 10 and Figure A2. 11 show the shedding profiles as observed from the data 
for RSV A and B, clustered by age and symptom status. 
 
Figure A2. 10: RSV A shedding profiles as observed.  
Each figure shows the viral loads on different days of shedding for each infection 
episode observed. The top row shows profiles for symptomatic RSV A shedding by age 
group in years, the bottom row shows profiles for asymptomatic RSV A shedding by 
age group in years. 
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Figure A2. 11: RSV B shedding profiles as observed.  
Each figure shows the viral loads on different days of shedding for each infection 
episode observed. The top row shows profiles for symptomatic RSV B shedding by age 
group in years, the bottom row shows profiles for asymptomatic RSV B shedding by 
age group in years. 
 
We sampled 5 sets of parameters (dependent sampling to maintain the correlations 
observed) and for each set simulated 200 epidemics to compare to the data. The 
sampled parameters relative to the posterior distribution are shown in Figure A2. 12. 
In addition to looking at the projected epidemics, we also look at the following 
outcome measures to make comparisons:  
- Total number of individuals infected  
- Total number of households infected 
- Proportion of individuals with repeat infections 
- Timing of epidemic peak 
 
Figure A2. 13 and Figure 3. 4 in the main text show the results of the simulations 
relative to the observed data. 
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Figure A2. 12: Histograms of the posterior distributions with vertical lines showing 
sample sets that were used in simulation.  
Each panel shows histograms of different parameters in grey. Red dashed lines show 
the value of the parameter in set1, dark pink shows set2, black set3, yellow set4 and 
blue set5. 
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Figure A2. 13: Outcome measures from simulated data when using different sets of 
parameters drawn from the posterior estimated from the observed data.  
Each box and whisker plot is the distribution of the specific outcome measure from 
200 simulations run from a single sampled data set. 
 
To check if the model can re-estimate known parameter values, we simulated an 
epidemic and compared the re-estimated densities to the densities given by using the 
observed data. Table A2. 2 gives the values of the parameters used to simulate the 
epidemic, Figure A2. 14 compares the real and simulated epidemics and Figure A2. 15 
compares the original and re-estimated parameter densities.  
 
Table A2. 2: Parameter set used to simulate an epidemic 
Parameter symbol Parameter name Set1 
 TU,MVW Prev.hom 0.544 
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 TU,M∞R Prev.het 1 
 TXY	 Age.2 0.662 
 TXZ Age.3 0.265 
 TX[ Age.4 0.138 
ηA Eta.A 0.026 
ηB Eta.B 0.0186 
 ±G	 hh.size 0.394 
  ±\Y HighAsym 0.356 
 ±\Z LowSym 1.77 
 ±\[ HighSym 6.85 
εA Epsilon.a 0.00289 
εB Epsilon.b 0.00545 
 ±]Y	 Eps.age2 1.29 
 ±]Z Eps.age3 2.57 
 
 
Figure A2. 14: Comparing the real (red lines) and simulated( black lines) epidemics 
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Figure A2. 15: Comparing the posterior densities obtained from using the observed 
data to those from using the simulated data.  
The posterior densities from using real data are shown in red while the ones from 
simulated data are shown in blue. The dashed red line shows the value of the 
parameter used to simulate the epidemic. ESS is the effective sample size. 
 
The re-estimated distributions capture the parameter used to simulate the epidemic 
and in general fall within the ranges of the original distributions obtained from the real 
data.  
 
A2.5. Sensitivity analysis 
We check if our results were sensitive to the background community density function 
by exploring 3 additional function forms. The results are presented in the following 
three figures. Option1 shows the density curves used in the main analysis, Options 2,3 
and 4 show the curves used in the sensitivity analysis. The first additional function 
form was sampling switching the RSV A curve with the RSV B curve to check for 
sensitivity to peak epidemic timing. The second function, option 3, is curves generated 
from RSV A and RSV B hospital incidence from the same sampling period. The data on 
RSV admissions was obtained from the main referral hospital in the area. The curve in 
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option 4 is a reverse of the curves in option 3, i.e. the RSV A curve was swapped was 
swapped with the RSV B curve.  
 
Figure A2. 16: Using different density functions for the background community rate 
and comparing results.  
The left side shows the density functions for RSV A and RSV B, the right side shows the 
re-estimated parameters after 20,000 iterations. 
Parameter Estimate(log scale)
−10 −8 −6 −4 −2 0 2 4
eps.age3 (ESS = 6188 )
eps.age2 (ESS = 5328 )
epsilon.B (ESS = 5222 )
epsilon.A (ESS = 6305 )
HighSym (ESS = 6117 )
LowSym (ESS = 5452 )
HighAsym (ESS = 3232 )
hh.size (ESS = 5208 )
eta.B (ESS = 4907 )
eta.A (ESS = 5003 )
age.4 (ESS = 6602 )
age.3 (ESS = 6357 )
age.2 (ESS = 6691 )
Prev.het (ESS = 4892 )
Prev.hom (ESS = 7992 )
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Figure A2. 17: Using different density functions for the background community rate 
and comparing results.  
Box plots comparing the estimated parameters. 
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Figure A2. 18: Using different density functions for the background community rate 
and comparing results.  
Density plots comparing the estimated parameters. 
 
We also looked at the distribution of cases by household size. In Figure A2. 19 we see 
that RSV A got into the largest household and infected significantly more people that 
RSV B. Looking at Figure A2. 20, it seems that all but one RSV A case were probably 
part of a single outbreak (based on perceived temporal distance). To check if this could 
be the reason for the difference in within household transmission coefficient 
estimated, we removed data from the largest household (HH5) and re-estimated the 
parameters. The results of this are show in Figure A2. 21 and Figure A2. 22. The slight 
difference between the RSV groups in the within household transmission parameter is 
still present.  
 
 
Figure A2. 19: Frequency distributions of RSV A and RSV B infections by household 
size 
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Figure A2. 20: Infection patterns in HH5 
 
 
Figure A2. 21: Caterpillar plot showing results obtained when household 5 data was 
removed from the set. 
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Figure A2. 22: Comparing densities of parameters estimates obtained when using all 
the data (light red) to densities obtained when using data without household 5 (light 
blue). 
 
A2.6. Checking the contribution of symptomatic and asymptomatic 
individuals 
In this section we show the results of simulations where infectiousness was altered, 
Figure A2. 23, and parameter estimation where only a subset of the data was used 
Figure A2. 24. For the simulation we compare three scenarios: Infectiousness of 
symptomatics and asymptomatics as given in the model parameters presented in 
Table 3; Infectiousness of the symptomatic individuals is reduced to match that of 
asymptomatic individuals (this is done so as to get an idea of what the effect of a 
vaccine that reduces symptoms would be); Infectiousness of asymptomatic individuals 
is assumed to be 0 such that they cannot transmit (this is done so as to get an idea of 
the contribution of asymptomatic infections to transmission). For each scenario, 10000 
simulations were used based on sampling 100 different parameter(and making the 
modifications necessary for scenario 2 and 3) sets and for each set simulation 100 
epidemics. 
 
 231 
 
Figure A2. 23: Densities comparing the relative total incidence, by RSV group and age 
group, when the infectiousness of symptomatic individuals is altered or when the 
infectiousness of asymptomatic individuals is removed.  
The black line shows the distribution of total number of people infected from 10000 
simulations for estimated (unaltered) parameters scenario where symptomatic 
individuals are more infectious than asymptomatic. The red line shows the case when 
where the parameters used in simulation have been altered to force symptomatic 
individuals to be as infectious as asymptomatic individual (i.e. reduced infectiousness). 
The blue line shows when asymptomatic individuals are assumed to not be infectious 
at all. 
 
From the figure above we notice that the greater shift in the distribution of cases when 
infectiousness of symptomatics is reduced occurs in the 1-15 year old age group. The 
reduction in the <1 year age group is not huge, presumably because transmission to 
this age group is from several sources as such reducing the infectiousness of 
symptomatics has little impact on the total numbers infected during an outbreak.  We 
also notice that assuming asymptomatic cases are not infectious leads to far less 
number than were actually observed. This highlights the importance of asymptomatic 
individuals in transmission. 
 
Following on from the simulation, we used a subset of the data that had only 
symptomatic episodes to re-estimate the model parameters (this is done to give an 
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idea of how much information would be missed if the sampling had only been of 
individuals who showed symptoms). In this case, we still had days in the data with 
shedding, but no symptoms and ARI episodes are not necessarily as long as the entire 
virus shedding episode. 
 
 
Figure A2. 24: Caterpillar plot of estimated parameters when only data from 
symptomatic episodes is used.  
The 15 parameters estimated, and their respective effective sample sizes are shown. 
Points represent posterior medians, the thick lines represent 50% credible region and 
the thin lines represent 95% credible region. Except ηA	and	ηB	(within	household	transmission	coefficients)	εA,	and	εB	(community transmission coefficients) all the 
other parameters represent relative effects where a reference group exists. If a 
relative effect parameter is equal to 1(0 on the log scale) then the group it represents 
and the reference group are not different.  Parameters where 50% credible interval 
overlaps with 0(dashed vertical line) are shown by open grey circles, where the 50% 
credible intervals do not overlap with 0 but the 95% credible interval does, filled grey 
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circles show these parameters. If there is not overlap with 0, the circles are black and 
filled. 
 
Figure A2. 25: Comparing densities of parameters estimates obtained when using all 
the data (light red) to densities obtained when using data from only symptomatic 
cases (light blue). 
 
A2.7. Fitting household size as an ordinal variable 
As the model was built up in stages, this section was done prior to the inclusion of 
symptom data; instead only viral load was used as a proxy to infectivity. To fit 
household size as an ordinal variable, the rate of exposure equation is as below ^_`a(%) = exp	(quá_
+ qraÖ_a(%)) cd_`(%)wa(≠_ − 1)B≤ eq{ã<`a(%)<S_ +	q§_}a~a(%)m 
The factor (≠_` − 1)B≤ modifies the within household transmission coefficient, where 
Ni is the household size for susceptible i and ω determines that kind of transmission. If ω	à	0,	it	points	to	density	dependent	transmission,	ω=1	implies	frequency	dependence.	The	estimation	of	ω	was	done	using	the	entire	data	set	and	again	using	a	subset	where	the	definition	of	a	household	was	changed	such	that	a	household	is	defined	as	individuals	who	share	a	building	unit.	The	results	of	this	are	shown	below. 	
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Figure A2. 26: Caterpillar plot showing the results of estimating a parameter ω	
(omega)	when	household	size	is	treated	as	an	ordinal	variable.		
These results were obtained when fitting was done using all the data available. 
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Figure A2. 27: Caterpillar plot showing the results of estimating a parameter ω	
(omega)	when	household	size	is	treated	as	an	ordinal	variable.		
These results were obtained when fitting was done using a subset of the data that had 
complete information on building units and hence a household could be redefined as a 
building unit. 
 
Neither the entire data set nor the subset with redefined households seems to be able 
to give proper estimates of ω (omega). The distribution for this parameter is wide, but 
it should be noted that it does not include 1 (0 on the log scale) as such, the 
transmission is not frequency dependent in the usual notation. We also used the 
subset with redefined households to fit for a categorical effect of household size, the 
results of which are shown in Figure A2. 28. The subset does not have enough 
information in it to narrow down on the effect of categorical household size, the effect 
of previous heterologous infection and the effect of high viral load.  In fact, the latter 
distribution seems to have a reversed direction from previous results, implying high 
viral load reduces transmission. This is a curious result that perhaps further highlights 
the need to also use information on symptoms.  
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Figure A2. 28: Caterpillar plot showing the results of estimation	when	household	
size	is	treated	as	a	categorical	variable	but	with	the	definition	of	a	household	
changed.		
These results were obtained when fitting was done using a subset of the data that had 
complete information on building units and hence a household could be redefined as a 
building unit. 
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A3: Supplementary appendix for Paper 2. 
A3.1. Normalizing the cluster specific background community exposure rate 
curves 
We define a background cluster-specific rate of exposure, ~≥(%), for a cluster c at time t 
as  ~≥(%) = ¥ + e â7tBµÑ,∂9∑_	s`v∏∏_Eaπ∫@	≥üªstv•	≥  
 
Where ¥ is the basic risk and º is the rate of exponential decay related to the time 
since onset of a case shedding cluster type c. º is a measure of the rate at which the 
cluster might disappear from the community. Ω_  is the onset time by person i. 
To ensure that ∑ ~≥(%)ßæ = ~a(%) we need to normalize the cluster level curves such 
that their sum adds up to the group level curve.  We describe how to do this using the 
illustration below: 
 
P1  x x x x x    
P2    x x x x x  
P3   x x x x x x x 
P4     x x x x x 
 T1 T2 T3 T4 T5 T6 T7 T8 T9 
 
Say person P1, P2, P3 and P4 all have RSV A but there are 6 clusters in this particular 
configuration. The issue with multiple clusters showing up like above is that we get 
onsets where we previously had none which leads to ∑~≥(%) > ~a(%). By looking at 
RSV, we have 4 onsets at T2, T3, T4 and T5 respectively. By cluster we have 6 onsets, 
with an extra one at T5 and T8. Up until T4 ∑~≥(%) = ~a(%), at T5 we can normalize such 
that ~a(%¿) is divided proportionally among the 4 cluster. In normalizing, the absolute 
value is reduced, but the clusters are weighed appropriately. At T8, by looking at RSV 
we see no new onset, but by cluster we have one and so ~a(%¡) = ¥ + (â(t¬Bt√)∑	 + â(t¬Btƒ)∑	 + 	â(t¬Bt≈)∑	 + â(t¬Bt∆)∑	) 
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 since the most recent onset was at %¿. At weighing, this value is divided proportionally 
among the red (~•v∏(%¡) = ¥ +	â(t¬Bt√)∑	), black (~«ü=≥»(%¡) = ¥ +	â(t¬Bt≈)∑	), green 
(à#ââ((%¡) = ¥ +	â(t¬Bt∆)∑	), dark blue (~….«üªv(%¡) = ¥ +	â(t¬Btƒ)∑	), purple ~©ª•©üv(%¡) = ¥ +	â(t¬Bt∆)∑	 and light blue (~ .«üªv(%¡) = ¥ + 	1	) clusters. The 
equation for the normalized function ~À≥(%) is given as: 
~À≥(%) = Ã¥ + e â7tBµÑ,∂9∑_	s`v∏∏_Eaπ∫@	≥üªstv•	≥ Õ × Ãe Ã¥ + e â7tBµÑ,∂9∑_	s`v∏∏_Eaπ∫@	≥üªstv•	≥ Õ≥∈ßæ Õ 
An example of the shapes of the background community rate of exposure curves is 
shown in Figure A3.1 for the 5 clusters in RSV A and FigureA3.2 for the 7 clusters in RSV 
B. 
 
Figure A3. 1: The background cluster-specific rate of exposure curves for RSV A.  
The normalized fC(t) curves are shown for the 5 different clusters and the group. 
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Figure A3. 2: The background cluster-specific rate of exposure curves for RSV B.  
The normalized fC(t) curves are shown for the 7 different clusters and the group. 
 
A3.2 Further details on the inference method (MH-MCMC) 
A3.2.1. Metropolis-Hastings Markov Chain Monte Carlo (MH-MCMC) for 
parameter inference 
The MH-MCMC algorithm is a popular first step for a situation where the target 
distribution is not simple and the dimension of the parameters is not small. As we have 
a total of 19 parameters this seemed like a natural starting point. For a given 
intractable target distribution, the MH-MCMC algorithm creates a chain of auto-
correlated samples, for each desired parameter, whose equilibrium distribution is 
drawn from the desired target density. The samples that form part of the chain are 
proposed from a distribution q and are either accepted or rejected based on an 
acceptance probability ρ.	A	generic	MH-MCMC	algorithm	is	as	follows:		For	a	desired	target	density	Œ(8),	where	x	is	the	set	of	parameters,	given	xn	(the	set	of	parameters	at	iteration	n	of	the	chain):	1. Generate	Yn	~	q(y|xn)	2. Take	the	next	set	of	parameters:			 	Xn+1	=	Yn	with	acceptance	probability,	œ = min ”1, ‘(r’)÷7áEìÖE9‘(u’)÷7ÖEìáE9◊																												xn	otherwise 
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For a symmetric proposal distribution where q(y|x) = q(x|y) the acceptance ratio ‘(r’)÷7áEìÖE9‘(u’)÷7ÖEìáE9 reduces to ‘(r’)‘(u’) making the acceptance probability independent of q(.). 
However the choice of q(.) does determine the performance of the algorithm as such 
q(.) has to be carefully chosen. The conditional probability q(y|x) means that the 
samples in the MH-MCMC chain are dependent. Variations of the algorithm can use an 
independent proposal g such that q(y|x)=g(y). The construction of an appropriate 
proposal distribution can be difficult as such, an alternative to doing this is to slowly 
approach the target distribution by exploring the parameter space close to current 
values of the MH-MCMC chain. This is what the random walk MH-MCMC does. The 
algorithm for this is: 1. Generate	Yn	=	xn	+	εn,	where	εn	~	g(.).	2. Take	the	next	set	of	parameters:			 	Xn+1	=	Yn	with	acceptance	probability,	œ = min ÿ1, ‘(r’)‘(u’)Ÿ																												xn	otherwise	If	g(.)	is	a	uniform	distribution	then		Yn	~	U(xn	-	δ,	xn	+	δ),	for	g(.)	a	Normal	distribution	Yn	~N(xn,	σ2).	For	a	pair	(xn,	yn)	the	acceptance	ratio	will	be	the	same	whether	yn	came	from	a	Uniform	or	Normal	proposal	distribution.	However	the	choice	of	g(.)	does	determine	the	range	of	proposed	values	as	such	must	be	made	such	that	the	boundaries	of	the	target	distribution	Œ(x)	are	explored[3].	However,	in	practice	an	additional	condition	to	accepting	a	proposed	value	is	used	to	make	sure	that	even	low	probability	regions	of	the	parameter	space	are	explored	and	thus	represented	in	the	final	equilibrium	distribution.	If	œ ≠ 1,	generate	#	~	€(&~'#l(0,1),	if	œ > #	then	the	proposed	value	is	accepted. 
 
A3.2.2 Our application of MH-MCMC  
We denote the observed data as D, the augmented data as DA and the set of 
parameters as í. The target distribution is given as ‹(í|!, !ﬁ) =Ç(!|!ﬁ)ë(í|!, !ﬁ)Ç(í); Ç(!|!ﬁ) = probability of the observed data give the 
augmented data; ë(í|!, !ﬁ) = the likelihood of the parameters given the observed 
and augmented data; Ç(í) = the prior probability of the data. The augmented and 
observed data are independent and we have no information to inform what the 
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missing cluster ids could be, making every combination of D and !ﬁ equally likely. 
Consequently, we did not include P(D|A) when calculating the posterior probability.  
 
The parameters will be updated first, followed by an update of the augmented data. 
We will assume weakly informative priors in the form of a normal distribution with 
mean 0 and a standard deviation of ~3 for the log of parameters. There is only one 
move to update the data with a probability of occurrence =1, i.e. the updates to !ﬁ are 
carried out at every iteration. Given the significant number of uninformed outbreaks, 
for the same set of parameter values, the likelihood value (and subsequently the 
posterior value) can vary drastically with new configurations of the missing cluster ids. 
This is very likely to lead to the proposed change in !ﬁ being rejected and if it is 
accepted subsequent updates to the parameter values might get rejected even when 
the standard deviation for the proposal distribution is small. As such, to mimic a 
gradual change in cluster configurations, at every iteration of the MCMC algorithm, the 
random allocation of cluster ids will be done for one household outbreak at a time.   
A3.2.3.1. Choice of proposal distributions for the parameters  
For the parameter set í we will use a multivariate normal distribution as the proposal 
distribution. For iteration n in the chain a new set í∗ will be proposed such that í∗~≠'#l$‚(íEB5|Σ). The choice of the variance-covariance matrix Σ will determine 
the size of the space that is explored and how fast the MCMC chain converges. This 
can be fixed at the start of the algorithm and regular manual checks conducted to 
make sure the chain is progressing well and modifying Σ if it is not, e.g. by making sure 
the acceptance rate is not too high (implying the standard deviation is too low and 
thus only the very close neighbours of a current value are being explored, leading to 
the acceptance ratio being high most of the time and hence more accepted values) or 
too low (implying the inverse problem). Alternatively the modification of Σ can be 
automated through an adaptive random walk MH-MCMC algorithm. There are several 
adaptation algorithms [4], we will chose one that learns from the empirical distribution 
of values up to the (n-1)th iteration to modify the Σ at iteration n. For samples {í5, í4, í+, . . . íEB5} in the MCMC chain so far, at iteration n the proposal density g(.) 
is given by 
  àE(. ) = (1 − })≠(íEB5|2.384ΣEB5/Á)) + 	}≠(íEB5|0.14ΣË/Á) 
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Where: } =	A small positive constant, chosen to be 0.05 as in [4]. ΣEB5 =	The empirical variance-covariance matrix derived from samples {í5, í4, í+, . . . íEB5} 	Á =	The dimension of the parameter set ΣË =	The initial guess of the parameter variance-covariance matrix. This is 
usually a diagonal matrix of variances.  
 
This notation means for a fraction of the time (1 − }), the proposal distribution will be ≠(íEB5|2.384ΣEB5/Á)) and the rest of the time it will be ≠(íEB5|0.14ΣË/Á). Prior to 
adaptation beginning at iteration n, the proposal distribution at iteration k is given by à»(. ) = ≠(í»B5|0.14ΣË/Á) 
 
A3.2.3.2 Pseudo algorithm for our implementation of MH-MCMC 
For each MCMC chain 
1. Set initial values for the parameters and assign cluster ids at random for the 
outbreaks with no sequence information (uninformed outbreaks). 
2. For every iteration n 
a. Update parameter values 
i. Propose a new set of parameters by sampling from the proposal 
distribution: í∗~≠'#l$‚(íEB5|Σ) 
ii. Calculate the acceptance probability œ(íEB5, í∗) =min È1, ©-í∗Í!, !ﬁEB52©-íEB5Í!, !ﬁEB52Î	 
iii. If œ(íEB5, í∗) > #~€(&~'#l(0,1) update íE = í∗ otherwise íE = íEB5 
b. Update cluster id for a single uniformed outbreak 
i. Randomly select an uniformed outbreak from the set of 
uninformed outbreaks, all with the same probability of being 
selected. 
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ii. Given the present cluster id for the chosen outbreak k•, 
randomly select a new cluster id from the set of all possible 
clusters excluding k•. 
iii. With  ks as the proposed cluster id, the proposed change to the 
augmented data is accepted with probability  œ′(!ﬁEB5, !ﬁ∗) = min È1, ‹(íE|!, !ﬁ∗)	‹(íE|!, !ﬁEB5)	 |k•||ks| + 1Î 
Where |k•| is the number of household outbreaks in k•  in the 
present  
permutation of the augmented data !ﬁEB5 and |ks| is the 
number of household  
outbreaks in ks.  
 
iv. If œ′(!ﬁEB5, !ﬁ∗) > #′~€(&~'#l(0,1) update !ﬁE, !ﬁ∗ otherwise !ﬁE, !ﬁEB5 
 The correction factor |ßÌ||ßÓ|Ô5 is introduced into the acceptance ratio for a proposed 
change in cluster id because the proposal distributions are not symmetric. For an 
update of cluster id from CS to Cr, the proposed change is uniformly distributed over 
the set of all household outbreaks/cases in cluster CS that are part of the augmented 
dataset. Conversely the reverse move of a change of cluster id from Cr to CS is 
uniformly distributed over the set of all household outbreaks/cases in cluster Cr that 
are part of the augmented dataset. As such, the proposal distributions are dependent 
on the number of uniformed household outbreaks in each cluster. 
A3.3. Establishing the highest probability transmission source (HPTS) 
We modified the likelihood to establish the most likely infection source (HPTS) for 
every case. For a given case i infected with RSV cluster c within group g, there are 
three possible sources of infection (Ω_), either a sampled housemate, a sampled 
neighbour or an unknown community source. The total rate of exposure is given as:  
^_,`,≥(%) = b_,a(%) cd_,`(%)effπ=tv`,≥,<→_(%)<S_ +	k'll_h$%â_,≥(%)m																					(1) 
Where (as in the main text): 
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b_,a(%) is the factor modifying exposure by recent group specific infection history, age 
and group specific shedding status at time t  k'll_h$%â_,≥(%) is the cluster specific community (external to the household) 
exposure rate.  
 
The probability of exposure is = prob(any exposure event) * prob(exposure to cluster c) _,`,≥(%) = 71 − â8‹B∑ óÑ,ô,∂(t)∂æ 9 ∗ † ^_,`,≥(%)∑ ^_,`,≥(%)≥æ °																									(2) 
 
For a given source of infection Ω_  in the same household as i, the rate of exposure is 
given by:  
 ^ÉÑ→_,`,≥(%) = b_,a(%)6d_,`(%) ×	ÇÉÑ→_ 	× 	wa 	× 	yz(f'"iâℎ'‚Á_i&Òâ_) 	× 	y{,_E|7ã(~âÚ%&Û&%ÙÉÑ,`,≥(%)9 	× 	dÉÑ,`(%): 
 
For Ω_  not in the same household as i but among the sampled individuals, the rate of 
exposure is given by: 
 ^ÉÑ→_,`,≥(%) = b_,a(%) *}à 	× 	y,=av -¨àâa•ïª©,_2 × d&,ℎ(%) 	× 	ÇÉÑ→_ 	× 	y{,_E| -ã(~âÚ%&Û&%ÙÉÑ,`,≥(%)2 	× 	ı7Á&,ÉÑ, ˆ9 	× 	dÉÑ,ℎ(%)3	 
 
For Ω_  an unknown source external to the household, the rate of exposure is given by: 
 ^ÉÑ→_,`,≥(%) = b_,a(%) *}à 	× 	y,=av -¨àâa•ïª©,_2 × ~Ú(%)3 
 
The probability of transmission from a single source Ω_  at time t thus becomes:  Ç#ÉÑ→_,`,≥(%) = ^ÉÑ→_,`,≥(%)^_,`,≥(%) 															(ã) 
 
The likelihood function 
The probability given in (ã) is calculated for a time point t = exposure time of individual 
i, %_. This is not observed in the data, however, given our assumption on the latency 
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duration, we can define a 6-day window of possibility. If case i had a shedding onset at 
time ç_é, then the window for transmission is from day 7ç_é − 59 to 7ç_é − 09. For 
each day in the window, potential sources are identified based on shedding status and 
for each combination of infection source Ω_  and exposure date %_, the likelihood is 
calculated using the formula below:  
 ë(íì{ç_ï, %_, Ω_})
= _,`,≥(%) ∗ õú -1 − _,`,≥(%)2tÑStÑö ù ∗ -ûü(ç_ï − %_)2 ∗ †^ÉÑ→_,`,≥(%_
)^_,`,≥(%_) ° 
 
The first part of the product is the probability of infection with cluster c at time %_, the 
second part is the probability of escaping infection at any time %_ ≠ %_, the third is the 
probability of a latency duration of length (ç_ï − %_)	and the last term is the 
probability of transmission from source Ω_  to i. 
 
Given the likelihood, the highest-probability-source is chosen as the infection source 
that gives the highest value of the likelihood.  
 
A3.4. Details of the model using pathogen data identified at group resolution  
The null model is similar in structure to the model of sequence data presented in the 
main text, however, there is no identification of the infecting pathogen at the cluster 
level, only at the group level. The rate of exposure to a particular RSV cluster g acting 
on a susceptible person i from household h at time t: 
 
^_,`,a(%) = b_,a(%) cd_,`(%)effπ=tv`,a,<→_(%)<S_ +	k'll_h$%â_,a(%)m																					(1) 
Where: b_,a(%) is the factor modifying exposure by recent group specific infection history, age 
and group specific shedding status at time t given by: 
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b_,a(%) = exp -qr,`_st7ã(~âÚ%&'(_f&i%'#Ù_(%)9 +	qu,=av7¨àâ_à#'"‹∫,_9+ q˜,≥ª••7bℎâÁÁ&(à_i%$%"i_(%)92 
 ff_h$%â`,a,<→_(%) is the group specific within household exposure rate given by:  
 ff_h$%â`,a,<→_(%)= 	 wa 	× 	yz(f'"iâℎ'‚Á_i&Òâ_) 	× 	y{,_E|7ã(~âÚ%&Û&%Ù<,`,a(%)9 	× 	d<,`(%) 
 k'll_h$%â_,a(%) is the cluster specific community (external to the household) 
exposure rate given by: k'll_h$%â_,a(%)= }à 	
× 	y,=av7¨àâ_à#'"‹,_9 ⎝⎜⎜
⎛
⎝⎜
⎛d&,ℎ(%) e b$l‹‚âÁ_≠â&àℎ˚'"#_h$%â`,a,<→_(%)¸≠&,			¸	('%	&(	&′i	ℎ'"iâ ⎠⎟
⎞	
+	~à(%)⎠⎟⎟
⎞
 
Where: 
 b$l‹‚âÁ_≠â&àℎ˚'"#_h$%â`,a,<→_(%) = yã,à,¸(%) 	× 	ı7Á&,¸, ˆ9 	× 	d¸,ℎ(%) 
 
The background function ~a(%) is derived the same way ~≥(%) is, as described in the main 
text. Since we do not use genetic distances in this version of the model, we do not 
estimate ! for  Ç<→_ = â8‹B∏ò"’(_,<)∗# or  Ç<→_ = 1	&~	ÁavE(&, ¸) 	≤ !, 0	'%ℎâ#$&iâ, 
making the total number of parameters 17. 
 
Following from the rate of exposure is the probability of exposure given by: _,`,a(%) = 71 − â8‹BóÑ,ô,ò(t)9																					(2) 
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The probability of onset is given as: 
‹_,`,a(%) = eûü_,`,a(% − ‚) ü™Ë  
Where L is the maximum latency period and ûü  is the probability that the latency 
period is exactly ‚ days.  
 
The likelihood for individual i's data is given as: 
ë_ = 	úc ú ‹_,`,a(")ª∈%Ñ,ô,ò ú 71 − ‹_,`,a($)9=∈ﬁÑ,ô,ò ma  
The total likelihood is thus given by the product of ë_  over all the individuals in the 
data 
 
ë = 	úcúc ú ‹_,`,a(")ª∈%Ñ,ô,ò ú -1 − ‹_,`,a($)2=∈ﬁÑ,ô,ò ma m_  
 
A3.5. Results of the MCMC algorithm 
 
The figures below show the evolution of the parameter value with increasing number 
of iterations for the model with pathogen identification at the genetic cluster level 
(cluster model) and at the group level (group model). 
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Figure A3. 3: Trace plots of parameters in the cluster model.  
Three chains were initiated at different parameter values and these are shown in black 
(Chain 1), green (Chain 2) and blue (Chain 3) lines. The x-axis shows the iteration 
number, while the y-axis shows the log parameter value.  
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Figure A3. 4: Trace plots of parameters in the group level data model.  
Three chains were initiated at different parameter values and these are shown in black 
(Chain 1), green (Chain 2) and blue (Chain 3) lines. The x-axis shows the iteration 
number, while the y-axis shows the log parameter value.  
 
To confirm convergence observed in the trace plots, we calculated the Gelman-Rubin-
Brooks statistic and the effective sample size. When using the GRB statistic, 
convergence is said to have occurred if the ratio of pooled/within chain variance is 
close to 1. The GRB statistic assumes that the target distribution is Normal. The plot 
below shows the value of the GRB statistic as the number of iterations increases for 
each parameter. This is to check whether a value close to one was reached by chance 
or if the trend line had truly stabilized close to 1. 
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Figure A3. 5: The evolution of the Gelman-Rubin-Brooks (GRB) statistic (shrink factor) 
as the number of iterations increases. 
Each grey line represents a model parameter in the cluster level data model and the 
dashed red line shows the value 1.  
 
The point estimated of the GRB and the values of the ESS after burn in are given in the 
table below.  
 
Table A3. 1: The value of the GRB statistic (to 3 significant figures) and the ESS after 
burn-in are shown for the parameters in the cluster level data model. 
Parameter Point estimate  
GRB statistic 
ESS 
Prev.hom 1 10607 
Prev.het 1 10073 
Curr.het 1.01 7131 
Sus.age.2 1.01 9154 
Sus.age.3 1.02 9771 
Sus.age.4 1.02 10384 
HH.rsv.a 1 9476 
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HH.rsv.b 1.01 9765 
HH.size 1 10147 
Low.Sym 1.02 9987 
High.Sym 1.01 9774 
Dist.rate 1.16 10455 
Gen.rate 1.04 10436 
Comm.rsv.a 1.09 7847 
Comm.rsv.b 1.09 7823 
Exp.age.2 1 8432 
Exp.age.3 1.01 9863 
Delta 1.04 7908 
Beta 1.03 6678 
The mGRB is 1.07 and the mESS is 10008. 
 
 
Figure A3. 6: The evolution of the Gelman-Rubin-Brooks (GRB) statistic (shrink factor) 
as the number of iterations increases. 
Each grey line represents a model parameter in the group level data model and the 
dashed red line shows the value 1.  
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Table A3. 2: The value of the GRB statistic (to 3 significant figures) and the ESS after 
burn-in are shown for the parameters in the group level data model. 
Parameter Point estimate 
 GRB statistic 
ESS 
Prev.hom 1.01 3713 
Prev.het 1.02 3978 
Curr.het 1.07 2309 
Sus.age.2 1.02 2998 
Sus.age.3 1.03 3617 
Sus.age.4 1.04 3694 
HH.rsv.a 1.01 3426 
HH.rsv.b 1.01 3361 
HH.size 1.02 3673 
Low.Sym 1.04 3957 
High.Sym 1.03 3744 
Dist.rate 1.07 3374 
Comm.rsv.a 1.05 4069 
Comm.rsv.b 1.05 4093 
Exp.age.2 1.02 2858 
Exp.age.3 1.02 3476 
Delta 1.04 5331 
Beta 1.04 3873 
The mGRB is 1.09 and the mESS is 4146. 
 
As a rule of thumb, a GRB of <1.1 is generally considered good, as such, it is safe to 
conclude that there was convergence.  
 
A3.6. Model validation 
 
The results of the model fitting are the posterior parameter distribution and 
corresponding augmented data for the cluster ids of cases with no genetic 
information. A simulation based on a set of parameter values will also be based on the 
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corresponding augmented data which will be used to derive a complete set of 
shedding profiles from the observed data. A single shedding profile is a combination of 
duration of shedding, viral loads and symptom status, and genetic cluster. The 
simulation pseudo code per simulation is as follows:  
 
1. Initiate system such that everyone one is susceptible to RSV.  
2. At every time step keep track of the following variables:  
a. Exposure status (by RSV cluster) 
b. Shedding status by group 
c. Shedding status by genetic cluster 
d. Infectiousness status (combination of viral load and symptom status) 
e. Infection history (by RSV group) 
f. The background rate of exposure from the community 
3. At every time step: 
a. Update the background community function to reflect any new 
shedding onsets 
b. Calculate the cluster specific rate of exposure, ^_,`,≥(%), as defined in the 
main text. 
c. Determine the number of group specific transmission events §a where  
§a = Ç'&ii'(õ e Çò,__∈∫öò ù bò 	=	set	of	all	individuals	susceptible	to	infection	event	Eg.	Çò,_ 	=	probability	of	person	i	experiencing	event	Eg	Çò,_ = e &71 − â8‹B∑ óÑ,ô,∂(t)∂æ 9 ∗ † ^_,`,≥(%)∑ ^_,`,≥(%)≥æ °'	≥	™	≥üªstv•s	_E	a 	
Where ^_,`,≥(%)= rate at which person i is exposed to infection of 
cluster type C. 
d. Given the number of group specific transmission events, determine the 
cluster id of each through weighted sampling. E.g. if Eg = 4 and c = 
{1,2,3} are the cluster ids in the group, the probability of a case being 
any one if the three clusters is: 
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È ^`,5(%)∑ ^`,≥(%)≥æ , ^`,4(%)∑ ^`,≥(%)≥æ , ^`,+(%)∑ ^`,≥(%)≥æ Î , ~'#	^`,5(%) =e^_,`,≥(%)_ 	 
e. Determine who experiences each cluster specific transmission event. 
For a given event, order individuals capable of experiencing the event. 
For a given person p to experience the event, the following inequality 
has to be satisfied. 
 
e Ç∂,__®©B5_™5 	< õh¨≠!	 × e Ç∂,__	∈∫ö∂ ù 	≤ 	eÇ∂,_
_®©
_™5  
 Where: 
 	 Ç∂,_ = 71 − â8‹B∑ óÑ,ô,∂(t)∂æ 9 ∗ † ^_,`,≥(%)∑ ^_,`,≥(%)≥æ ° b∂ 	=	all	individuals	susceptible	to	infection	of	cluster	type	c.	
RAND = a random number between (but not including) 0 
and 1.  
 
This is illustrated in the figure below. 
 
 
Repeat this until the required number of events 
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f. For each individual experiencing a transmission event, assign a latency 
duration and shedding profile by sampling from the relevant empirical 
distributions. The empirical latency distribution is the same as was used 
in estimating the parameters and is homogeneous for every individual. 
Shedding profiles are derived from the observed data and a 
combination of duration of shedding, viral loads and symptom status, 
and genetic cluster. The shedding profiles are grouped by age in the 
following 4 groups <1,1-5, 5-15 and ≥15 years. Once latency durations 
and shedding profiles have been assigned, the state variables for each 
individual are updated accordingly.  
 
To explore how much variation there can be in the simulations from a single 
parameter set, a set of 12 parameter set samples were used, and for each set, 100 
simulations were run, giving a total of 1200 simulations. We then sampled 100 
parameter sets and run single simulations from each to explore between-parameter-
set variation. The results of the simulations are presented in the form of epidemic 
curves and summary measures that are used to compare the main features of the 
outbreak. The summary measures shown in the subsequent figures are: total number 
of people infected, the proportion of cases that had multiple onsets and the number of 
cases in the first and last week of the observation/simulation period.  
 
The results of the simulation are shown in Figure 4. 7 and Figure 4. 8 in the main text 
and Figure A3. 7, Figure A3. 8 and Figure A3. 9. 
 256 
 
Figure A3. 7: Violin plots showing the distribution of the total number of people 
infected in the simulations by RSV group and age. 
Each panel shows the distribution of the total numbers infected in the simulations run 
using 12 different parameter sets (violin plots) compared to the total number from the 
observed data (dashed red line). The y-axis shows the total number and the x-axis is 
labelled by parameter set used. Top row: RSV A results for all the cases (1st column), 
cases < 1 year old (2nd column), cases between 1-5 years old (3rd column) and cases > 5 
years old (4th column). Bottom row: RSV B results. Violin plots are a combination of box 
plots and density distributions, the shapes should therefore be interpreted as density 
plots would while the ranges should be interpreted as the tips of whiskers in a box and 
whisker plots.  
 
 
Figure A3. 8: Violin plots showing the distribution of the proportion of cases that had 
multiple onsets in the simulations by RSV group and age.  
Each panel shows the distribution of the proportion of cases that had multiple onsets 
in the simulations run using 12 different parameter sets (violin plots) compared to the 
proportion from the observed data (dashed red line). The y-axis shows the proportion 
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and the x-axis is labelled by parameter set used. Top row: RSV A results for all the 
cases (1st column), cases < 1 year old (2nd column), cases between 1-5 years old (3rd 
column) and cases > 5 years old (4th column). Bottom row: RSV B results.  
 
 
Figure A3. 9: Violin plots showing the distribution of the number of cases in the first 
(1st column) and last (2nd column) week of the observation/simulation period in the 
simulations by RSV group.  
The y-axis shows the total number of people infected and the x-axis is labelled by 
parameter set used. The dashed red line shows what was observed in the data, i.e. 
there were no cases observed in the first and last week of the 180-day observation 
period.  
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A4: Supplementary appendix for Paper 3. 
A4.1 Extra results  
 
 
Figure A4. 1: Distributions of shedding durations for the different infectious agents.  
Each panel shows data from the 5 different infectious agents and the white histograms 
show the pathogen level distribution of durations. The medium and 90% interval are 
given in text in each panel.  
 
Table A4. 1: Results of parameter estimation using data identified at the pathogen 
level and group level. 
Pathogen level Group level 
Parameter Median 
(95% CrI) 
Parameter Median (95% CrI) 
risk.rsv.prev.rsv 0.599 
(0.395, 
0.878) 
risk.rsva.prev.rsva 0.598 (0.265, 
1.13) 
risk.rsvb.prev.rsvb 0.589 (0.317, 
1.01) 
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risk.rsva.prev.rsvb 0.591 (0.302, 
1.06) 
risk.rsv.prev.corona 1.33 (1.14, 
1.57) 
risk.rsva.prev.229e 0.698 (0.383, 
1.17) 
risk.rsva.prev.nl63 1.15 (0.846, 1.53) 
risk.rsva.prev.oc43 1.05 (0.728, 1.45) 
risk.rsvb.prev.229e 1.17 (0.811, 1.64) 
risk.rsvb.prev.nl63 1.14 (0.828, 1.54) 
risk.rsvb.prev.oc43 1.81 (1.4, 2.34) 
risk.corona.prev.corona 0.843 
(0.706, 1) 
risk.229e.prev.229e 0.724 (0.435, 
1.15) 
risk.229e.prev.nl63 1.1 (0.806, 1.46) 
risk.229e.prev.oc43 0.784 (0.576, 
1.05) 
risk.nl63.prev.nl63 0.617 (0.438, 
0.844) 
risk.nl63.prev.oc43 1.16 (0.914, 1.48) 
risk.oc43.prev.oc43 0.58 (0.413, 0.79) 
risk.rsv.curr.corona 1.09 (0.786, 
1.46) 
risk.rsva.curr.229e 1.996 (0.841, 
3.95) 
risk.rsva.curr.nl63 0.741 (0.281, 
1.76) 
risk.rsva.curr.oc43 0.733 (0.418, 
1.21) 
risk.rsvb.curr.229e 1.15 (0.375, 2.53) 
risk.rsvb.curr.nl63 2.3 (0.774, 4.31) 
risk.rsvb.curr.oc43 0.804 (0.321, 
1.57) 
  risk.rsva.curr.rsvb 1.98 (0.831, 3.95) 
  risk.229e.curr.nl63 1.04 (0.465, 1.99) 
  risk.229e.curr.oc43 1 (0.508, 1.79) 
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  risk.nl63.curr.oc43 0.799 (0.387, 
1.41) 
HH.rsv 0.00387 
(0.00291, 
0.00508) 
HH.rsva 0.00544 (0.00379, 
0.00758) 
HH.rsvb 0.00408 (0.00282, 
0.00555) 
HH.corona 0.00636 
(0.00518, 
0.00755) 
HH.229e 0.00795 (0.00577, 
0.0108) 
HH.nl63 0.0117 (0.00939, 
0.0145) 
HH.oc43 0.00547 (0.00428, 
0.00681) 
Comm.rsv 0.000296 
(0.000146, 
0.000798) 
Comm.rsva 0.000186 
(0.000101, 
0.000317) 
Comm.rsvb 0.000217 
(0.00012, 
0.000357) 
Comm.corona 0.000395 
(0.000199, 
0.00119) 
Comm.229e 0.000242 
(0.000132, 
0.000398) 
Comm.nl63 0.000181 
(0.0000996, 
0.000297) 
Comm.oc43 0.000297 
(0.000167, 
0.000485) 
Delta 1.55 (0.567, 
3.94) 
Delta 1.55 () 
Beta 0.338 
(0.148, 
2.19) 
Beta 0.294 (0.148, 
0.557) 
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mu.rsv 3.05 (2.19, 
3.7) 
  
sigma.rsv 0.683 
(0.323, 
1.21) 
  
mu.corona 2.95 (2.4, 
3.62) 
  
sigma.corona 0.712 
(0.518, 
0.938) 
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Figure A4. 2: Distribution of shedding episodes for coronavirus 229E and RSV A by 
household and time.  
The x-axis shows the time in days while the y-axis shows the individuals, where each 
notch is a single individual. The horizontal lines demarcate the different households.   
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Figure A4. 3: Distribution of shedding episodes for coronavirus OC43 and RSV B by 
household and time.  
The x-axis shows the time in days while the y-axis shows the individuals, where each 
notch is a single individual. The horizontal lines demarcate the different households. 
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Figure A4. 4: Distribution of shedding episodes for RSV A and RSV B by household 
and time. 
The x-axis shows the time in days while the y-axis shows the individuals, where each 
notch is a single individual. The horizontal lines demarcate the different households. 
 
●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●●
●●●●
●●●●●●●●●
●●●●●● ●●●●
●●●●●●●●
●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●
●●●●●
●●●●●●●●
●●●●●●●●●●●
●●●●●●●
●●●●●●●
●●●●
●●●●
●●●●●●●
●●●● ●●●●●●●●●●●●●●●
●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●● ●●●●●●●●●●●●●●
●●●●●●
●●●●●●●
●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●●
●●●●●●●
●●●●
●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●
●●●●
●●●●●●●●●●●●●●●
●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●
●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●●●
●●●●●●●●●●●●●● ●●●●●●●●
●●●●●●●
●●●●●●●
●●●●●●●●●
●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●
●●
●●●●●●●●●●●
●●●●
●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●
●●● ●●●●
●●●●
●●●●●●●●●●●●●●●●●●●
●●●●●●●●
●●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●
●●●● ●●●●●● ●●●●●●●
●●●●●●●●●●●
●●●●●●●● ●●●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●
●●●●
●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●
●●●●
●●●●●●●●●●●●●●
●●●●●●
●●●●●●●●●● ●●●●●●●
●●●●●●● ●●●●●●●
●●●●●●●●●●●●● ●●●●●●●
●●●●●●●●●● ●●●●
●●●●●● ●●●●●●●
●●●●●●●●●●●●●●
●●●●●●
●●●●● ●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●
●●●●●●●●●●●
●●●●●●●
●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●
●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●
●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●● ●●●●
●●●●●● ●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●●
●●●●
●●●●●●● ●●●●●●●
●●●●●●●●●●●
●●●●●●● ●●●●●●●
●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●● ●●●●●●●●●●●
●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●● ●●● ●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●
●●●● ●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●● ●●●●●●●
●●●●●●●
●●●●●●●●●●●
●●●●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●
●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●
●●●●
●●●●
●●●●
●●●●
●●●●●●●
●●●●●●
●●●●●●●
●●●●●●●●●●
●●●●●●●●●
●●●●●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●
●●●●●●●●●●●●●●●●●●
●●●●
●●●●●●●
●●●●●●●
●●●●●●● ●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●●
106
301
304
306
309
310
313
315
502
503
504
505
506
507
508
509
511
512
513
514
515
517
518
521
523
524
525
528
529
531
534
535
536
601
603
606
1106
1201
1202
1203
1204
1205
1206
1207
1401
1402
1403
1404
1405
1406
1601
1602
1610
1701
1702
1705
1802
1803
1901
1902
1903
1904
1907
1908
1910
1911
1912
1913
2004
2005
2101
2204
2206
2209
2501
2502
2503
2504
2601
2602
2603
2604
2605
2703
2803
2804
2805
2901
2902
2903
2904
2905
2906
3101
3103
3105
3303
3401
3404
3501
3502
3503
3505
3508
3603
3801
3802
3803
3804
3805
3806
3807
3808
3809
3810
3813
3814
3816
3821
4001
4002
4003
4004
4101
4102
4104
4107
4108
4201
4202
4204
4401
4402
4404
4405
4406
4407
4423
4424
4501
4502
4504
4506
4508
4605
4606
4701
4702
4703
4808
4809
4901
4902
4903
4905
4906
4912
5101
5103
5104
5105
5106
5107
5109
5113
5301
5305
5306
5501
5605
5701
5702
5703
5704
5707
5710
5801
5803
5804
50 100 150
Days
Pe
rs
on
RSV groups
●
●
●
co−inf
rsva
rsvb
 265 
 
●● ●●●●
●●
●●●● ●●●●●●●●●●
●●●●●●●●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●
●●●●●●●●●●●● ●●●●
●●●●●●●●●●●
●●●●●●●
●●●●●●●●●
●●●●●●●●●●● ●●●●
●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●
●●●● ●●●●●●●●
●●●● ●●●●●●●●●●● ●●●
●●●●●●●●●●●●●● ●●●●●●●●●●●●●
●●●●●●●
●●●● ●●●●●●●●●●●●●●●●●●●●●●● ●●●●
●●●● ●●●●
●●●● ●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●● ●●●●●●●●●●
●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●
●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●●●
●●●●●●●● ●●●●●●●●
●●●●●●●●●●●● ●●●●●●●●●●●
●●● ●●●● ●●●
●●●●●●●●●●●●●●● ●●●●●●●●
●●●●●●●●●●●●●● ●●●
●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●● ●●●●
●●●● ●●●●●●●●●●●●●
●●●●●●●●●●●●●●● ●●●●●●●●●●● ●●●●●●●●●●●
●●●
●●●●●●●●●●●●
●●●●●●●●
●●●● ●●●● ●●●●●●
●●●●●●●●
●●●●●●●●●●●●●● ●●●●●●●
●●●● ●●●●●●●●
●●●●
●●●●●●●●
●●●●●●●● ●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●
●●●●
●●●
●●●●
●●●●
●●●●
●●●●●●●
●●●
●●●● ●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●●
●●●
●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●● ●●●●●●●●●● ●●●●●●●●●●●
●● ●●●●●●●●●●●●●●
●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●●
●●●● ●●●●●●● ●●●●●●●
●●●●●●●●●●●●●● ●●●●
●●● ●●●●
●●●●
●●●●
●●●●● ●●●●●●
●●●● ●●●●
●●●● ●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●●●●●●●●●
●●●
●●●●●●●●●●●●●●●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●●●
●●●●●●● ●●●●
●●●●●●●●●●● ●●●●●●●●●●●●●●●●●
●●●● ●●●● ●●●●●●●●●
●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●
●●●● ●●●● ●●●●●●●●●●●●●●
●●●● ●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●●●●
●● ●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●● ●●●●●●●●●●●●●● ●●●●
●●●●●●●●●●●●●●●●●
●●●●●● ●●●●●●●●●●●●●●●●●●●●● ●●●●
●●● ●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●● ●●●●●●● ●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●
●●●●
●●●●
●●●●●●●●●●●●●●●●●
●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●● ●●●●●●●●●●●●●●●●●●●●● ●●●●
●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●●
●●●●
●●●●●●●●
●●●● ●●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●
●●●●●●● ●●●●●●●●●●●●●●●●●● ●●●●●●●
●●●● ●●●●●●●●●●● ●●●●●●●
●●●●●●●●●●●●●● ●●● ●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●
●●●●●●●
●●●●●●●●●●●●●●●●●● ●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●● ●●●●
●●●●●●●●●●●●●●
●●●●●
●●●●●●●●●●●●●●
●●●●● ●●●●
●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●
●●●●
●●●●●●●●●●●●
●●● ●●●
●●●●●●●●●●●●●●●●●●●●●
●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●● ●●●● ●●●
●●●●●●●●●●● ●●●●●●●●●●● ●●●●●●●●●●●●●●● ●●●●●●●●●●●●●●
●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●● ●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●● ●●●● ●●● ●●●● ●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●
●●●●●●●●●●●●●●●●●● ●●● ●●●
●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●●●● ●●●●
●●●●●
●●●●●●●●●●
●●●●●● ●●●● ●●●●
●●●●
●●●●●●●●● ●●●●
●●●● ●●●●●●●●●●●
●●●●●●●
●●●●
●●●●●●●●●●● ●●●●
●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●●●● ●●●●
●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●● ●●●●
●●●●
●●●● ●●●●●●● ●●●●●●●●●●●
●●●●●●●●●●
●●●●●
●●●●●●●●●●●●●
●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●● ●●●●
●●●●●●● ●●●●●●●●●●●●●●●
●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●
●●●● ●●●●●●●●●
●●●● ●●●●●●●●●●●●●●●
●●●● ●●●● ●●● ●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●● ●●● ●●●● ●●●●
●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●
●●●●●
●●●● ●●●●●●●
●●●●●●●●●●●
●●●
●●●●● ●●●● ●●●●●●●
●●●●
●●●●● ●●●●●●●●●●●●●●
●●●● ●●●● ●●●●●●●
●●●●●● ●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●●●●●●●●●
●●●●
●●●●
●●●●
●●●● ●●●
●●●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●
●●●●● ●●●●
●●●●●●●●●●●●●●●●●
●●●● ●●●●
●●●●
●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●
●●●
●●●●●●●●●●●●●●● ●●●●●●●
●●●
●●●●●●●●●●●
●●●●●●●●●●● ●●●●
●●●●
●●●
●●●●
●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●● ●●●●●●●
●●●●●●● ●●●●●●●●●●●
●●●●●● ●●●●●●●●●● ●●●●●●●●●●●●●●●●●●
●●● ●●●● ●●●●
●●●●
●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●● ●●●●
●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●● ●●●● ●●●● ●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●
●●●●●●● ●●●●●●●●●●●●●●
●●●●●●● ●●●●
●●●●●●● ●●●●
●●●●●●●●●●●●●●●●●●●●●●●●● ●●●●
●●●●●● ●●●●
●●●●
●●●● ●●●●
●●●●●●●●●●●
●●●●●●●●●●●
●●●● ●●●●●●●
●●●●●●●
●●●●●●●● ●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●
●●●●●●●
●●●●
●●●●●●●●●●●
●●●●
●●●● ●●●● ●●●●●●●●●●●●●
●●●●●●●
●●● ●●●
●●●
●●●●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●●●●●●●●●●●
●●●●●●●
●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●● ●●●●●●●
●●●●●●●●●●●
●●●●
●●●●●●●●●●● ●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●
●●●●●●●
●●●●
●●●●●●●●●● ●●●●●●●
●●●●●● ●●●● ●●●●●●●
●●●● ●●●●
●●●●●●●
●●●
●●●●●● ●●●●
●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●● ●●●●●●●●●●●●●●●●●●●●● ●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●●●●●
●●●● ●●●●
●●●●●●● ●●●●
●●●●●●● ●●●●
●●●● ●●●● ●●●●
●●●● ●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●
●●●●●●
●●●●●●●●●●●●●
●●●●●●●●●●●●
●●●●●●●
●●●●
●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●
●●●●●● ●●●● ●●●●●●●
●●●●●●●●
●●●●
●●●●
●●●●●●●●●●
●●●●●●● ●●●●●●●●●●●●●●●●●
●●● ●●●● ●●●●●●●●●●●●●●●●
●●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●●●● ●●●● ●●●●
●●●● ●●●●● ●●●● ●●●
●●●●● ●●● ●●●●●●
●●● ●●●● ●●●●●●●●
●●●● ●●●●
●●●●●●● ●●● ●●●●
●●●●● ●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●● ●●●●●●●●●● ●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●●
●●●●
●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●● ●●●● ●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●●●● ●●● ●●●●
●●●●
●●●●●●●
●●●●●●●●●● ●●●
●●●●●●● ●●●●●●●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●● ●●●
●●●● ●●● ●●●
●●●●●
●●● ●●●●
●●●● ●●●●●●●●●●●●●●●●
●●●●
●●●●●●●●
●●●●●●●●●●●● ●●●●● ●●●●●
●●● ●●●● ●●●●●●
●●●
●●●●●●●●●●●
●●●●●●●●●●●●●●●●●●●●●●●●
●●●●●●●
●●●●●●●
●●●●●●●
●●●●●●●
●●●●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●
●●●●●●●●●●●●●
102103
106107
108301
302303
305306
307308
310315
316502
503504
505506
507508
509510
511512
513514
515516
517518
519521
522523
524525
526529
531532
534535
536601
602603
6051001
10041007
10081101
11041105
11061108
12011202
12031204
12051206
12071208
12091210
12121215
12161220
14011402
14031404
14051601
16021603
16041605
16061607
16081609
16101611
16121701
17021705
18011802
18031804
18051806
18071901
19051908
19102001
20022003
20042005
20062007
20082101
21022103
21042105
21062108
22042205
22062207
22092211
22142301
23022303
23052501
25022503
25042601
26022603
26042605
27012702
27032704
27052801
28032804
28052806
29033001
30023003
30063007
30083101
31023103
31043105
31063108
31103303
33043306
34013402
34033404
34053406
34073501
35023503
35043505
35063508
36033607
36093612
38013802
38043805
38073808
38103811
38123813
38143815
38173818
38193820
38213822
39044001
40024003
40044005
41024103
41044105
41064107
41084201
42024203
42044206
43014305
44014402
44044405
44064407
44084409
44104412
44134414
44164417
44184419
44204421
44224423
44244425
44264502
45044508
45094601
46024603
46054606
47014702
47034704
47054802
48034804
48054807
48084810
48114812
48134815
48174901
49024903
49054906
49084909
49104912
51015102
51035105
51065107
51085109
51145301
53025303
53045305
53095310
54015402
54035404
54055406
54075501
55025503
55045507
55085510
55115601
56025603
56045605
56065607
56085610
56115701
57025703
57045705
57065707
57085709
57105711
57125713
57145715
57165801
58025803
58046002
60036004
60066007
0 50 100 150
Days
Pe
rs
on
Corona groups
●
●
●
●
●
●
●
229E
229E−NL63
229E−NL63−OC43
229E−OC43
NL63
NL63−OC43
OC43
 266 
Figure A4. 5: Distribution of shedding episodes for coronavirus 229E, NL63 and OC43 
by household and time.  
The x-axis shows the time in days while the y-axis shows the individuals, where each 
notch is a single individual. The horizontal lines demarcate the different households. 
 
 
A4.2. Results of the MCMC algorithm 
In Chapter 4, there were 4 different model fits; a fit of the multi-pathogen model to 
data with pathogen identification at the group level, a fit of the multi-pathogen model 
to data with pathogen identification at the pathogen level, a fit of the single-pathogen 
model to RSV data with pathogen identification at the group level, a fit of the single-
pathogen model to hCoV data with pathogen identification at the group level. The 
following sections show the parameter trace plots, GRB statistic values and ESS values 
for each of the 4 fits. 
A4.2.1. Multi-pathogen model fit to data with pathogen identification at the 
group level 
 
The following are trace plots of the 37 parameters in the multi-pathogen model with 
pathogen identification at the group level. 
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Figure A4. 6: The evolution of the Gelman-Rubin-Brooks (GRB) statistic (shrink factor) 
as the number of iterations increases. 
Each grey line represents a model parameter in the multi-pathogen model with 
pathogen identification at the group level and the dashed red line shows the value 1.  
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The burn-in point was chosen as 225,000 for chain 1, 125,000 for chain 2 and 150,000 
for chain 3.  
 
Table A.4 1: The values of the GRB statistic (to 3 significant figures) and the effective 
sample size are shown for all the parameters in the multi pathogen model with 
pathogen identification at the group level. 
Parameter Point estimate 
 GRB statistic 
ESS 
risk.rsva.prev.rsva 1.25 616 
risk.rsva.prev.rsvb 1.08 865 
risk.rsva.prev.229e 2.73 736 
risk.rsva.prev.nl63 1.1 929 
risk.rsva.prev.oc43 1.13 877 
risk.rsvb.prev.rsvb 1.26 823 
risk.rsvb.prev.229e 1.1 758 
risk.rsvb.prev.nl63 1.1 894 
risk.rsvb.prev.oc43 1.34 1010 
risk.229e.prev.229e 2.51 717 
risk.229e.prev.nl63 1.1 787 
risk.229e.prev.oc43 1.83 848 
risk.nl63.prev.nl63 3.63 864 
risk.nl63.prev.oc43 1.09 921 
risk.oc43.prev.oc43 4.76 828 
risk.rsva.curr.rsvb 2.41 886 
risk.rsva.curr.229e 1.11 601 
risk.rsva.curr.nl63 2.23 545 
risk.rsva.curr.oc43 1.43 776 
risk.rsvb.curr.229e 1.13 521 
risk.rsvb.curr.nl63 1.11 375 
risk.rsvb.curr.oc43 1.33 580 
risk.229e.curr.nl63 1.36 600 
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risk.229e.curr.oc43 1.18 631 
risk.nl63.curr.oc43 1.28 635 
eta.rsva 1.1 1060 
eta.rsvb 1.01 1250 
eta.229e 1.12 1290 
eta.nl63 1.43 1190 
eta.oc43 1.16 1070 
epsilon.rsva 1.03 1060 
epsilon.rsvb 1.01 1180 
epsilon.229e 1.03 935 
epsilon.nl63 1.01 1090 
epsilon.oc43 1.01 1110 
delta 1 1900 
beta 1.01 1090 
The mGRB is 7.43 and the mESS is 1099. 
 
 
 
Visually the chains look like they do converge, but the values of the GRB and ESS 
suggest that longer runs are needed.  
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A4.2.2. Multi-pathogen model fit to data with pathogen identification at the 
pathogen level 
 
Figure A4. 7: Trace plots of parameters in the multi-pathogen model with pathogen 
identification at the pathogen level.  
Two chains were initiated at different parameter values and these are shown in black 
(Chain 1) and pink (Chain 2). The x-axis shows the iteration number, while the y-axis 
shows the log parameter value.  
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Figure A4. 8: The evolution of the Gelman-Rubin-Brooks (GRB) statistic (shrink factor) 
as the number of iterations increases. 
Each grey line represents a model parameter in the multi-pathogen model with 
pathogen identification at the pathogen level and the dashed red line shows the value 
1.  
 
Burn-in point was chosen as 75000.   
 
Table A.4 2: The values of the GRB statistic (to 3 significant figures) and the effective 
sample size are shown for all the parameters in the multi pathogen model with 
pathogen identification at the pathogen level. 
 
Parameter Point estimate 
 GRB statistic 
ESS 
risk.rsv.prev.rsv 1.07 1840 
risk.rsv.prev.corona 1.05 2940 
risk.corona.prev.corona 1.29 1560 
risk.rsv.curr.corona 1.23 1160 
eta.rsv 1.02 2160 
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eta.corona 1.04 1770 
epsilon.rsv 1.04 1250 
epsilon.corona 1.04 1110 
delta   1.01 2050 
beta 1.04 981 
mu.rsv   1.13 1220 
sigma.rsv   1.14 1570 
mu.corona 1.16 1130 
Sigma.corona 1.13 1460 
The mGRB is 1.23 and the mESS is 1893. 
 
 
A4.2.3. Single-pathogen model fit to RSV data with pathogen identification at 
the group level 
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Figure A4. 9: Trace plots of parameters in the single-pathogen model for RSV with 
pathogen identification at the group level.  
Two chains were initiated at different parameter values and these are shown in black 
(Chain 1) and blue (Chain 2). The x-axis shows the iteration number, while the y-axis 
shows the log parameter value.  
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Figure A4. 10: The evolution of the Gelman-Rubin-Brooks (GRB) statistic (shrink 
factor) as the number of iterations increases. 
Each grey line represents a model parameter in the single-pathogen model for RSV 
with pathogen identification at the group level and the dashed red line shows the 
value 1.  
 
Burn-in was set at 40,000 for each chain. 
 
Table A.4. 3: The values of the GRB statistic (to 3 significant figures) and the effective 
sample size are shown for all the parameters in the single pathogen RSV group 
model. 
Parameter Point estimate 
 GRB statistic 
ESS 
risk.rsva.prev.rsva 1.05 3970 
risk.rsva.prev.rsvb 1.06 4290 
risk.rsvb.prev.rsvb 1.05 3920 
risk.rsva.curr.rsvb 1.04 4250 
eta.rsva 1.03 4820 
eta.rsvb 1.01 5180 
epsilon.rsva 1.00 4990 
epsilon.rsvb 1.00 4580 
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delta   1.00 7580 
beta 1.01 4180 
mu.rsv   1.02 3720 
sigma.rsv   1.07 3770 
The mGRB is 1.08 and the mESS is 5239. 
 
 
A4.2.4. Single-pathogen model fit to hCoV data with pathogen identification at 
the group level 
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Figure A4. 11: Trace plots of parameters in the single-pathogen model for hCoV with 
pathogen identification at the group level.  
Two chains were initiated at different parameter values and these are shown in black 
(Chain 1) and pink (Chain 2). The x-axis shows the iteration number, while the y-axis 
shows the log parameter value.  
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Figure A4. 12: The evolution of the Gelman-Rubin-Brooks (GRB) statistic (shrink 
factor) as the number of iterations increases. 
Each grey line represents a model parameter in the single-pathogen model for hCoV 
with pathogen identification at the group level and the dashed red line shows the 
value 1. 
 
Chose a burn-off of 100,000 for each chain.  
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Table A.4. 4: The values of the GRB statistic (to 3 significant figures) and the effective 
sample size are shown for all the parameters in the single pathogen hCoV strain 
model. 
 
Parameter Point estimate 
 GRB statistic 
ESS 
risk.229e.prev.229e 1.05 2660 
risk.229e.prev.nl63 1.06 2730 
risk.229e.prev.oc43 1.07 2640 
risk.nl63.prev.nl63 1.09 2970 
risk.nl63.prev.oc43 1.06 2720 
risk.oc43.prev.oc43 1.08 2500 
risk.229e.curr.nl63 1.04 2000 
risk.229e.curr.oc43 1.06 1950 
risk.nl63.curr.oc43 1.04 2070 
eta.229e 1.00 2920 
eta.nl63 1.04 3120 
eta.oc43 1.02 3190 
epsilon.229e 1.03 1290 
epsilon.nl63 1.03 1360 
epsilon.oc43 1.03 1320 
delta 1.02 1570 
beta 1.04 1160 
mu.corona 1.19 3070 
sigma.corona 1.22 3850 
The mGRB is 1.11 and the mESS is 3097. 
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